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SUWARY
The protein bodies of the endosperm of the seeds of the castor oil 
plant Ricinus cannon is contain a variety of storage proteins, 
along with two lectins, ricin and Ricinus communis agglutinin.
Ricin is a heterodimer consisting of an A chain which is toxic to 
cell-free translation systems, and a B chain which has galactose-binding 
activity; the thole molecule is toxic to cells and animals by 
virtue of the ability of the A chain to enzymatically inactivate 
ribosomes after it crosses the cell membrane, this latter being 
achieved after binding of the molecule to cell surfaces by the 
B chain. The agglutinin consists of two ricin-like species linked 
non-covalently, is divalent, and is not significantly toxic to cells.
Previous work on the synthesis of the lectins indicated diet 
each subunit had its own precursor, each being cotranslationally 
segregated and glycosylated, and assembly of the lectins was thought 
to occur after transport to the protein bodies. However, the 
putative B chain precursor was far larger than the mature B chains, 
and further protein-based evidence Indicated that It contains both 
A and B chain sequences. The former A chain precursor was 
Identified as an albumin which contalmlnated lectin preparations 
used for raising antisera.
The work reported here confirms that the putative B chain 
precursor contains A and B chain sequences, by mesns of d m  cloning 
of cDNA complementary to lectin-specific mRNA. Clones of nearly 
full length have been obtained and sequenced, and the precursor is 
shown to have an N-terminal signal sequence, which is followed by the 
A chain sequence, and then by the B chain sequence. A linker of 
12 amino acids is shown to be present beoaaen the o*o chains.
Sequences corresponding to both lectins are reported, and the 
similarities and differences between them are discussed. The sequences 
are placed into context by comparison with other plant nucleotide 
and protein sequences.
Literature on the castor bean lectins is reviewed, and the 
uses of the clones are discussed, with special reference to their 
possible use in lnmunotoxins for csneer therapy.
CONTENTS
Acknowledgements 
Declaration 
List of figures 
Abbreviations
Chapter 1: Introduction
1A
IB
1C
ID
IE
IF
Erasable 1
Isolation and structure of castor bean lectins 7
Synthesis of the lectins 
Biological functions of the lectins 
1D1 General features 
1D2 Properties of the A chains 
1D3 Properties of the B chains 
IDA Entry of rlcin into cells 
Uses of castor been lectins 
Castor been lectin cENA cloning
Chapter 2t Materials and Methods 
2A Materials 
2B General methods
2B1 Growth and harvesting of castor beans 
2B2 Growth end maintenance of E coll
2B3 Preparation of competent cells 1 transformation
2B4 Extraction and purification of plasmid ENA
2BS Restriction enzymes and mapping
2B6 In vitro protein synthesis snd lmnunoprecipltatlon
2B7 End-labelling of ENA fr^ m n t s
52
52
54
54
54
54
56
57
58
59
612C Gel electrophoresis
2C1 Neutral agarose gels 
2C2 Alkaline agarose gels 
2C3 Formamide agarose gels 
2C4 SDS-Polyacrylamide gels 
2C5 DNA sequencing gels 
2C6 Elution of ENA from gels 
2D Extraction and fractionation of castor bean nRNA 
2E Construction of cENA library In pBR322 
2E1 Synthesis of double-stranded cENA 
2E2 Construction of recombinants 
2F Screening of the cENA library 
2F1 Differential hybridisation 
2F2 Oligomer hybridisation 
2F3 Translation of hybridisation-selected nRNA 
2G Subcloning into pUC8 
2H M13 cloning and dldeaxy sequencing 
2H1 Cloning into M13 
2H2 Dldeaxy sequencing 
21 Msxsm and Gilbert sequencing
211 Preparation of ENA frapoants
212 Modification and cleavage reactions 
2J Primer extension
2J1 Cloning of the primer 
2J2 Primer extension reaction 
2K Nucleic acid transfer and hybridisation 
2K1 Southern blotting 
2K2 Northern blotting
61
61
62
62
62
.3
64
66
66
67
69
69
70 
72
74 i
75
75
76 
78
78
79 
82 
82 
84 
86 
86 
86
Chapter 3t Results and Discussion 87
3A Isolation and charactarlsation of nRNA 87
3B cDNA synthesis 93
3C Construction of clonss 98
3D Screening of ths cENA library 100
3E Characterisation of clonss 108
3F Subcloning into pUC8 115
3G Sequencing: Introduction 119
3G1 Suanary of results 119
3G2 Ml 3 cloning and dldeaxy sequencing 126
3G3 Msxam it Gilbert sequencing 129
co chunk my Supervisor, r>rJH Lo #d, foe «Hotinoel help,
3H The preproricin sequence 135
31 Ths preprosgglutinin sequence 137
3J Analysis of protein sequences 139
3J1 Comparison with protein-determined sequences 139
3J2 Comparison of deduced aaino acid sequences 149
3J3 The signal and litter peptides 158
3K Analysis of nucleotide sequences 165
3K1 Comparison of prepro-lectin sequsnces 165
3K2 Base compoeltion, dinucleotides and codon usags 168
3K3 The 5' non-coding region 173
3K4 The 3' non-coding region 185
3L Primer extension 193
3M Northern blotting 195
Chapter 4i Final Discussion 199
Appendix It 
Appendix 2i 
References
Computer programme 
Restriction data
213
237
243
.1 -
ACKNOWLEDGEMENTS
I wish to thank my Supervisor, Dr JM Lord, for continual help, 
advice and encouragement, and Dr LM Roberts and many others at 
Warwick for Information, suggestions and materials, and to 
Professor H Woodland for performing the oocyte injections.
I am indebted to Celltech Ltd for the provision, free of charge, 
of the oligodeaocynucleotlde with which the cDNA library was screened, 
and especially to Dr T Harris and Dr M  Bodmer, for two weeks spent 
at Celltech learning M13 cloning and dldeaxy sequencing.
My thanks also to the Agriculture and Food Research Council 
for the grant which supported this work.
I am very grateful to my wife Helen for moral support and tolerance, 
and for assistance with the manuscript, and to my mother for 
helping with access to the books and Journals of tha British Library.
- ii
The conclusions reached In this Thssis are my own, and are baaed on 
the experiments reported, on many discussions with my Supervisor,
Dr JM Lord, with Dr LM Roberts, and others, and on published 
works (opp cit).
The experiments were performed In the Department of Biology, 
University of Bradford (first year) and the Department of 
Biological Sciences, Uhlverslty of Warwick. They were carried 
out by myself, though Dr Roberts provided much ssslstance with 
cDNA synthesis; Dr Lord performed the experiments described in 
fig 3A-2, and Professor H  Woodland carried out the oocyte Injections 
end 1 shelling.
Ml

List of figures (continued)
F i g ___Title____________________________________________________ .Pjg£ .
3G-2 Map of plasmid pRQ.17 124
3G-3 Junction region in pRCT.17 125
3G-4 Extant of M13 dona libraries 127
3G-5 Maxam & Gilbert strategy: clone pRCL6 131
3G-6 Maxam Si Gilbert strategy: d o n a  pRCL17 132
3G-7 Maxam Si Gilbert strategy: clone pRCL52 133
3G-8 Maxam Si Gilbert strategy: clone pRCL57 134
3H-1 Preproricin cDNA aequance 136
31-1 Preproagglutinin cDNA sequence 138
3J-1 Amino acid compositions and molecular weights 140
3J-2 Differences between rlcin cDNA and Funatsu sequences 141
3J-3 Plot of 'genuine' differences between two rlclns 143
3J-4 Amino acid sequences of prepro-lectins 150
3J-5 Amino a d d  differences between the lectins 151
3J-6 A chain hydropathy plots 154
3J-7 B chain hydropathy plots 155
3J-8 Hydropathy difference plots 156
3J-9 Signal sequence hydropathy plot 159
3J-10 Plant signal sequence cleavage sites 161
3J-11 Plant precursor protein processing sites 163
3K-1 Prepro-lectln cDNA sequences 166
3K-2 Plant ofiNA base caapoeltlons 169
3K-3 Preproricin dinucleotlde frequencies 170
3K-4 Preproricin codon usage 171
3K-5 Preproricin cDNA S' end: sequencing gel 174
3K-6 Plant a«NA S' non-codirg regions 178
Jfc7- _ £\n£ .riPLUlttUtiW JWUOTWtt_______________ Ul  _
-  V
Liât of figures (continued)
Fi£ _  _  Title__________________________________________________
3K-8 Plant mRNA Initiation environments: selected sequences 
3K-9 Plant nRNA termination environments
3K-10 Bases flanking plant termination codons
3L-1 Primer extension
3M-1 Northern blot of castor bean mRNA 196
3N-1 Oocyte injection products 198
4-1 Homology of conA and favin 203
4-2 B chain halves: Funatsu data 204
4-3 B chain halves: Ricin cDNA data 205
4-4 B chain halves: Ricin hydropathy plots 207
4-5 B chain halves: Agglutinin cDNA data 208
4-6 Putative B chain signal sequence 210
e

Ribonucléase
Sodimi dodecyl sulphate
Standard saline citrate
ne
- 1 -
CHAPTER 1: INTRODUCTION
1A Preamble
The endosperm cells of Che castor bean plane Ricinos communis 
• contain protein bodies in « M c h  a variety of proteins are stored 
prior to germination. These include the nitrogen-rich albunins, 
the 11 S globulins, and two lectins: the toocic ricin, and the 
related agglutinin RCA (Ricinos comnunls agglutinin) (1,2).
The toxic and medical actions of the beans have been known 
since ancient times, and were used in classical Greek and 
Sanskrit medicine (3); the oil Is noted for its purgative effects. 
More recently, attention has focussed on the anti-tumour 
properties of ricin (4), and as recently as 1984 a report was 
published describing clinical trials using ricin in the treatment 
of terminal cancer (3). However, since ricin is a lectin, 
and consequently displays relatively non-specific binding to cell 
surfaces, most cancer work is now directed towards the exploitation 
of conjugates between ricin and antibodies. It is hoped that 
such conjugates will have specificity for tuaour cells, and 
trill represent the ultimate development of Ehrlich's 'magic bullet’ 
concept (6).
Ballnt (7) has collected descriptions of over 700 cases of 
ricin poisoning in man, though by far the most notorious case 
is that of Georgi Markov, a Bulgarian expatriate who vns 
assassinated by the injection from an umbrella of a ricin- 
impregnated metal ball in 1978, near Waterloo Bridge (8).
The possibility of ricin poisoning on a vastly larger scale 
is indicated by the granting of a patent to the US Army for a
method of purifying very large quantities of ricln from castor 
beans (9). All work on rlcin In Bulgaria Is apparently 
classified (10).
Considerations of such possibilities have led to controversy 
regarding more contemporary approaches to the study of ricln and 
other toxic proteins: a letter published in Nature (11) 
advocated the outright banning of cloning of toxin nucleotide 
sequences, though a later correspondent pointed out that large 
supplies of diphtheria toxin are available without cloning (12).
It Is of note that the anti-cloning letter was from an employee 
of the Cetus Immune Corporation of California - eight months 
later, Cetus published the sequence of cloned diphtheria 
toxin (13). This latter sequence has been expressed In E coll 
(14,15,16), and a number of other toxin DNA sequences have also been 
cloned. Examples are bee venom melittln (17), cholera toxin (18,19), 
E coll heat-labile enterotoocln (20,21) and Pseudomonas 
exotoxin (22). Cetus hold a patent on the E coll toxin, and 
claim expression (23).
The extreme toxicity of ricin Is Indicated by its LDj q values: 
one estimate gave 12 pg per kg in mice, while more recent 
determinations give 2.7 pg per kg In mice and 1.75 pg per kg 
in dogs (see ref 5). Fodstad et al (5) believe that the maxlnun 
does tolerable by man is some 23 pg per aq m, given Intravenously. 
Doses of 1 ng/ml of ricln are adequate to Inhibit the activity 
of cell-free protein synthesising eye tame, and it is believed 
diet a single molecule can kill a cell (24).
The castor bean plant is a native of tropical Africa, but 
has been introduced and naturalised in many other climates.
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European varieties tend to grow as small bushes - often a bare stem 
carries just a few leaves at the top - and flower only with 
difficulty. Tropical specimens can grow rapidly to a height of 
30 - AO feet (23): It Is sometimes named the 'miracle tree', 
one of which was used by God to teach Jonah the virtue of 
mercy (26). Etymologically, the name Rlcinua probably derives 
' from the Hebrew kikar, which means 'round', via the Greek 
kikinos (3).
A brief history of scientific work on rlcin follows, and 
is condensed from Balint's thorough review (7).
The proteinaceous nature of the toxic component of castor 
beans was noted in 1878 by Ritthausen, and confirmed In 1887 
by Dixon. In that year, Stlllmark named this component rlcin.
The first detailed description of human rlcin poisoning was 
published in 1899 by Muller. The resistance of rlcin to 
proteolytic enzymes was noted around the turn of the century, and 
was long t-hr.ight- to be related to the protease activity attributed 
to It - as late as 1973, Funatsu's group described experiments 
demonstrating this function (27). Klein Is no longer believed 
to have proteolytic activity (eg ref 28).
These early experiments were performed using crude extrects 
of castor beans; better preparations were obtained in 1903 
by Osborne. In 1913 Robert improved the methodology by die 
introduction of amaonlua sulphate precipitation, and in 1923 
Karrer Introduced inorganic adsorbents. Affinity chromatography 
on aephaross, exploiting the galactose specificity of rlcin, 
was first used In 1963, by Dirhelmar. This is now die most 
widely used method of preparation.
4The toxicity of rlcin was for many years attributed to 
a haamagglutlnatlng activity, but with the advent of more 
discriminating fractionation techniques, the toxic and 
agglutinating activities were assigned to two different proteins, 
referred co as rlcln and Ricinus ccnmunia agglutinin respectively. 
- At the same time, die existence of multiple forms of the lectins 
became apparent - for example, Schone, in 1958, obtained five 
bands on paper electrophoratograms. Most contemporary workers 
report two riclns and two agglutinins (eg refs 29,30), though 
occasionally more are reported (31). It was shown in the early 
1970s that both the toxin and the agglutinin are composed of 
two dissimilar types of subunit - the agglutinin being essentially 
a dimer of ricln. Although the A chains and the B chains of 
the two proteins cross-react immunologically (though A chains 
and B sera do not react, and vice versa), they must clearly be 
different, in order to account far the differences in structure, 
toxicity and sugar specificity. The toxic and sugar-binding 
activities of the proteins have been assigned to different 
subunits, the A  chains being toxic, while the B chains have 
lectin activity. Although the agglutinin A  chain is toxic to 
cell-free systems, its activity is only a fraction of that of 
the ricln A chain, and the whole protein is virtually non-toxic 
to animals. It is likely that this is due to haamagglutlnation 
brought about only by the agglutinin, and a failure of its A chain 
to penetrate oell membranes.
The sequences of both chains of rlcin have been determined, 
by Funatsu's group in the late 1970s (32 - 36), though only 
partial sequences are available for the agglutinin (31).
N-terminal sequences of the subunits of both proteins show
almost complete identity.
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The toxicity of ricin was for many years attributed to 
a haemagglutinatlng activity, but with the advent of more 
discriminating fractionation techniques, the toxic and 
agglutinating activities were assigned to two different proteins, 
referred Co as ricin and Rlcinua conmunla agglutinin respectively. 
- At the same time, die existence of multiple forms of ths lectins 
became apparent - for example, Schone, in 1958, obtained five 
bands on paper electrophoretograms. Most contemporary workers 
report two ricins and two agglutinins (eg refs 29,30), though 
occasionally more are reported (31). It was shown in d m  early 
1970s that both the toxin and d m  agglutinin are composed of 
two dissimilar types of subunit - the agglutinin being essentially 
a dimer of ricin. Although the A chains and the B chains of 
the two proteins cross-reset Immunological 1 y (though A chains 
and B sera do not react, and vice versa), they must clearly be 
different, in order to account for the differences in structure, 
toxicity and sugar specificity. The toxic and sugar-binding 
activities of the proteins have been assigned to different 
subunits, d m  A  chains being toxic, while the B chains have 
lectin activity. Although d m  agglutinin A  chain is toxic to 
cell-free systams, its activity is only a fraction of that of 
the ricin A chain, and the whole protein is virtually non-toxic 
to animals. It is likely that this is due to haamagglutination 
brought about only by the agglutinin, and a failure of its A chain 
to panetrate cell mambranss.
Ths ssqusnces of both chains of ricin have been determined, 
by Funatsu's group in the late 1970s (32 - 36), though only 
partial sequences are available for d m  agglutinin (31).
N-terminal sequences of the subunits of both proteins show
almost complete Identity.
It Is striking that' the castor bean lectins are related to 
a variety of other plant proteins, in terns of the structural 
distribution of the toxic and sugar-binding activities, and the 
mechanism of toxicity. For example the jequirity bean (Abrus 
precatoriua) contains a toxin, abrin, with the same sugar 
specificity and toxicity as ricin, along with an agglutinin 
which is related to abrin in the same way as the castor bean 
agglutinin is related to ricin (3). A number of other examples
are known, and several plants contain proteins which resemble 
the A chains of abrin and rlcin, but lack sugar-binding properties 
(and B chains). For a recent review of plant toxin proteins, 
see reference (37), in which all such proteins known up to 1982 
are listed. More such proteins are regularly discovered, for
example volkensin, found in June 1984 (38).
It is curious that all the highly toxic two-chain lectins 
have galactose as their sugar specificity - including ricin, abrin, 
modeccin, viscumin and volkensin. This may imply that only
cell surface glycoproteins and glycoliplds bearing terminal 
galactose residues are able to transport such molecules into the 
interior of the cell.
A number of bacteria also contain toxic proteins which separate 
their call-binding and enzymatic activities onto different 
polypeptide chains - these include diphtheria toxin (39), E coll 
heat-labile enterotaxin (20), Pseudomonas exotoxin A (40), pertussis 
toxin (41), cholera toxin (42) and tetanus toxin (43). Of these, 
diphtheria toxin and exo toxin A interfere with protein synthesis; all 
catalyse ADP-ribosylatlon of cell components.
The synthesis and intracellular assembly of the castor bean 
lectins haws not been widely studied. Roberts fc Lord (44)
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proposed Chet the A and B chains have separate precursors» on the 
basis of detecting two precursors with anti-agglutinin sera. 
However» Butterworth & Lord (45) compared the Immunological 
properties and enzymatic cleavage products of both precursors 
with the mature lectin subunits» and found that both chains are 
contained within a single precursor. The other, smaller» precursor 
was Identified as a pre-albumin. This is believed to copurify 
with the lectins (in camnarclal preparations as well as those 
carried out In die laboratory) - and since it is an extremely 
allergenic protein, antisera raised against the agglutinin 
contain high anti-albumin titres.
A fairly large number of plant proteins appear to be 
synthesised by comparable mechanisms» Including a variety of 
lectins and storage proteins. Examples are also known in animals, 
such as insulin, and more are emerging.
Interest in ricin continues to flourish, not only because 
of its awn complex and perplexing nature, but also because of 
its great potential for lmamotaxins. This report describes die 
application of recombinant ENA methods to the castor bean lectlnet 
cENA clones fbr both are described, along with their nucleotide
sequences, and the future uses of these clones will be discussed.
Note that a isobar of reviews of the extensive literature 
on ricin are available. Including reference 46 (1982), other 
articles in die same volume, reference 7 (1974), reference 3 (1976). 
and reference 47 (1984), and reference 48 (1979).
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IB Isolation and Structure of the Lectins
The lectins are generally isolated and purified by adsorption 
chromatography on columns containing materials such as CM-cellulose 
followed by affinity chromatography on sepharose. The properties 
of the proteins In the various fractions may be assayed by 
hemagglutination, toxicity and gel electrophoresis (30,31,45,49). 
Multiple forms of the lectins are usually reported, the properties 
and number of vrtiich appear to depend on the variety of beans 
In use. Although at least 21 varieties of the castor oil plant 
are recognised (7), very few workers specify which they use.
At best, the beans are described as 'small', grown in Texas or 
Japan, or as 'large', grown In Thailand (50). The beans used In 
this laboratory are probably a heterogeneous mixture, and they vary 
in size and patterning.
Funatsu's group reports one toxin (ricin D) from large 
beans (51) and two (ricins D and E) from small Japanese beans (52); 
Lin & Li (30) report two toxins and two agglutinins from small 
beans, and Olsnes et al (49) also find two forms of each lectin, 
though they do not specify bean size. Cawley et al (28,31) find 
three ricins and two agglutinins, again from undescribed beans.
Toxins and agglutinins may be distinguished by elution from 
CM-cellulose at different salt concentrations (49) or by successive 
elution from sepharose columns with N-acetylgalactosanlne and 
galactose respectively (31,45). The molecular weights of the two 
lectins, as determined by sedimentation analysis, gel filtration 
and gel electrophoresis, generally fall within the ranges 
54 - 65 kOel for ricins, and 110 - 140 kDal for agglutinins 
(30,31,45,49,53,54), though Nicolson points out (29) that 
estimates depend on the conditions used In the
. _________
The molecular weight of rlcln, calculated from the complete 
sequence data, la 62,057 Dal, Including carbohydrate (33,35).
There la reaaon to believe that this estimate la in error, since 
evidence to be presented Indicates that the sugars are more 
complex than Funatsu supposed, and the sequences to be reported 
here imply that those of Funatsu may contain errors.
Funatsu investigated the similarities and differences between 
ricins D and E (52): in terms of molecular weight, N-terminal 
amino acids, toxicity and agglutinating activity, the two proteins 
were very similar, though they had different Isoelectric points, 
amino acid compositions, affinities for sepharose, and taxlcities 
for certain malignant cells.
It la likely that the castor bean lectins represent a family 
of related proteins, differing within and between varieties. 
Differences between the primary sequences, while probably small, 
must nonetheless account for the quite gross differences in 
quaternary structure of toxins and agglutinins. The existence 
of gene families in plants la well documented! for example 
there are believed to be over 100 genes for rain in Zea mays (55).
Bolling of the lectlns in the presence of SD6 reduces the size 
of the agglutinin to about that of rlcln, while rlcln Itself 
la unchanged (28). Along with the evidence of the similarity of 
the subunits between the two, this supports the idea that the 
agglutinin contains two rlcln-like heterodimers linked non-covalently 
While the mechanisms which hold the two dimers together are unclear, 
It has been suggested that proton donation or sulphydryl -catalysed 
disulphide exchange are possible mechenisms (28).
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Reduction of the agglutinin prior to dissociation with SOS produces 
bands which correspond to dimers of two A chains, and of two B chains: 
the non-covalent forces holding the ricin-like heterodimers 
together may thus act both on the A chain half of the molecule, 
and on the B chain half (56). This is presented in schematic form:
AjBj RSËüStinn ^  + ^  SOS..,. ^  + ^
Although studies on viscumin indicate that tetrameric forms 
comparable to Ricinus communis agglutinin form by aggregation 
of dimers at high concentration (57), such concentration-dependent 
agglutination of ricin is not observed to an extent sufficient 
to explain the structure of RCA (58).
SffiSÊ From Ref (45)
Ricin A chain 29.5 - 33.0 32.0 (34.0)
Ricin B chain 32.0 - 34.7 34.7
RCA A' chain 27.5 - 33.0 32.0 (34.0)
RCA B' chain 33.0 - 37.0 36.0
Figures in brackets correspond to ricir^ and RCA^ the less 
abundant variants found in reference (45).
It is often observed that ricin and RCA share an A chain 
of similar length, while the B chains differ (29-31,45,52), though 
other workers have found the opposite (49,54). However, 
isoelectric points determined for the subunits of the two proteins 
found differences for both chains (31). When the B chains are of 
different lengths, the ricin chain is generally 1300 - 3000 Dal 
smaller than that of RCA. The significance of these 
differences may sometimes lie in the systems used for measurement
(see reference 29), or may reflect heterogeneity between seeds.
One group (31) suggested that the agglutinin B chain may have 
an extra 30 or so residues at the C-tarminus (the N-terminus 
amino acids were Identical), and deglycosylation of B chains with 
EndoH (45) indicated that the agglutinin B chain remained larger 
titan the ricin B chain. However, the significance of this is 
unclear, since in vivo synthesis of the lectins in tits presence of 
tunicamycin, which blocks N-glycoaylation, produces only two bands. 
One of these corresponds to A chains, while the other corresponds 
to B chains, implying that they may be of very similar size 
(JM Lord, personal casmunicatlon). The structural model 
currently accepted for the two proteins using size data from 
reference (45), for the major variants, is shown in fig IB-1.
Ricin
gosaccharide
A Chain 32,000
B Chain 34,700
qgglutinin
Hj. A' Chain 32,000 
B' Chain 36,000
Structuras of ricin and RCA.
Hg. valuas ara dsrived fron glycoaylatad chaîna.
Fig lB-ls
The two c*stor been lectins ere related inmunologically - that 
Is, the two A chains cross-reect, as do the two B chains (3), 
though sera specific to each protein have been made (59).
The A' chain apparently lacks antigenic determinants present 
on the ricln A chain (54). The chains are also related by peptide 
mapping (29,54) and by amino acid composition (29,30,54,59-61).
For both pairs of chains, comparison of N-terminal sequences 
reveals great similarity: the first 9 amino acids of the 
A chains, and die first 19 of the B chains are Identical (31).
Although Gurtlsr & Horstmann (54) report similarities 
between the A and B chains of ricln, and Olsnes at al (61) 
claim relationships based on amino acid compositions, the 
A and B chains do not cross-reset Immunologically (3).
(Calculation of SOQ values from the amino acid compositions 
of the ricln A and B chains, using data derived from the published 
sequences, yields a value of 585. This large result does 
not Imply a does relationship between the two (62).)
Olsnes suggests that the chains may be folded differently 
in the n o  proteins (63).
Both chains of both proteins are glycosylated (30,54), and 
all bind conA (30). Abrin la only glycosylated on the B cheln (46). 
Funatau's group has shown that the ricln A chain contains one 
carbohydrate group, attached to residue lusher 10 (asparagine), 
while the B chain carries two carbohydrate groups, attached 
to aaparaglne residues 93 and 133 ( 33,35). The sequences around 
these sites are characteristic of N-glycoeyl ation sites in proteins 
(64,65). The compositions of the carbohydrate moieties have 
bean determined (35,61), and are consistent with the classical 
structures of N-linked oligosaccharides (65). More recant
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work (JM Lord, personal communication) Indicates that both 
lectins contain fucose: both A chains and die B chain of the 
agglutinin can be labelled In vivo with trltiated fucose, 
though the sugar is not incorporated into the ricin B chain.
Although the detailed structures of the castor bean lectin 
oligosaccharides have not been elucidated, other examples of 
fucoaylation indicate that this sugar is likely to be attached to 
the proximal N-acetylglucosamine unit of the classical 
N-linked oligosaccharide (65-67). The ricin B chain may 
contain xylose (B Faxwell, personal communication), as has 
been reported for Phaaeolua vulgaris phytohaamagglutlnin (68), 
and lima bean'lectin (69). However, these latter two proteins 
contain fucose as wall as xylose.
It is noteworthy that fucoaylation generally results in 
Insensitivity to cleavage by EndoH, as is the case with pineapple 
stem bromelain (67) and Phaaeolua phytohaemagglutlnln (70), 
but this appears not to occur with the RCA B* chain (JM Lord, 
personal communication). Such sensitivity of a fucosylated 
protein to EndoH has also been reported for rat alpha^-antitrypein (66) > 
in the presence of swslnsonins (an inhibitor of lysosomal 
alpha-memosidase II), a partially processed product was 
obtained. This contained fucose attached to the proximal 
N-acetyl glucosamine, and was EndoH-sensltive - the completed 
RCA B' chain may perhaps resemble this product.
The complete ssdno acid sequences of the A and B chains of 
ricin 0 have been determined by Funatsu's group (32-36), and are 
presented in fig IB-2. Other workers have sequenced parts of the 
a »  chains, mainly at the N-termlni. Bull et al (50) sequenced 
three cyanogen bromide frsgssnts of the ricin A  chain, covering
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Aolno acid — guanea» of cha A  «id B chaina of riela 0, as 
determined by Funatau'a group.
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74 residues, o n  of thich was not Ldontifiad. Apart fran this ana, 
and ona glutamlne/glutamic acid uncertainty, the results ware in
B chain, however, a number of differences ware noted. These will 
be discussed in detail In the Results and Discussion section, where 
it will be shown that the results of Bull at al are in closer 
agreement with the sequences deduced from the cDNA donas than with 
the Funatsu sequences. Bull et el point out that these differences 
are likely to represent heterogeneity between seed types - Funatsu 
uses large beans, whereas Bull et al use small beans. However,
mistakenly transposed two residues.
Cawley et al (31) obtained N-terminal sequences for both chains 
of ricin and of the agglutinin, and found diet both were 
extremely similar:
A  chain
Ricin (34)* I F P K Q Y P I I N F T T A G A T V Q  
RCA (31) I F P K Q Y P I  X(X)F T Y A 0 A(T)V Q
*The A chain sequence of ricin is that of FUnatsu, since Cawley et al 
determined only the first seven residues, which are Identical to 
those of ftaatsu*
Residues underlined in the • chain were not identified by 
Cawley et el, so the results of Ihnetsu's group haws bean inserted.
complete accord with those of FUnatsu's group. In the case of the
for one of the differences, they suggest that FUnatsu's group
â-Çhain
Ricin (31) A D V £ M D P E P I V R I V G R N G L
RCA (31) A 0 V 7 M D P B P I V R I V G R N G L
16 -
The sequence of ths rleln A chain reveals d u e  it contains 
two cysteine residues. Funatsu (34) has shown that cysteine - 257 
Is Involved in the disulphide linkage with the B chain, the other 
cysteine not being involved in any disulphide bridge. This residue 
is apparently extremely Inert, perhape because of its very 
hydrophobic environment (34). The B chain containa nine cysteine 
residues, which were shown to participate in four intrachain 
disulphide bonds, and one interchain bond. Thua, cysteine - 4 of the 
B chain is linked to cysteine - 257 of the A  chain (35).
Fig IB-3 show« the orientations of the intrachain bonds in the 
B chain.
The interchain bond is apparently more susceptible to 
reduction than the intrachain bonds (61), and has been examined 
in more detail by Lappl at al (71). They found that the bond 
required soma 50 times as much 2-mercaptoethanol to reduce it in 
native rlcln than in the SD6-danacurad protein, suggesting that 
the bond is in the hydrophobic interior of the molecule. 
Oithloerythritol, normally a more efficient reducing agent, was 
less effective than 2-mercapcoethanolt it is a larger molecule, 
and is presumably unable to gain access Co a buried disulphide bond.
A preliminary X-ray analysis was unable to define the position  of 
the bond unambiguously (72).
Good X-ray diffraction data for rlcln are not yet available. 
Although rlcln crystals were obtained as long ago as 1964 ( 73), 
these were too small for analysis. Larger crystals made more 
recently (53,74) were unstable on irradiation. Villafranca fc 
Robertus in 1961 (72) obtained better results, finding that rlcln 
is a compact molecule with two elongated subunits, roughly parallel.
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bm made for ricin and • variety of other proteins, laeluding  
the plant toxins from species other then Abrus. the sir^le - 
chain ribosome inhibitors, such as gslonin, and other lactlna.
One report suggests that two lectins from Momordice char anti a 
may be homologous to ricin, starting at residue 9 of the A chain (78). 
Although s number of gaps must be included to show the homology 
to full effect, 12 out of 30 residues can be aligned (the 30 residues 
represent the N-terminal 27 which were sequenced, plus 3 gaps 
relative to the ricin A  chain):
It D V S F R L S G A D P R S  - - - Y G M F I K D L R N A L P F
t i i • i i • i i i i  i i i
lit D V N F D L S T A T A K T -----Y T K F I E D F R A T L P F
• t it i i i i i i  ii
Rt I I N F T - - T A G A - T V Q S Y T N F I - - - R A V R G R
I “ Momordlca charantia lectin I.
II - Momordlca charantia lectin II.
R  “ Ricin A chain from residue 9.
Lectins I and II are identified as an agglutinin and a toxin respectively 
(78); both are apparently dimers linked by disulphide bonds, all 
chaine being approximately 26 kDel in size. SoQ values determined 
from the amino acid compositions do not Indicate e dose 
relationship with ricin (comparison of either Honordlca lectin with 
ricin gives e value of 930, whereas comparison of the two Momotdlca 
lectins with each other gives 330, which may imply homology. Values 
were calculated as in ref 62; see List of Abbreviations, p vil).
The leek of iaeunological cross -reactivity between the 
castor bean lectins and these other proteins does not absolutely 
rule cut the possibility of sequence relationships - phased in and 
oonglydnia, which are related by sequence, do not cress react (79).
,On the ocher hand, broad sCruccural and functional elmilarlclea 
do not guarantee evolutionary re 1 atlonahlpa: if a given function 
la required by a group of otherwlae dlatently related planta, 
each may evolve Its own protein to fulfil that need.
Such convergent evolution may indeed produce proteins which 
superficially appear to be related, but in sequenoe terms may be 
entirely distinct.
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1C Synth— la of the lectins
The lectins axe synthesised during seed development, first 
appearing about 20 days after pol1inatlon (80), corresponding to 
the first stages of taste formation (81). It la not known 
- whether the developmental regulation la mediated at the 
transcriptional or translational level, but translatable nRNA 
only appears at this time (81,82). Certain other storage proteins 
In plants have bean shown to be developmental ly regulated by 
alteration of transcriptional activity (83,84).
An Initial report describing the synthesis of the castor bean 
lectins (44) Indicated that the A and B chains are derived from 
separate precursor at In vivo labelling of endosperm tissue, 
as well as In vitro translation of mRNA, was shown to produce two 
proteins of molecular weights 33.5 kOel and 59 kOal, which 
were reactive with, antisera directed against the agglutinin. 
Addition of dog pancreas membranes to the in vitro system 
resulted in die appearance of a group of proteins of 66 - 69 kDal. 
These were prestiesri to derive from the 59 kDal species by cleavage 
of a signal sequence and by glycoeylatlon. Both apparent 
precursors.were cotrsnslatlonally segregated. On digestion of 
the larger group with EndoH, the multiple forms were replaced 
by a single b « d  of 57 kDal, Implying that the signal sequence 
is some 2 kDal la else. In vivo pulse-chase experiments 
demonstrated the disappearance of the larger precursor from the 
endoplasmic reticulum fraction, with the concomitant arm sail at ion 
of the mature subunit polypeptides In the protein body fraction (45) 
The larger precursor was tentatively Identified as a B chain 
while the maallar one was Identified as an A chain
23
These Idantlflcations «ere not confirmad by ingr other amane at 
this stage.
The anomalously high molecular «tight of thè putativa B chain 
precursor led to furtber workt tí» A and B aubunits of both 
lactina «ere purifled and antlbodlaa «era ralead agalnat tham (43). 
Both A  and B chain tara recognieed tha 59 kDal precursor and ita 
glycosylated derivativas, «hile neither raactad «idi tha putativa 
A chain pracursor. This suggasts that tha largar molécula containa 
sequences corraeponding to both chaina, «hila tha amaller one is 
a contaminant. To support this, partial protaolyala of tha 
aubunits with papain (45) showad that similar pattarne «ara 
obtained with all A-type aubunits, and that a compari son of tha 
producta obtained frcm thè agglutinin A' chain and frcm the 
putativa A chain pracursor «ere grossly different. This lattar 
protain «as than idantif led by ite la eunoraactivity with 
antisera ralead agalnat castor baan 2 S albumine (45).
It is suggestad that thesa albuedns copurlfy in amali quantitlea 
with the lactins uniese vary caraful aeparatione of die A and B 
chaina are perfomad, and, as highly imeainganir proteine (85), 
gansrate diaproportlonataly larga amounte of antibodies In aera.
Tha problam was also ancounterad uslng ccaaasrcially preparad 
sera. Tha complete amino acid aequance of an 11 kDal castor baan 
Storage protain has baan determinad (86), and ita amino acid
atrongly auggasts that lt is a maabar of the 2 S albundn 
group. Zt is a hatsrodlmsr of 4 kDal and 7 kDal aubunits lihked 
by a disulphlde bridge i if lt is a produci of tha 32 kDal 
precursor, considerable poet-translatlonal processing  must oeour.
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U »  pulse-chase studlu already nenCloned Indicate that 
the caetor bean lectins are synthesised on the endoplasmic 
reticulum membrane; in support of this is the exclusive 
location there of the enzymes responsible for glycosylation (44). 
Although cereal protein bodlea often have ribosomes attached to 
-than (87,88), this is not observed in other plants (89), and is 
unlikely to be the case in castor beans.
It has not bean demonstrated that the lectins pass through 
the Golgi apparatus, though their glycosylated nature implies 
that they do - this organelle is characteristically the site of 
m odification  of core sugars (90,91). Similarly, the mode of 
transport of the lectins is ill-defined. Sucrose density gradient 
fractionation of castor bsan endosperm yields a smooth membrane 
fraction distinct from the endoplasmic reticulun (JM Lord, 
personal comnicatton), which may represent transport vesicles. 
Phaaaolus vulgaris lectin has been shown to pass from the Golgi 
apparatus to the protein bodies in 'dense vesicles' (92).
A. number of other hstsrodimeric plant proteins are known 
to be synthesised as single-chain precursors, including 
psa legtanin (93), pea saad lectin (94), rapeased nap in (93), and 
others. Examples are also known in animals, the best known of which 
is insulin (96), and a maher of final microvillar enzymes 
ate assaabled by cleavage of a single precursor (97).
L’lbceune
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ID Biological functions of rlcln and RCA 
1D1 General features
As will be discussed, the two chains of the lectin molecules are 
responsible for different facets of the function of the whole 
molecule. Thus, the B chain functions as a lectin, attaching the 
dimer to cell surfaces and, in the case of ricin, promotes the 
transfer of the A chain to the cytosol. The A  chain of ricin 
then enzymatically inactivates ribosomes, leading to cell death.
The agglutinin A' chain is also capable of inactivating 
ribosomes, but since It does not gain access to the cell interior, 
this Is presumably not biologically important.
Many plants contain toxic proteins which, like rlcln, act by 
inhibition of protein synthesis. A recent review (37) shows that 
they can be grouped into two classes. First, the ricin-like 
proteins, which have two chains, and secondly the single-chain 
proteins, in which the chain Is analogous to the rlcln A chain.
The range of plants containing one or other class of protein Is wide, 
including cereals, legumes, Euphorbiaceae, Solanaceae, etc.
They are present in various parts of the plants, Including leaves, 
seeds and stems, though in most cases information on the 
subcellular localisation Is sadly lacking. In castor beans, the 
toxin end the agglutinin are sequestered in protein bodies (1,80), 
and a similar situation Is likely to occur with the other proteins - 
In order to protect the cell from its own toxins. However, as will 
be discussed, the sensitivity of a given cell to its awn 
ribosome inhibitors Is a controversial point.
The mechanisms of action have in most cases not been determined, 
but it is probable that most will be very similar to ricin, abrin 
and modeccln, the best characterised of the toxins. For example, 
one single chain ribosome inhibitor, gelonin, is known to inhibit 
ribosomes by the same mechanism as ricin (98).
Although one study (99) found that of 27 lectins, only 6 
were highly toxic (including one from the roe of the fish 
Rutilus rutilus), most lectins are considered toxic in high 
concentrations (100), and it has been suggested that toxicity 
should be considered a general property of lectins (99).
A variety of other organisms contain toxic proteins which, 
like the plant toxins, display structural segregation of 
toxic and binding functions. Most notable among these are 
bacteria (for example, diphtheria toxin, cholera toxin, pertussis 
toxin), though others have comparable toxins.
Historically, ricin was long considered to be a proteolytic 
enzyme - on this basis,.Funatsu (27,101) suggested a role in the 
degradation of storage protein during germination. This may now be 
discounted as ricin is no longer considered to be a protease (eg 28).
The most obvious possible biological role of ricin is as 
a protective agent, preventing predation either by grazing 
animals, or by burrowing insects, and against infections 
(see reference 102 for a discussion of plant defence). However, 
the large quantities present (103) might argue for a role as a 
storage protein. Of course, there is no reason why, once a 
plant's basic storage requirements are fulfilled by other appropriate 
proteins, other useful proteins should not be co-opted for this purpose.
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1D2 Properties of the A chains
The A chains are enzymatic inhibitors of protein synthesis, acting 
on the 60 S subunit of eukaryotic ribosomes. Prokaryotic ribosomes 
are highly resistant (104), though one study found that a partial 
tryptic digest of ricin inhibited a cell-free system from E coli 
(105). Animal ribosomes are more sensitive than those from plants: 
the concentration of ricin required to inhibit plant ribosomes is 
some 23,000 times that needed for animal ribosomes (106).
Castor bean ribosomes have been reported to be less sensitive 
to ricin than those of other plants (107): resistance of plant 
ribosomes to their own toxins or single-chain inhibitors has been 
observed in other systems (108,109). However, one study (106) 
found that castor bean ribosomes were as sensitive as other plant 
ribosomes, but Stirpe (108) points out that in these experiments 
soluble factors were provided by a wheatgerm extract, which might 
contain tritin - the single chain inhibitor of this tissue. 
Resistance of plant ribosomes to toxins from the same plant may 
well be a general feature.
Reports of sensitivity of mitochondria to ricin are in 
conflict (110,111): the general resistance of prokaryotic ribosomes 
suggests that they should also be resistant. Nuclear protein 
synthesis also appesrs to be resistant to ricin, though since this 
system is relatively ill-defined, its significance is unclear (111). 
0ns report (112) suggests that protozoan ribosomes may be 
resistant.
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Although ricin la notoriously the toxic lectin from castor beans, 
the A chain of the agglutinin is also toxic to cell-free systems: 
Harley & Bee vers (106) found that in plant systems SO 1 inhibition 
of protein synthesis required some 5 - 1 0  times the amount of 
RCA A' chain as was needed with ricin A chain. Other workers 
have obtained similar results (31,59).
It is believed that the ricin A chain can inactivate 
ribosomes at a rate of some 1,500 per minute per A  chain (113), 
confirming the catalytic nature of its action. The effect can 
be stopped at any time by the addition of anti - A-chain serun.
The extreme toxicity of ricin, whereby a single molecule can, 
under appropriate conditions, kill a cell (24), may be partly 
accounted for by the probability that only one or two 
ribosomes per polysome may need to be affected. Once these have 
been inactivated, they would stop migrating along the nRNA, 
thus blocking all other ribosomes in the polysome (114).
The Involvement of the 60 S subunit hss been Indicated 
by reconstitution experiments: rlcln-treated ribosomes mixed 
with untreated soluble fsctors (EF-1 end EF-2) did not support 
protein synthesis, while the reverse experiment produced a 
competent system (115). Similarly, when 40 S and 60 S subunits 
were separetely treated and reconstituted with untreated partners, 
proteins were synthesised except when ricln-treated 60 S subunits 
were involved (115,116). Also, subunits from ricln-treated cells 
were mixed with those from untreated cells: 40 S subunits 
were active from treated cells, but 60 S subunits were not (117).
This latter is direct evidence thst the 60 S subunit is the tsrget 
of ricin in vivo as well as in vitro.
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There la evidence that rlcln inhibits the Initiation phase 
of protein synthesis: a reduction in the amount of mRNA 
associated with polysomes was observed after treatment of 
cell-free systems with abrin (which acts In the same way as 
rlcln) (118). The results indicated inhibition of binding of the 
40 S subunit to the 60 S subunit In the formation of the 80 S 
Initiation complex.
More evidence exists for the effect of rlcln on elongation. 
Addition of A  chain to cell-free systems, in the presence of 
aurin tricarboxylic acid (an inhibitor of initiation) 
produced no change in the polysome profile (119,120) - thus, ricin 
does not result in premature termination of protein synthesis by 
polysome degradation. However, polysomes are eventually broken 
down in vivo (46).
Ricin appears to inhibit the EF-1 - catalysed ability of the 
ribosome to hydrolyse GTP (115), and decreases the binding of 
amlnoacyl-tRNA (121,48). Some authors have not observed this 
(122,123) - It has been suggested that this reflects excessively high 
concentrations of EF-1 in their reactions, protecting the 
ribosomes from rlcln (46).
Peptidyltransferase activity, also associated with the 
60 S subunit. Is unaffected, as Is evidenced by the failure of ricin 
to decrease the incorporation of puromycin (115,122). This 
antibiotic binds to the ribosomal A site, and the growing 
polypeptide chain la transferred onto it by peptidyl transferase 
(123). Since the resulting puramycyl-peptide Is no longer 
e substrate for translocation to the P site, It detaches from 
the ribosome.
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Many reports point to the translocation step as the major 
site of ricin action. Binding of EF-2 to the ribosome Is 
decreased (122,124), and GTP, GDP and their non-hydrolysable 
analogues are also prevented from binding (125-128). Again, the 
concentration of EF-2 appears to be Important, possibly because 
prebound EF-2 protects the site of action against ricin, or because 
modification of the ribosome does not completely abolish the 
affinity of the ribosome for EF-2, merely diminishing it.
Prebound aninoacyl-tSNA also protects against ricin (see 46).
The incompleteness of the Inhibition of EF-2 binding, along with 
the partial reversibility of ricln-mediated inactivation by 
high concentrations of magnesium ions (118,129) or high EF-2 
concentrations (130) has been interpreted to suggest that 
In ricin-treated ribosomes, same functional groups are spatially 
disturbed, and that under the conditions described, these changes 
can be reversed (46).
The exact site on the 60 S subunit which Is affected by ricin 
Is unknown. The effect on the EF*2 - dependent GTPase activity 
led one group to examine the effects of ricin on a group of 
rlbosomal proteins as follows (131). Prokaryotic GTPase Is 
associated with proteins L7 and L12, and these can be selectively 
removed by washing with aomonium chloride and ethanol. Untreated 
and treated eukaryotic ribosomes were thus washed, and assayed 
by reconstitution: the proteins which were removed were able to 
complement untreated rlbosomal cores, but not treated cores. 
Analysis of the proteins removed Indicated that at least 10 were 
Involved, and no differences were detected In those from treated 
ribosomes. This Is not unexpected, since the effect appears to 
be on the ribosomal cores, and it was not shown that they 
<w p 1ii>u h  che EF-2 - stimulated GTPase activity.
Cleavage of ribosomal RNA has been suggested by analogy with 
the action of colicin E3 (104) and with that of alpha-sarcin (132). 
Thus, an 8 S complex was released from the 60 S subunit by washing 
with EDTA, and this contained the 5 S rRNA and one protein.
Neither of these species was decreased in size by ricin, even though 
the GTPase and ATPase activities associated with the 8 S complex 
were both inhibited (115). Houston (130) searched for 
dephosphorylation of the major phosphoprotein of the 60 S subunit, 
but failed to detect this. It has also been suggested that, 
since ricin A chain can act in simple buffer solutions without 
added cofactors, it may function as a hydrolytic enzyme (46).
In contrast, an elongation inhibitor from wheatgerm requires 
added ATP and tRNA (133).
The N-terminal 18 amino acids were removed from the ricin 
A chain with nagarase, which had no effect on the toxicity (134). 
Since the carbohydrate of the A chain is attached within this region, 
it is clear that this is not involved in the toxicity.
Peptides obtained from partial hydrolysis have also been shown to 
be toxic in cell-free systems, though insufficient characterisation 
was carried out to localise the active site upon the A chain (see 46).
In sunmary, although the broad location of the ricin A chain 
target is known, the details are proving elusive. It is 
possible that ricin affects a ribosomal component in a 
particularly subtle way - and that the component is as yet 
relatively poorly characterised.
1D3 Properties of the B chains
The B chains of both lectins confer upon them the ability to 
bind to the surfaces of a wide variety of cell types (see 46).
This binding is prevented by the presence of lactose or 
galactose, as is discussed below. Thus, binding is to the 
oligosaccharide moieties of glycoproteins and glycolipids - 
treatment of cells with neuraminidase, which removes terminal 
sialic acid, thus revealing subterminal sugars, often increases 
the number of binding sites (46).
The sugar specificities of both lectins are similar in that 
both bind terminal galactose residues - for example galactose, 
lactose and melibiose. However, the ricin B chain is also able 
to bind N-acetylgalactosamine (29,49). The agglutinin binds fucose 
more strongly than does ricin (49). The importance of the 
terminal location of the galactose is indicated by the stronger 
binding of galactose than of lactose (135). Ricin equally 
binds alpha- and beta-linked sugars, but the agglutinin binds 
beta-linked sugars more strongly (29). The inhibition of agglutination 
by both lectins by rhamnose has been interpreted to imply that the 
important attribute of the binding sugars is the arrangement of the 
hydroxyl groups at the C-l, C-2 and C-4 positions (numbered as in 
galactose) (29). However, it has been suggested that rhamnose binds 
at a site other than the galactose-binding site, because its 
effect on the circular dichroism spectrum was grossly different 
from those of other hapten sugars (75).
The biologically meaningful targets of the lectins, as far as 
binding to cell surfaces is concerned, are oligosaccharides 
linked either to proteins or to lipids. One study has 
investigated the binding of both lectins to a variety of glycopeptides 
(136). The agglutinin bound dlbranched oligosaccharides more
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tightly than did ricln, while the association constants for 
tribranched sugars were Indistinguishable (all these sugars 
were attached to core mannose structures). In contrast, 
ricin bound oligosaccharides consisting of galactosyl- 
N-acetylgalactosamine - seryl moieties same 2-10 fold better 
than RCA, and the affinity depended on the spatial organisation 
of the disaccharides along the peptide backbone. This report 
also noted that the addition of sialic acid residues to the 
terminal sugars generally reduced binding, while removal of 
terminal galactose, leaving terminal N-acetylglucosamine, 
abolished binding. Only ricin was able to bind to structures 
having terminal N-acetylgalactosamine. Thus, the results 
obtained with simple sugars are consistent with those obtained 
with biologically more significant haptens.
The number of saccharide binding sites on each B chain has 
been the subject of seme disagreement: equilibrium dialysis seems 
usually to point to one site per chain (49,137), but the X-ray 
structure (72) implies two binding sites, one "more highly 
occupied" than the other. A number of workers (eg 60) 
point out that since ricin is able to agglutinate cells, albeit 
weakly, it should have two sites. Funatsu (60) also considers 
the existence of two sugar specificities for ricin (that is, for 
galactose and for N-acetylgalactosamine) to imply two sites. 
Perhaps in the case of the agglutinin, the single observed 
specificity indicates that two sites exist, and are identical.
A study of sugar binding by microcalorimetry (135) found that there 
may be one or two sites - if there is only one, then it is an 
extended one, able to bind more than one sugar. This is 
consistent with the X-ray structure with its two sites linked by
a prominent groove (72).
The location of the sites on the B chains have not yet been 
determined; although the duplicate nature of the B chain (72) 
might indicate conservation of sequences surrounding the sites, 
it is just as likely that the sites are formed by the 
' apposition of different parts of the polypeptide chain, so that 
conserved residues are not necessarily reflected in conserved 
sequences. Attempts to identify the binding site have involved 
the modification of specified amino acids in the chain, followed 
by assay of sugar binding. In one study, modification of 
charged amino groups, and (separately) modification of tyrosine 
residues, resulted in the inhibition of agglutination by RCA (138); 
the tyrosine results have been repeated for ricin (75,139).
Analysis of these results implicate two lysine residues and one 
tyrosine. Other modifications, to tryptophan, arginine 
and carbaxy-group - containing residues, had no effect on 
binding (138).
The involvement of the sugar moieties attached to the B chains 
in their binding functions have been ruled out, by demonstration 
of the ability of RCA with conA attached to its oligosaccharides 
to bind lactose (137), and oxidation of mannose residues with 
periodate did not affect binding activity (140).
The binding of sugars to the lectins appears to cause 
conformational changes: alterations in the circular dichroism spectra 
were reported (75), indicating that binding resulted in the 
alteration of the environment mainly of tyrosine residues 
exposed at the molecule's surface. These changes were more 
marked in RCA than in ricin. In the case of the Abrus lectins,
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galactose caused changes involving the burying of tryptophan 
residues which were otherwise partially exposed (141).
In the castor bean lectins, tryptophan residues were more 
buried to start with, and no change was seen. Conformational 
changes on sugar binding have been observed with several other 
lectins (142).
Spectral and immunological evidence indicates that release 
of the A chain from the B chain, at least in abrin, results 
in a conformational change in the A chain (143). Such a change 
might facilitate the interaction of either the A or the B chain, 
or both, with membrane components, and could be an obligate step 
in the uptake of the A chain. Lappi et al (71) suggested that a 
conformational change might: occur prior to dissociation of the chains, 
that is, on binding to cell surfaces, which might be required 
to allow reduction of the otherwise quite stable interchain 
disulphide bond.
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1D4 Entry of ricln into cells
It ts well documented that the onset of symptoms of ricin 
poisoning is delayed by several hours (3,7); a lag phase, albeit 
much shorter, is also observed in cultured cells, though not 
in cell-free systems (144). Much evidence indicates that the 
lag is associated with the transfer of the A chain from the 
surrounding median to the cytosol - ie the site of action.
The process is divided into three distinct stages: binding 
to the cell surface, internalisation, and crossing of a cell 
membrane.
Binding to cell surfaces
This is a rapid process: even at 4°C extensive binding of 
ferritin-labelled ricin was observed within 10 minutes (145,146). 
Similarly, at 20°C (at which the whole lag phase takes about 6 hours), 
anti - B chain serum was able to protect cells for only 10 - 15 minutes 
(144,147), after which free toxin was no longer accessible to the 
serum. However, the continued sensitivity to anti - A chain 
serum indicates that the bound toxin remained at the cell 
surface for a further period after binding.
Similarly, lactose added to ricin-treated cells can only displace 
the toxin in the early phases (146) - that is, while the toxin is 
present at the cell surface. Most of the lag phase is thus 
involved with steps subsequent to binding. These experiments also 
point out the importance of cell surface attachment, in that 
non-bound or displaced toxin has no effect on the cells.
A number of studies have shown the extent and affinity of 
binding to several cell types (see 46 for details and table).
HeLa cells had seme 3 x 107 sites per cell, and the affinity
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constants Indicated that ricin bound to cells more strongly than 
to free lactose - note that blocking of binding with lactose is 
generally done at concentrations of 100 - 200 nM.
Quantitative analysis of binding demonstrated that all binding 
sites have the same affinity, and that the affinity of free B chain 
is comparable to that of whole ricin. In fact, isolated B chains 
are able to bind to cells and enter in the same way as intact 
ricin (148). Prebound B chain is also able to promote the 
uptake of subsequently added A chain, as long as the latter is 
added before the B chains are internalised (148). Free A chain 
is not bound and does not enter cells in the absence of B chain.
Although the receptor for ricin clearly involves 
oligosaccharides with terminal galactose residues, the functionally 
relevant binding molecule has not yet been identified. Ricin can 
bind to glycolipids such as GM^  (149,150), the association 
constants being similar (151) or slightly less (46) than those 
for binding to HeLa cells. The importance of GM^  was suggested 
because it is almost certainly the receptor for other 
membrane-penetrating toxins (eg cholera toxin, ref 152), but since 
these enter by a mechanism different from that of ricin, their 
relevance must be treated with great caution.
Most data show that ricin binds to membrane glycoproteins. 
There appears to be little consistency in the nunber and sizes of 
ricln-binding proteins between different cell types (see ref 46), 
and, as the lectin will bind any structure with terminal 
galactose, the identification of the relevant species is likely 
to be extremely difficult. This difficulty is aggravated by the 
probability that, although only one molecule is needed for 
complete toxicity, it appears that several thousand must bind
to the cell to ensure entry of that one molecule (24).
InternalIsation
This second part of the lag phase is characterised by the 
inaccessibility of bound ricin to antisera (144,147) or to 
lactose (146): the toxin is presumably sequestered somewhere within 
the cell. Several groups have followed the fate of ricin by 
labelling it with ferritin, horseradish peroxidase or radioactive 
iodine. Nicolson (145,146) found that after binding randomly over 
the cell surface, ricin clustered, and was then endocytosed 
into vesicles, subsequently appearing in the cytosol.
Gonatas (153-155) found that after internalisation by endocytosis, 
horseradish peroxidase - labelled ricin accumulated in the 
GEXL system of membranes ("Golgi-Endoplasmic Reticulum-Lysosome"). 
The ricin eventually found its way to the trans face of the 
Golgi apparatus. Seme was recycled to the exterior of the 
cells, as might be expected from the receptor- and membrane­
recycling roles of the GERL system. These results are strongly 
suggestive of internalisation by receptor-mediated endocytosis, 
but differ from the classical version in that other proteins, 
such as epidermal growth factor and low density lipoprotein 
enter very rapidly via coated vesicles and are transferred to 
lysosomes, the receptors being recycled (155). Most studies do 
not report ricin in lysosames.
The importance of endocytosis is further indicated by the 
resistance to ricin of cells deficient in this process, 
either by mutation (156) or by chemical blockade (157). 
Reticulocytes, which bind large quantities of ricin, but display 
very little endocytosis, are resistant to ricin (144).
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Thus, ricin enters cells by bulk endocytosis. However, 
the requirement to bind much more ricin than is needed for 
toxicity, implies that this is not the only process of 
internalisation - and that it is not the 'efficiency-limiting' 
step. Diphtheria toxin, which also requires endocytosis, 
is also taken up in bulk, but one study showed that only 300 or so 
molecules gain entry to the cytosol (See 159). Further 
evidence for another stage involves ricin-resistant cell lines 
which are endocytosis-competent, and have sensitive ribosomes (158).
As will be described, the nature of this final step in the 
transport of ricin into the cell is that of a membrane-crossing 
process.
Membrane crossing
Early models for this stage were simple: Nicolson (145) suggested 
that it is mediated by the rupture of a minority of endocytotic 
vesicles. However, certain ricln-resistant cell lines, which 
endocytosed ricin, and had sensitive ribosomes, were sensitive to 
abrin and modeccin (160). If vesicle rupture is important, 
these cell lines would be unlikely, unless different toxins 
are selectively endocytosed into different classes of vesicle.
It seems unlikely that different toxins with the same sugar specificity 
should use distinct vesicles, especially since other proteins 
which enter cells by endocytosis have been observed to share vesicles, 
for example alptu^ -macroglobulin, insulin and epidermal growth factor (161).
A direct Interaction of endocytosed rlcin with internal 
membranes is possible, by analogy with diphtheria toxin.
This t^ r<" is endocytosed, and when it reaches an acidic compartment
it is nicked to separate the toxic A fragment from the binding 
B fragment (116), and undergoes a conformational change such that
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a previously concealed hydrophobic portion at the N-terminus of 
the B fragment is exposed (162-164). This inserts into the 
lipid bilayer, and may form a channel through which the toxic 
A fragment passes (165), perhaps driven by membrane potential (166).
Ricin can readily penetrate protein-free liposomes (167) 
as long as some galactose-containing receptor is present 
(such as ganglioside GM^  (151)). Interactions of ricin and its 
isolated subunits indicate that all can insert into simple 
biological membranes (in this case Newcastle Disease Virus) (168), 
but only the interactions of whole toxin and B chain with the 
membrane were inhibited by lactose, and penetration was 
greatly enhanced by reduction of the toxin. Another study found that 
ricin A chain was able to bind to lipid vesicles much more 
efficiently than the A fragment of diphtheria toxin (169), but in 
this case most of the bound material was accessible to proteinase K. 
The same study reported a conjugate of the ricin A chain and the 
binding subunit of Wisteria floribunda lectin, which was toxic, 
while a similar conjugate involving diphtheria toxin fragment A was 
not. It was suggested that the hydrophobic C-terminus of the 
ricin A chain was responsible for the difference - note that the 
hydrophobic portion of diphtheria toxin is at the N-terminus of 
the B fragment, a nearly analogous position in terms of the 
unreduced forms of the toxins.
Thus it was proposed (169) that the ricin A chain crosses 
the membrane by insertion of this hydrophobic domain, which is 
followed by an as yet unclear stage. However, another conjugate, 
of diphtheria toxin fragment A with conA (170) was toxic - though 
in this case an analogous ricin A chain conjugate was not made.
ConA may confer the membrane-crossing function to diphtheria toxin
f
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fragment A which Is supplied by ricin A chain in the Wisteria 
conjugates. Alternatively, the ricin A chain may not play a 
direct role in penetration at all.
A secondary membrane-crossing function may also be associated 
with the B chain: acetylation of ricin (139) prevents its 
binding to cells via galactose residues. Similar treatment of 
ricin conjugated with monophosphopentamannose produced a molecule 
which was non-toxic by the galactose-binding route, but which could 
enter fibroblasts via the lysosomal hydrolase pathway. However, 
the product was still non-toxic, and it was suggested that a second 
galactose-binding stage is required for uptake. Non-acetylated 
ricin - monophosphopentamannose is toxic, which validates its use (54). 
However, upon chemical blockade of the galactose-binding site of 
abrin, conjugates with antibodies were still toxic: this argues 
that the second B chain function may not involve the galactose­
binding site (171). Also, antibody-ricin conjugates are toxic 
in the presence of lactose (171), so again, the second B chain 
function may not involve galactose binding. It is important that 
the nature of this second function be clarified, as imnunotoxins 
made with ricin A chain are insufficiently toxic; development of 
conjugates'using whole ricin, with the galactose binding site 
modified in some way, will depend very strongly on this A chain - 
uptake - promoting activity.
Ricin, unlike diphtheria toxin, does not require an acidic 
compartment for membrane penetration. Lysosmotropic amines (160,172) 
and certain carboxylic ionophores (157), all of which increase the 
vesicular and lysosomal pH, all stimulate ricin toxicity, 
whereas acidification of endocytotic vesicles by incubation of
cells at pH of 6 or less prevents toxicity (157). In contrast, 
under the latter conditions, diphtheria toxin is able to 
penetrate the plasma membrane directly (116). Perhaps an 
acid - mediated mechanism would be inappropriate for ricin, 
a priori, since protein bodies contain acid proteases (173).
Conformational change may nonetheless still be Important, and 
has been observed on dissociation of A chains from B chains 
(61,143,174).
Another membrane-crossing mechanism has been proposed by 
Olsnes et al (175). They find that cal dun deprivation 
decreases the sensitivity of cells to ricin. Thus, the penetration 
of membranes by ricin may be linked to calcium ion influx, 
which may in turn be regulated by vesicular pH or calcium ion 
concentration - membrane channels controlled by the latter have been 
shown to change in pore diameter in rat liver gap juction
channels, whose diameters are reduced by calcium (176). It was 
suggested (160) that the ricin A chain might pass through such 
pores, perhaps in an extended conformation. In an attempt to 
substantiate this hypothesis, various other treatments were 
investigated for their effects on ricin sensitivity: the calcium 
ionophore A23187 was added, and this protected against abrin, but not 
against ricin (175). It was suggested that the ricin A chain can 
pass through either type of calcium channel, but that abrin A chain 
can only utilise natural channels. However, the addition of 
lanthanum ions, and of other lanthanides (all of which 
inhibit calcium influx), and iron ions (which do not), all 
protected against abrin and ricin. These may bind to calcium 
channels in such a way as to close them - the iron ions having a 
slighter effect than the lanthanides, resulting in a change in 
selectivity, rather than outright blockade. It is of note that 
lanthanum ions alter membrane fluidity and permeability in general -
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and that they killed the cells after overnight incubation!
A mechanism of this type might explain the inefficiency of 
ricin entry, in that relatively few A chain molecules would be able 
to penetrate a channel designed for smaller species.
A number of retinoids also affect the uptake process, in that 
- they protect cells against modeccin, and to a lesser extent against 
abrin and ricin. Some phorbol esters have an opposite effect.
The effects appear to be on trans-membrane transport, but their 
mechanisms of action are unclear (160). Phorbol esters have been 
shown to stimulate the intracellular transport of proteins, and to 
stimulate protein secretion (177).
In sunnary, the means by which ricin and other toxins cross 
cell membranes is unclear. The selective resistance of certain 
cell lines, along with the different effects of various agents on 
the toxicities of different toxins implies that a number of routes 
are employed, which may have some steps, but not all, in common.
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IE Uses of castor bean lectins
The lectins have been exploited for a variety of purposes, including 
medical, scientific, and some more sinister uses. A selection of these 
are listed in fig IE-1. Current interest is directed mainly 
.towards cancer therapy, especially with regard to conjugates of toxins 
with tumour cell - specific antibodies.
The anti-cancer effects of abrin and rlcin have been known 
for some time; Lin et al (4) reported dramatic effects with both 
proteins on Ehrlich ascites tumours in mice. A review of the subject 
is provided in reference 46, the authors of which point out that 
the plant toxins are as effective as many of the currently used 
alkaloids, and in some cases have fewer side effects. Most 
notably, combinations of sub-therapeutic doses of conventional 
drugs along with small doses of toxins often have synergistic 
effects on cancer cells, the effects on other cells being less 
than additive. For example, the combination of ricin and 
adriamycin increased the lifespan of animals given intracerebral 
injections of leukaemic cells, while either agent alone had no 
effect. It is suggested that the access of one of the drugs to 
the site of action is somehow facilitated by the presence of the 
other, but details are unknown.
More recently, phase I clinical trials were reported for 
abrin and ricin in terminal cancer patients (5). Ricin was given 
intravenously, the highest tolerable dose corresponding to 
23 pg per sq m. Of 38 evaluable patients, one with lymphoma had 
a partial response (treatment with ricin was stopped because of a 
developing immune response. Continued therapy with abrin produced 
complete remission). In a further eight patients, advancement 
of was stopped. No toxic deaths occurred with ricin, but
two were adnitted with abrin.
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The problem with using toxins as such, as with all other r m v w  
drugs, lies in the non-specificity of their targets of action.
As long ago as 1906, Paul Ehrlich (6) suggested that the 
specificity of antibodies could be used to direct drugs to 
specific locations within the body. Early attempts to do t M n  
involved joining conventional anti-cancer drugs to 
antibodies (See 187-189), and these continue. Although sane 
success has been achieved with this approach, the stoichiometric 
nature of the actions of these drugs generates the necessity to 
deliver large amounts of such conjugates to the affected cells, 
with the result that the conjugates are often not as effective as 
the drugs given alone.
An obviously important factor in the use of any antibody- 
directed therapeutic agent is the availability of suitably 
specific antibodies. Much knowledge is currently being accvmulated 
on the expression of tumour-specific antigens (See for example, 
Immunological Reviews Vol 62). It has been suggested that 
antigens could be induced by Infection with viruses which show 
tunour specificity (190), and work on innunotoxins has Involved 
SV40 - transformed cells (191) and mumps virus - infected cells (192). 
The most significant advance in recent years, which has provided a 
major stimulus in this field, is of course the development of 
monoclonal antibodies (193). The important question now is 
whether antigens expressed by a given tunour will also be expressed 
by all other tunours of the same type. The Importance of this 
is that it is Impractical to generate a special monoclonal antibody 
and link it to a toxin, for every patient requiring treatment.
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The enzymatic character of toxins such as ricin and diphtheria 
toxin has made them extremely attractive as the toxic agents in 
conjugates - as is indicated by the large number of recent 
publications in leading cancer journals.
It was at first supposed that immunotoxins should contain 
only the A chains of the toxins, in order to avoid non-specific 
binding by the B chains. This was hoped to prevent general 
toxicity, as well as attachment to plasma proteins and 
erythrocytes, forming complexes which cannot leave the bloodstream (1%). 
For examples of this approach see references 195 - 197. However, 
conjugates containing only A chains tend to be erratic in their 
toxicity, and less effective than expected from the amounts of 
A chain present (171,191), in agreement with the evidence described 
earlier that the B chain plays a role other than initial binding 
in the transport of the A chain to the cytosol.
A number of attempts have been made to circumvent this 
problem. For example, one group (198) treated cultured cells with 
a non-toxic A chain conjugate, and added free B chain. This 
resulted in intoxication of the cells, again demonstrating the 
Importance of the B chain. However, this is unlikely to be of use 
in vivo because of the problem in getting the B chains to the 
target cells.
Another approach (199) involved the simultaneous use of two 
conjugates - one containing the A chain, and the other containing the 
B chain. In this case, both contained the same antibody, but 
it might be advantageous to use antibodies with two different 
specificities (both for the target cell) to further reduce non­
specific toxicity. Again, the results obtained in vitro were 
favourable, but the B chain binding problem remains.
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Yet another possibility is to use antibodies of dual 
specificity: separate antibodies are raised against the toxin 
component and the target cells. These are reduced, and then 
mixed, to form molecules containing one 'arm' from each of 
the original antibodies. These are bound to the toxin 
and then used as immunotoxins (200).
The most obvious way to abolish the galactose-binding property 
of an inrnunotoxin, while retaining the secondary function of the 
B chain is to use chemical blockade. Abrin has been treated 
with an agent which modifies lysine residues, and in so doing 
abolishes galactose binding. Inmunotoxins constructed with 
this product were toxic to their target cells, but considerable 
residual non-specificity was noted, which was shown not to be due 
to binding via galactose residues (171). It is possible that 
the antibody used was insufficiently specific.
Perhaps the most promising approach so far has been the 
construction of the conjugates in such a way as to physically 
interfere with the galactose binding site - so-called 
steric hindrance. Preliminary results indicate that the conjugates 
are effective in mice, even when given intravenously (194). 
and they have been used to remove cancer cells from bone marrow 
which was subsequently reintroduced into an irradiated 
patient (PE Thorpe, personal comnunication).
The current interest in immunotoxins arises from the remaining 
method of abolishing the galactose-binding site: once cDNA clones 
which express ricin are available, it may be possible to 
introduce mutations which result in a protein with all the 
requisite properties except galactose binding. A second potential 
advantage of this approach is that present conjugates are less 
effective than the expected maxinun because of removal from the
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circulación by the reticuloendothelial system (201). Since 
this is likely to be largely a consequence of the sugar moieties 
attached to ricin, the production of the mutated product in a 
non-glycosylating system may well avoid this problem.
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IF Castor bean lectin cDNA cloning
IC will be clear from Che discussion thus far Chat a great many 
problems remain to be solved, including purely academic points, 
as well as more practical aspects. Many of these are amenable to 
recombinant DNA approaches, inasmuch as structural and functional 
information can be obtained; hybridisation probes can be nmA» 
available, and the starting material for imnunotoxins is 
provided.
The structure of ricin and the agglutinin can be approached by 
determination of their sequences - the differences between them may 
help explain the characteristics of their different structures and 
functions. Protein sequencing data are of course applicable, but 
these are only available for ricin. Also, protein sequencing 
fails to provide any information on the synthesis of the lectins, 
in terms of the nature of the precursor. However, c£NA sequences 
define the initial translation product and reveal features such 
as signal sequences and the organisation of subunits within 
precursors.
The construction of expressing derivatives of cDNA clones will 
help in elucidating the mechanisms of action of the two chains.
The introduction of mutations can be correlated with the effects 
these have on the expressed products - for example, A chain mutants 
may be obtained which attach to the ribosome, but go no further. 
Analysis of these would help locate the target of ricin action.
Similarly, the site within the B chain of the galactose-binding 
function should be clarified.
From the practical point of view, the overriding importance 
of any expressing toxin clone is its potential for making 
imnunotoxins. Mutation of the galactose binding site has already
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been discussed, and the removal of glycoprotein immunotoxins from 
the circulation has been mentioned. The latter problem may be 
overcome by expression In bacterial systems, which do not 
glycosylate proteins, though bacteria may be unable to allow 
the correct folding and processing of the molecule. However, 
ricin can be reformed from Its reduced subunits (71), so the 
Important point will probably be the preparation of separate 
subunits. This could be achieved by an In vitro cleavage of 
an expressed ricin precursor (the castor bean enzyme which carries 
this out Is presently being characterised, JM Lord, personal 
conmunication), or by separate expression of both subunits, 
followed by reassociation.
In any event, non-glycosylating yeast mutants have been 
described (339), and for these reasons, the clones are currently 
being recloned in a yeast expression vector (see Results and 
Discussion section), as well as Into E coll expression systems.
The work described here Involves the cloning of cDNA 
sequences encoding both ricin and RCA, along with the 
determination of their nucleotide sequences. The protein sequences 
are compared with those of Funatsu, and In a limited 
survey, the nucleotide sequences are compared with other plant
sequences.
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CHAPTER 2: MATERIALS AND METHODS 
2A Materials
Castor beans were obtained from Croda Premier Oils. The beans 
supplied are of uncertain origin, and may represent a mixture of 
strains. The patterning of the testa differs considerably between 
the seeds; those of even reddish-brown colour being sorted for 
use here, to try to minimise sequence variation. All bacterial 
growth reagents were from Difco, and plasmids pUC8 and pBR322, 
and the latter, cut with PstI and tailed with G residues, were from 
URL. An 1413 cloning / dideoxy sequencing kit, including Ml3 mp8 
and E coll JM101 cells was obtained from BRL, and a Universal Ml3 
sequencing primer was from New England Biolabs. Rabbit 
reticulocyte lysate kits were purchased from New England Nuclear, 
and all isotopes were from Amersham International.
The 20-mer oligonucleotide used for screening the cDNA library 
was a generous gift from Cell tech Ltd. Restriction and other 
enzymes were from BRL, Boehringer and NBL; terminal transferase 
was obtained from Miles and reverse transcriptase from 
Life Sciences Inc. Anti-RCA serum was from Vector Labs, and is known 
to react with the 2S albumins as well as with the lectins (see p 22).
General chemicals, solvents and antibiotics were obtained 
from BDH, Sigma and Fisons, as were agarose and acrylamide.
Nitrocellulose was Schleicher & Schuell type BA85/1.
01igo(dT)-cellulose was obtained from Collaborative Research.
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New England Biolabs, 32, Tozer Rd, Beverly, MA, USA
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2B General methods
2B1 Growth and harvesting of castor beans
Castor bean plants (Ricinus communis) were grown from seed in John 
Innés Nç 1 compost in the greenhouse. They were maintained at 
20°C and illuminated with sodiun lamps (10,000 -12,000 lm m-2) 
with a lightsdark regime of 16 hr s 8 hr (ref 81).
The development of castor bean plant seeds has been divided into 
seven stages based on size, formation of the testa and state of 
hydration (81). Seeds were harvested at stages D-E for cDNA 
cloning, and at earlier stages for screening by differential 
hybridisation (see Results and Discussion section 3D).
2B2 Growth and maintenance of E coli
Details for E coli JM101 appear in section 2H1. Strain DH1 (202) 
was stored at -20°C in 50 X glycerol, 0.5 x LB (LB is 1 l tryptone,
1 X NaCl, 0.5 X yeast extract), and were replated on LB plates 
containing 1.5 l agar each week. Cells containing plasmids were 
grown in, or plated on, LB containing tetracycline at 14 pg/ml. 
Ampicillin sensitivity was determined by plating on LB 
containing ampicillin at 50 pg/ml.
The identity of DH1 cells was periodically checked by 
plating on LB containing 100 pg/ml nalidixic acid, to which they are 
resistant (202).
2B3 Preparation of competent E coli cells and transformation 
DH1 cells to be transformed with pBR322 and its recombinants were 
rendered competent with RbCl and MhCl2> as this gave transformation 
frequencies considerably higher than the simple CaCl2 method 
(107 - 10® transformants per pg of supercoiled plasmid, and
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10^  - 10A transformants per pg respectively). Recombinants 
in pUC8 were transformed into cells prepared with CaCl2, as this 
simpler method was found to give satisfactory results (1(P - 10^  
transformants per pg)•
The RbCl / MnCl2 method was as follows: cells were grown 
in 10 ml cultures of psi broth (2 X tryptone, 0.5 X yeast extract,
10 mM NaCl, 20 nM MgCl2 pH 7.6), and grown at 37°C in a shaking 
incubator until the absorbance at 530 nn was 0.3 units. A one ml 
aliquot was diluted to 25 ml with fresh psi broth and the culture was 
grown to an absorbance of 0.48 A^q units. The cells were chilled on 
ice for 15 minutes and then harvested at 5,000 rpm for 5 minutes 
at 4°C. They were resuspended in 10 ml of 100 mM RJbCl, 50 nM MnCl2, 
10 nM CaC^, 35 nM NaAc pH 5.8, 15 X glycerol and kept on ice for 
15 minutes. The cells were again harvested, and resuspended in 1 ml 
of 10 nM RbCl, 10 nM MOPS pH 5.8, 75 nM CaCl2> 15 X glycerol and kept 
on ice for a further 15 minutes.
Aliquots of 100 pi of cells were mixed with the DMA samples 
and were incubated on ice for 30 minutes, after which they were 
heat-shocked at 42°C for 90 - 120 seconds. The mixtures were 
diluted to 1 ml with fresh psi broth and grown at 37°C for one 
hour. Cells were then pelleted, resuspended in 100 pi of psi 
broth and plated on LB containing tetracycline at 14 pg/ml. After 
18 - 24 hours growth, colonies were counted and spotted onto LB plates 
containing ampicillin at 50 pg/ml to identify colonies harbouring 
recombinant plasmids.
The calciun chloride method was as follows: cultures of 10 - 
15 ml of cells were grown in LB until the A ^  was 0.6 units, 
at which point the cells were harvested and resuspended in 10 ml of 
50 nM CaCl2. After 40 minutes on ice they were again harvested and
resuspended in 1 ml of 50 nM CaCl2, and kept on ice for a further
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40 minutes. Aliquots of 100 pi of cells were mixed with DNA samples 
and incubated on ice for another 40 minute period, and were then 
heat-shocked at 45°C for 2 minutes and plated on LB containing 
50 pg/ml ampicillin, and grown overnight at 37°C.
2B4 Extraction and purification of plaanrH DNA
Plasmids were prepared from E coli by a modification of the alkaline 
lysis method of Bimboim & Doly (203). Ten ml overnight cultures 
were grown at 37°C with shaking, in LB containing the appropriate 
antibiotic. This was diluted to 1 litre with fresh LB and growth 
was continued until the A^q was approximately 0.8 units, at which 
point chloramphenicol was added to 175 pg/ml to amplify the 
plasmids (204), and the cultures were grown for a further 15 - 18 
hours. Amplification was not carried out with pUC8 clones, since 
adequate yields were obtained from overnight cultures.
Bacteria were harvested by centrifugation at 5,000 rpm for 
5 minutes at 4°C, and resuspended in 3.4 ml of 50 oM glucose,
10 nM EDTA, 25 nM tris-HCl pH 8, 2.5 mg/ml lysozyme. After Incubation 
on ice for 10 minutes, 6.6 ml of 200 mM NaOH, 0.1 X SDS was added, 
nrivorf thoroughly and the mixture was kept on ice for a further 
10 minutes to allow lysis. Chromosomal DNA and high molecular weight 
RNA were precipitated by the addition of 5 ml of 3 M NaAc pH 4.8, 
with a 30 minute incubation on ice. After removal of this material 
by centrifugation at 10,000 rpm for 10 minutes, nucleic acids were 
precipitated from the supernatant with 0.6 volunes of isopropanol, 
and an incubation of 10 minutes at roam temperature, and harvested 
by centrifugation at 10,000 rpm for 10 minutes. Isopropanol does not 
efficiently precipitate proteins under these conditions (205).
Plasmid DNA was washed out of the pellet by thorough resuspension in
3.2 ml of 2 M NH^ Ac , followed by a further round of centrifugation 
as above - the pellet being discarded, taclelc acids were
again precipitated with isopropanol, as above, and were washed with
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antibiotic. This was diluted to 1 litre with fresh LB and growth 
was continued until the A^q was approximately 0.8 units, at which 
point chloramphenicol was added to 175 pg/ml to amplify the 
plasmids (204), and the cultures were grown for a further 15 - 18 
hours. Amplification was not carried out with pUC8 clones, since 
adequate yields were obtained from overnight cultures.
Bacteria were harvested by centrifugation at 5,000 rpm for 
5 minutes at 4°C, and resuspended in 3.4 ml of 50 nM glucose,
10 nM EDTA, 25 nM tris-HCl pH 8, 2.5 mg/ml lysozyme. After incubation 
on ice for 10 minutes, 6.6 ml of 200 nM NaOH, 0.1 X SOS was added, 
mixed thoroughly and the mixture was kept on ice for a further 
10 minutes to allow lysis. Chromosomal DNA and high molecular weight 
RNA were precipitated by the addition of 5 ml of 3 M NaAc pH 4.8, 
with a 30 minute Incubation on ice. After removal of this material 
by centrifugation at 10,000 rpm for 10 minutes, nucleic acids were 
precipitated from the supernatant with 0.6 volunes of isopropanol, 
and an incubation of 10 minutes at room temperature, and harvested 
by centrifugation at 10,000 rpm for 10 minutes. Isopropanol does not 
efficiently precipitate proteins under these conditions (205).
Plasmid DNA was washed out of the pellet by thorough resuspension in
3.2 ml of 2 M NH4Ac , followed by a further round of centrifugation 
as descfih«ri above - the pellet beiig discarded, ttacleic acids were 
precipitated with isopropanol, as above, and were washed with
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70 X ethanol. After brief drying in vacuo the DNA was dissolved in 
10 nM tris-HCl pH 7.6, 1 nM EDTA, and RNase T1 (to 100 units/ml) or 
RNase A (to 5 pg/ml) was added, and the mixture was incubated at 
37°C for 30 - 60 minutes. The resulting DNA was twice extracted with 
phenol equilibrated with 10 nM tris-HCl, 1 nM EDTA, and precipitated 
from 0.‘3 M NaAc pH 6 with 2 volumes of ethanol at -80°C for 
30 minutes. The DNA was dissolved in up to 500 pi of 10 nM tris-HCl 
pH 7.6, 1 nM EDTA and an aliquot was analysed on a neutral agarose 
gel.
Supercoiled plasmid DNA was further purified on CsCl density 
gradients (206) consisting of 31.8 ml of 10 nM tris-HCl pH 7.6,
1 nM EDTA containing 28.9 g CsCl, 18 mg EtBr and the DNA sample.
This was centrifuged in a VT150 rotor at 45,000 rpm for 16 hours.
The lower (plasmid) band was removed with a syringe and extracted 
three times with amyl alcohol to remove the EtBr. The final aqueous 
phase was diluted with 4 volumes of 10 nM tris-HCl pH 7.6, 1 nM EDTA 
to prevent precipitation of CsCl, and precipitated with ethanol.
After centrifugation, the pellet was rinsed several times with 70 X 
ethanol, dried briefly, redissolved in 10 nM tris-HCl pH 7.6, 1 nM EDTA 
and an aliquot was analysed on a neutral agarose gel.
2B5 Restriction enzymes and mapping
Restriction enzymes were used in accordance with the manufacturer's 
instructions. Where possible, the 10 x core buffer provided by 
BRL was used; otherwise buffers were prepared from sterile stocks.
DNA concentrations were typically 10 - 100 ng/pl in the final reactions 
which were incubated at 37°C for 1-16 hours, with the exceptions 
of TaqI which was incubated at 65°c and Smal, which was incubated 
at 30°C.
The products of digestion were analysed on 0.7 - 1.5 l neutral
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agarose gels, and were stained after running with a solution of 
0.5 pg/ml EtBr In water for 30 minutes. If necessary, gels were 
destairied In water for 10 - 30 minutes. Stained DNA was visualised 
under UV light and gels were photographed with a Polaroid camera.
Gels with radio actively labelled samples were dried and exposed to 
X-ray film.
No complex restriction mapping was required for this work, so 
straightforward approaches were used. Mapping was done by single and 
double digestion, or by sequential digestion (See ref 205).
2B6 In vitro protein synthesis and immunoprécipitation 
Rabbit reticulocyte lysate kits were obtained from New England Nuclear 
and used in accordance with the manufacturer's instructions, 
except that reactions were carried out in the presence of 75 raM KAc 
and 0.62 ntt MgAc2 (207). Reactions were incubated in 25 pi volumes 
at 37°C for 40 minutes and protein synthesis was assayed by uptake of 
(35S)methionine into hot TCA - insoluble material, samples being 
processed by the method of Mans & Novell! (205) and counted in 
Bray's scintillant (209) or in Beckman conmercially supplied 
scintillant cocktail.
Samples for Immunoprécipitation were mixed with an equal volune 
of 1 l Nonidet P40 in 20 nM Tris-HCl pH 7.4, 2 nM EDTA, 150 rrM NaCl,
200 nM lactose and 40 pg/ml PMSF (81). After a 45 minute incubation 
at room temperature insoluble material was pelleted in a Beckman 
airfuge at 20 psi for 5 minutes and 2 pi of null serum was added 
to the supernatant. After 15 minutes at room temperature 30 pi of 
protein A - Sepharose was added and the mixture was reincubated at room 
temperature for 30 minutes. The beads were pelleted and 2.5 pi of 
anti-RCA serum (Vector Labs) was added to the supernatant. After one 
hour at room temperature 50 pi of protein A - Sepharose was added
and the mixture was incubated at roan temperature for 30 minutes.
The beads were then pelleted and washed three times with
20 nM tris-HCl pH 7.4, 150 nM NaCl, 1 mM EDTA, 0.2 X NP40,
then twice in the same buffer but containing 500 nM NaCl,
and once in 10 nM tris-HCl pH 7.4. Material eluted from the beads
with SDS/PAGE sample buffer was analysed on polyacrylamide gels
as described in section 2C4.
2B7 End-labelling of DNA fragments
DNA fragments were labelled at their 3’ ends after cutting with 
restriction enzymes which produce protruding 5' termini. Labelling 
was with ot -(^ P^)dNTPs in the presence of the large fragment of 
E coli DNA polymerase I (Klenow enzyme). The reactions were carried 
out in any restriction enzyme buffer (205), using 0.1 - 0.5 Units of 
enzyme and 5-10 pCi of isotope (3000 Ci/mmol) per pg of DNA. After 
ethanol precipitation the DNA was thoroughly washed with 70 X ethanol 
and further purified as required. Non-radloactive dNTPs were added 
as appropriate, to 100 pM each.
This procedure was satisfactory for sequencing fragments labelled 
at BamHI, Bglll, Sau96I and TaqI sites. For Aval sites, which require, 
at least in the case of the site in pUC8, the incorporation of two 
adjacent C residues, a second aliquot of enzyme, along with 
non-label led dCTP to 100 pM, was added, and the reaction was reincubated 
as above.
Oligomers and some DNA fragments were labelled at their 5' ends 
with polynucleotide kinase. In the case of DNA fragments, the 
termini were dephosphorylated with calf intestinal alkaline 
phosphatase prior to labelling.
DNA was dephosphorylated at 10 - 100 ng/pl in 50 nM tris-HCl 
pH 9, 1 nM MgCl2, 0.1 nM ZnCl2, 1 nM spermidine, vising 1-5 units of 
phosphatase per pg of DNA (205). For treatment of protruding 5'
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termini, the reactions were Incubated at 37°C for 30 minutes, and 
a second aliquot of enzyme was added and the incubation was repeated.
For other types of terminus, each incubation was split into a 
15 minute part at 37°C followed by 15 minutes at 56°C (205).
Reactions were stopped by adding an equal volume of 20 raM tris-HCl 
pH 8, 200 nM NaCl, 2 mM EDTA and SDS to 0.5 X, and heating to 
65°C for 15 minutes. DNA was recovered by ethanol precipitation 
after three phenol and one chloroform extractions.
Dephosphorylated 5' termini were labelled in the presence of 
1-10 units of polynucleotide kinase and 2 -5 pCi of f -(32P)ATP (5000 Ci/mmol 
per pg of DNA, and 50 nM tris-HCl pH 8.5, 10 nM MgCl2> 5 nM DTT,
0.1 nM spermidine, 0.1 nM EDTA, with a 30 minute incubation 
at 37°C. The reactions were phenol extracted and the DNA 
was purified by ethanol precipitation or gel purification.
Oligomers were obtained with 5'-hydroxyl groups, so were not 
dephosphorylated. They were 5'-end-labelled at a concentration of 
10 ng/pl in the presence of 50 nM tris-HCl pH 8.5, 10 nM Mg&2>
5 nM DTT, 0.1 nM spermidine, 0.1 nM EDTA. 2.5 pCi/pl (y-^P)ATP 
(5,000 Ci/ranol) and 0.2 units/pl of polynucleotide kinase.
After incubation at 37°C for 30 minutes the reaction was stopped 
by the addition of an equal volume of 600 nM NH^ Ac and the labelled 
oligomers were separated from unincorporated isotope by centrifugation 
through a spinning column of Biogel P60 in 20 nM tris-HCl pH 7.6,
140 nM NaCl, 5 nM EDTA and 0.1 X SDS.
2C Gel electrophoresis
2C1 Neutral agarose gels
Samples were mixed with 2-10 volunes of 40 nM tris-acetate pH 7.8,
4 nM EDTA, 1 7, glycerol, 0.01 X bromophenol blue, and analysed
ion 0.7 - 1.5 X (depending on the size range to be separated) agarose 
gels (Sigma medium EE0 agarose) in TAE (40 tsM tris-acetate pH 7.8,
5 mM NaAc, 1 nM EDTA) or In TBE (89 raM tr is-borate, 20 nM EDTA).
The buffer system depended on the purpose of the gel: where clear 
resolution of topological isomers or accurate size estimations 
were required, TAE was used. For rapid checking of restriction 
digests» and for preparative gels, TBE was used.
When accurate sizing was required, gels were stained with 0.5 pg/ml 
EtBr for 30 minutes, with, if necessary, a 30 minute destaining period 
in water. Otherwise, EtBr was included in the gel buffer at 0.5 pg/ml. 
Nucleic acids were visualised under UV 11 limination and photographed 
with a Polaroid camera. For autoradiography, gels were dried and 
exposed to X-ray film.
2C2 Alkaline agarose gels
cDNA synthesis was followed on denaturing agarose gels (210) made in 
30 nM NaOH, 2 nM EDTA. Sample buffer was as for neutral gels, but 
broroocresol green replaced bromophenol blue. Running buffer was 
30 nM NaOH, 2 nM EDTA» and gels were soaked for 30 minutes in 
100 nM NH^ Ac and stained for 30 minutes in 0.5 pg/ml EtBr prior to 
examination under UV light. Gels were dried and exposed to X-ray 
film as appropriate.
2C3 Formamide agarose gels
RNA samples were analysed under denaturing conditions in the 
presence of formamide (211). 10 x E buffer is 36 nM tris base,
30 mM Na^PO^, 2 mM EDTA. Samples were made 50 l in formamide, 
lx in E buffer, 5 % in glycerol and 0.01 X in bromophenol blue, 
and were denatured by heating to 60°C for 3 minutes and cooled in 
ice-water. They were run on 1.2 X agarose gels in 50 X formamide,
1 x E buffer. After running, gels were stained and photographed as 
above. Prior to blotting, they were soaked for 1-2 hours in 
10 X formaldehyde, and then in 20 x SSC for 30 minutes.
2C4 SDS-Polyacrylamide gels
Products of In vitro translation and lmmunoprecipitated samples were 
run on SDS-polyacrylamide gels (212) with a 10 X acrylamide, 0.26 X 
bisacrylamide resolving gel in 400 nM tris-HCl pH 8.8, 0.1 X SDS, 
and a stacking gel of 5 X acrylamide, 0.13 X bisacrylamide in 
60 mM tris-HCl pH 6.8, 0.1 X SOS. Gels were run in 60 mM tris-HCl 
pH 8.8, 500 mM glycine, 0.1 X SDS.
Samples were mixed with 5-10 volumes of 200 mM tris-HCl pH 8.4, 
500 mM sucrose, 2 mM EDTA, 0.01 X bromophenol blue, 1 X methionine,
4 X SDS, 10 mM DTT, and were heated to 95°C for 2 minutes. They were 
then alkylated by the addition of iodoacetamide to 50 mM, with a 
15 minute incubation at roam temperature.
Gels were fixed in cold 10 X TCA for 30 minutes and 
fluorographed by impregnation either with diphenyloxazole (213) 
or with salicylate (214).
2C5 DMA sequencing gels
DNA sequencing samples were analysed on 40 cm long, 0.4 rim thick,
6 X polyacrylamide, 0.3 X bisacrylamide gels in 7 M urea,
89 nM tris-borate, 20 nM EETA (215). Running buffer was 89 nM tris- 
borate, 20 nM EDTA.
Samples were mixed with 0.4 - 1.0 volune of 90 X formamide,
10 nM EDTA, 0.01 % bromophenol blue, 0.01 l xylene cyanol and heated 
to 95°C for 2 minutes prior to loading on gels which had been pre-run 
for 30 minutes.
For short runs with dideoxy sequencing samples, buffer gradient 
gels (216) were used, samples running from 1 x buffer at the top 
towards 2.5 x buffer at the bottom.
Gels were cast between glass plates, the notched plate having 
been created with Repelcote and the back plate treated with 
gacma-methacryloxypropyl trimethoxys il ane as described by Ansorge & 
DeMaeyer (217) to covalently bind the gel to the plate.
After running gels were fixed in 10 X acetic acid for 15 minutes, 
dried, and exposed to X-ray film.
To obtain sequence close to the labelled site in Maxam & Gilbert 
samples, 16 X acrylamide, 0.8 X b is aery 1 amide gels were used, these 
samples being mixed with 90 X fom am1.de, 10 nM EDTA lacking dyes, 
as these were found to distort the DNA banding pattern.
When marker bromophenol blue in an unused lane was approximately 
one - third to one - half of the way down the gel, the plates were 
separated and the gel was covered in clingfilm and exposed wet.
2C6 Elution of DNA from agarose gels
The DNA band to be purified was visualised under UV light, and 
electrophoresed onto a piece of Whatman No 1 filter paper backed 
with a piece of dialysis membrane which had been boiled for 5 minutes 
in 20 nM EDTA (205). DNA was recovered from this by centrifugation 
through a hole in a 0.4 ml tube placed inside a 1.5 ml tube. The DNA 
was phenol extracted three times and chloroform extracted once, prior 
to ethanol precipitation.
-  6 3  -
-  6 4  -
2D Extraction and fractionation of castor bean nftNA
Castor bean mRNA was prepared essentially as described by Bowden-Bonnett 
& Lord (218): 100 -200 g of beans were frozen and ground to a
powder in liquid nitrogen, and homogenised in a Waring blendor 
. for 1-2 minutes in 50 mM tris-HCl pH 9, 150 mM NaCl, 5 mM EDTA,
5 l SD6. The homogenate was extracted with an equal volune of 
phenol:chloroform (1:1) and the phases were separated by centrifugation. 
The organic phase and residue were reextracted with 0.5 volume of 
20 nM tris-HCl pH 9, 2 nM EDTA and the two aqueous phases were 
combined. The aqueous material was reextracted with phenol: 
chloroform until no material was present at the interface. The final 
RNA solution was made 200 mM in NaCl and precipitated with 2 volumes 
of ethanol at -20°C overnight. All glassware was siliconised and 
autoclaved, and all solutions were autoclaved.
RNA was recovered by centrifugation and was washed several times 
with 3 M NaAc pH 5.5 until no polysaccharide was detected in the 
supernatant by ethanol precipitation.
RNA molecules bearing poly(A) tails were extracted by affinity 
chromatography on oligo(dT)-cellulose: after hybridisation 
for 30 minutes at room temperature in 400 mM NaCl, 20 mM tris-HCl pH 7.6, 
0.1 l SDS the beads were pelleted and washed three times in the 
above buffer, and twice in 200 mM NaCl, 20 mM tris-HCl pH 7.6,
0.1 % SDS. The slurry was poured into a column and washed further 
with the latter buffer until the A26Q of the eluate (monitored with an 
ISOO continuous flow UV cell) reached the background level.
Poly (A) - containing RNA was then eluted with 20 mM tris-HCl pH 7.6 
at 50°C, precipitated with ethanol, dried and dissolved in 
10 mM tris-HCl pH 7.6 to approximately 1 pg/pl.
Approximately 400 pg of poly(A)+ mRNA was layered on top of a
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10 - 30 X riborruclease-free sucrose (Sigma) density gradient in 
100 nW tris-HClpH 7.5, 0.5 1 SDS, 1 trM EDTA, and centrifuged in an 
SW27 rotor at 25,000 rpm at 17°C for 14 hours (219). Fractions of 
400 pi were collected using an I SCO density gradient fractionator
and monitored with the UV cell.
«Each fraction was precipitated with ethanol, washed with 
70 X ethanol, and redissolved in 10 pi of 10 mM tris-HCl pH 7. 
Fractions were subsequently translated in rabbit reticulocyte 
lysates, imnunoprecipitated and analysed on SDS-polyacrylamide gels.
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2E Construction of cDNA library in pBR322 
2E1 Synthesis of double-stranded cDNA
Poly(A) - containing mRNA species encoding the lectin precursor 
were identified by in vitro translation and iranunoprecipitation. 
Appropriate fractions were reverse transcribed (220,221) at 
50 ng/pl in the presence of 50 mM tris-HGl pH 8.3, 10 raM Mgd2t 
100 raM KC1, 1 raM each of dATP, dTTP, and dGTP, 250 pM dCTP,
60 ng/pl oligo(dT)^ 2_i8* *0 0*^  units/pi reverse
transcriptase. (^ H)dCTP or ot-(^P)dCTP were included in the reaction 
as appropriate.
The reaction mixture was incubated at 42°C for 45 minutes, at 
which point an equal volume of 5 raM tris-HCl pH 8.3, 5 raM DTT,
250 pM dCTP was added along with the same amount of reverse 
transcriptase as previously. The reaction was incubated for a 
further 45 minutes at 45°C, and was terminated by freezing.
Aliquots were analysed on a 1 X alkaline agarose gel along with the 
products of second strand synthesis and nuclease reactions.
The mRNA-cDNA hybrids were denatured by boiling for 3 minutes and 
cooling rapidly (220). After pelleting insoluble material and 
transferring the supernatant to a fresh tube, the following reagents 
were added, ignoring elements already present: dATP, dGTP and dTTP 
to 100 vW each, HEPES-KOH pH 6.9 to 105 raM, KCl to 92 nM, 
dCTP, labelled as appropriate, to 80 pM and 0.1 units /pi of 
DMA polymerase I from E coli (222,223). The reaction was allowed to 
proceed for 6 hours at 20°C, at which time nucleic acids were 
purified by gel filtration on 1 ml columns of Biogel P60 in 
10 nM tris-HCl pH 7.6, 20 nM NaCl, 1 mM EDTA. Fractions were 
monitored by Cerenkov or liquid scintillation counting, and peak 
excluded fractions were pooled and precipitated from 0.3 M NaAc pH 6
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with 2 volumes of cold ethanol. Precipitates were recovered by 
centrifugation and dissolved in water to about 2.5 pg of 
RNA-equivalent material per pi.
The double-stranded molecules were then digested with nuclease
a
from Aspergillus oryzae to remove single-stranded regions downstream 
and the hairpin loop upstream (223). The reaction was performed in the 
presence of 300 nM NaCl, 30 mM NaAc pH 4.5, 3 nM ZnCl2,
100 ng/pl of cDNA (RNA-equivalent) and 0.05 units/pl of 
Sj nuclease. Incubation was for 15 minutes at 37°C, and then 
for 15 minutes at 15°C, and the reaction was terminated by the 
addition of tris-HCl pH 7.6 to 130 nM and EDTA to 10 nM. The reaction 
was then extracted with phenol; chloroform (1:1) and DNA was precipitated 
with 2 volumes of ethanol. The DNA was dissolved in 10 nM tris-HCl pH 8, 
0.1 nM EDTA to 250 ng/pl of RNA-equivalent material.
2E2 Construction of recombinants
Double-stranded cDNA was tailed with dCTP (224) at 1 - 10 ng/pl 
in the presence of 140 nM potassium cacodylate pH 7.6,
30 nM tris base, 0.1 nM DTT,1 nM CoCl2 and -(^ P^JdCTP in
75-150 - fold excess over 3' termini at 37°C for 6 minutes
with a concentration of terminal transferase of 0.5 - 1.0 units/pl.
The extent of incorporation of label was followed by 
assaying the TCA-insoluble radioactivity as a proportion of the total 
by liquid scintillation counting. The reaction was stopped by chilling 
and adding EDTA to 10 mM, after which the DNA was purified by gel 
filtration. DNA was precipitated with ethanol and dissolved in 
1 M NaAc pH 8, 10 nM tris-acetate pH 8, 1 nM EDTA.
Tailed DNA was fractionated on 5 - 20 X linear sucrose density 
gradients in 1 M NaAc pH 8, 10 nM tris-acetate pH 8, 1 nM EDTA 
and centrifuged overnight at 39,000 rpm in an SW50.1 rotor.
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DNA sedimentation was checked on a parallel gradient loaded with a 
mixture of Hinfl and PstI digests of pBR322 DNA. Fractions from the 
gradient were diluted with an equal volume of water and precipitated 
with ethanol, and pooled to give three final fractions: a large 
cDNA fraction (larger than 2200 bp), an intermediate fraction 
(1000 - 2200 bp) and a small cDNA fraction (less than 1000 bp). 
Smaller cDNA molecules were discarded. The three final fractions 
were dissolved to approximately 5 ng/pl in 150 mM RbCl,
10 mM tris-HCl pH 7.6, 0.1 mM EDTA.
dC-tailed cDNA was mixed with equimolar quantities of 
dG-tailed Pstl-cut pBR322 DNA (225) at a concentration of 
0.4 ng/pl of vector DNA. The mixtures were heated to 70°C for 
3 minutes and cooled overnight to room temperature. E coli DH1 
cells were rendered competent and transformed as described in section 
2B3; recombinant clones were identified by plating tetracycline- 
resistant colonies on ampicil 1 in-containing LB plates.
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2F Screening of the cDNA library 
2F1 Differential hybridisation
The cDNA library was initially screened by colony hybridisation (226) 
using single-stranded cDNA probes prepared from mRNA extracted from 
Immature and mature castor beans (81). It was expected that 
lectin clones would hybridise with 'late' probes but not with 
'early' probes.
The colonies were grown on nitrocellulose filters (Schleicher 
& Schuell type BA85/1) on LB containing tetracycline at 14 pg/ml 
until the colonies were 1 - 3 nm in diameter. The filters were 
then transferred to LB containing chloramphenicol at ISO pg/ml 
and tetracycline, to amplify the plasmids.
The filters were processed by placing them on pieces of Whatman 
3Mi paper wetted with the appropriate reagents. They were twice 
treated with 0.5 M NaOH for 10 - 15 minutes - when complete lysis 
was observed by the change in appearance of the colonies, the alkali 
was neutralised by two treatments with 1 M tris-HCl pH 8, followed 
by two treatments with 1M tris-HCl pH 8 containing 1.5 M NaCl.
Protein was then digested by floating the filters on minimal 
volumes of 0.1 x SSC containing 0.33 pg/ml of proteinase K, both 
sides of the filter being treated. They were then rinsed in
2 x SSC and dried. After a further rinse in 300 nM NaCl, the filters 
were dried and baked in vacuo for 2 hours at 80°C.
The filters were prehybridised in a minimal volume of
3 x SSC, 50 X formamide, 50 mM HEPES-NaOH pH 7, 5 x Denhardt's 
solution, 500 pg/ml total yeast RNA, 10 pg/ml sheared denatured 
salmon sperm DNA at 43°C for 4 hours. Radioactive cDNA was added 
to 106 cpm per ml, and the filters were incubated for 60 hours at 
43°C. After rinsing several times in 2 x SSC at room temperature.
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the filters were washed four times in 2 x SSC for 15 minutes each 
time at room temperature, then for two 15 minute periods in 
0.1 x SSC at 65°C, and finally rinsed in 0.1 x SSC, dried, and exposed 
to X-ray film at -80°C with intensifying screens.
The cDNA probes were prepared by priming synthesis with 
oligomeric calf thymus DNA (227,228). Two pg of poly(A)+ mRNA were 
reverse transcribed at 37°C for 45 minutes in the presence of 
250 pCi of ec-(^ P^)dCTP, 100 ng/pl of oligomeric calf thymus DNA 
(denatured by heating), 1 unit/pi reverse transcriptase, 50 mM tris-HCl 
pH 8.3, 40 mM KC1, 8 mM MgClj, 200 pM dATP, dGTP and dTTP, and 
0.5 mM DTT.
After the incubation 5 pg of denatured salmon sperm DNA 
was added and the mixture was extracted with phenol:chloroform (1:1) 
and ethanol precipitated. The material was resuspended in 
300 mM NaOH and incubated at 60°C for 50 minutes to hydrolyse the 
RNA. Finally the probe was reprecipitated with ethanol, thoroughly 
washed and used as described above.
2F2 Oligomer hybridisation
The library was again screened by colony hybridisation, this time 
using an oligomer of 20 bases, in a mixed synthesis of 16 sequences, 
provided by Cell tech Ltd.
The oligomer was designed from the published amino acid sequences 
of the ricin A and B chains (33,35): the region whose coding sequence 
is least ambiguous is in the B chain, and encodes residues 214 - 220:
Amino acids: N - Trp Met Phe Lys Asn Asp Gly - C
mRNA sequence: 5' - UGG AUG uuji AAq AA^  GAq OGN - 3'
The oligomer was complementary to the mRNA sequence:
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Oligomer sequence: 5’ - CC £rC £lT £lT ^ AA CAT CCT - 3’
The conditions for hybridisation and washing were determined by the 
'2-4' rule, by which, starting with 0°C, 2°C are added for every 
A or T residue, and 4°C for every G or C residue. The resulting 
temperature is the apparent melting point in 6 x SSC (229): 
hybridisation is carried out 10 - 15°C below this, and the most 
stringent wash is done at this temperature.
In this case, the '2-4' rule gives apparent melting temperatures 
with a range of 32 - 60°C. To cover this range, the screening was 
done in triplicate, with hybridisation at 37°C and the stringent 
washes at 52, 36 and 60°C.
The oligomer was labelled with polynucleotide kinase as 
described in section 2B7, with the oligomer at 10 ng/pl, enzyme at 
0.2 units/pl, and x -(^P)AIP at 2.5 pCi/pl. After incubation at 
37°C for 30 minutes, an equal volume of 600 raM NH^ Ac was added and 
the oligomer was purified by gel filtration on a 1 ml spinning 
column (205) of Sephadex G-100. An aliquot was assayed for 
incorporation of radioactivity by counting in Beckman aqueous 
scintillant cocktail.
The library was grown up on nitrocellulose filters and prepared 
as described in the previous section. They were prehybridised 
for 2 hours at 55°C in 900 raM NaCl, 90 mM tris-HCl pH 7.4,
6 nM EDTA. 0.5 1 NP40, 2 x Denhardt’s solution, 100 pg/ml 
denatured E coli DNA, and 70 pg/ml yeast tRNA (T Harris, personal 
communication). This buffer was removed and a minimal volume of 
the sane solution was added, but containing 106 cpm per ml of 
radioactive oligomer. Hybridisation was at 37°C for 16 hours.
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The filters were washed in 6 x SSC: after three 30 minute washes at 
roan temperature, stringent washes were performed at the temperatures 
described for 15 minutes, and the filters were finally rinsed at 
roan temperature, and exposed to X-ray film at -80°C with 
intensifying screens.
2F3 Hybridisation - selected translation
All colonies which were positive by hybridisation with the oligomer 
were subjected to small-scale plasmid preparations, and the eight 
largest were confirmed by translation of hybridisation-selected 
mRNA (230).
The plasmids were linearised (or in sane cases were cut into two 
fragments) with EcoRI, phenol extracted and ethanol precipitated. 
Aliquots of 10 - 15 pg of each plasmid were denatured in 1 ml of 
0.5 M NaOH in 0.05 x SSC at roan temperature for 15 minutes, after 
which the alkali was neutralised by the addition of 5 ml of 
250 mM tris-HCl pH 8, 250 raM HC1, 1.5 M NaCl, and the samples were 
chilled. The following steps were carried out in the cold.
A nitrocellulose filter (S&S type BA85/1) was wetted in water and 
placed in a suction tower with a negative pressure of 20 cm of 
water and washed with 5 ml of water. The sample was then applied 
and run through, after which the filter was washed with 5 ml of 
6 x SSC. The filters were then dried and baked in vacuo for 
2 hours at 80°C, and then prehybridised in 0.5 ml of 50 % formamide, 
400 mM NaCl, 10 nW PIPES-NaOH pH 6.4, 4 mM EDTA, 500 pg/ml 
E coll tRNA, and 10 pg/ml poly(A) for 4 hours at 41°C. Poly(A)+ 
nf(NA from maturing castor beans was added to fresh hybridisation 
buffer to a concentration of 40 pg/ml and 0.5 ml of this replaced 
the prehybridisation buffer. After incubation at 41°C for
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16 hours, the buffer was removed and kept for recycling of the nRNA.
The filters were washed in 2 ml quantities of 1 x SSC, 0.1 X SDS 
(roan temperature, 30 minutes, twice), then in 0.1 x SSC, 0.1 X SDS 
(roan temperature, 13 minutes, twice), then for 15 minutes 
in 0.1 x SSC, 0.1 X SDS at 50°C. They were finally rinsed in 0.1 x SSC 
at room temperature for 15 minutes.
RNA was released from the filters at 40°C for 30 minutes in 
200 pi of 10 rcM PIPES-NaOH pH 6.4, 1 cnM EDTA, 0.5 X SDS, 90 X 
formanide, and rinsed in 200 pi of water, which was added to the 
release buffer. Salt was added to 200 mM and the RNA was precipitated 
with ethanol. An aliquot was translated and immunoprecipitated 
as Hesrr-ihftd in section 2B6 and products were analysed on
SDS-polyacrylamide gels.
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16 hours, Che buffer was removed and kept for recycling of Che mRNA.
The filters were washed in 2 ml quantities of 1 x SSC, 0.1 X SD5 
(room temperature, 30 minutes, twice), then in 0.1 x SSC, 0.1 X SDS 
(room temperature, 15 minutes, twice), then for 15 minutes
in 0.1 x SSC, 0.1 X SDS at 50°C. They were finally rinsed in 0.1 x SSC
*
at room temperature for 15 minutes.
RNA was released from the filters at 40°C for 30 minutes in 
200 pi of 10 nM PIPES-NaOH pH 6.4, 1 mM EDTA, 0.5 X SDS, 90 X 
formamide, and rinsed in 200 pi of water, which was added to the 
release buffer. Salt was added to 200 mM and the RNA was precipitated 
with ethanol. An aliquot was translated and immunoprecipitated 
as described in section 2B6 and products were analysed on 
SDS-polyacrylamide gels.
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2G Subcloning into pUC8
The inserts of a number of the original pBR322 clones were subcloned 
into pUC8 (231) to facilitate the sequencing of the insert ends, 
the construction of entire coding sequences from overlapping clones,
- and construction of expression plasmids.
The inserts were excised with PstI and purified from agarose 
gels. pUC8 DNA was also cut with PstI, and was then dephosphorylated 
with calf intestinal alkaline phosphatase as described in section 
2B7, and purified from an agarose gel.
The two DNA preparations were mixed in approximately 
equimolar quantities and ligated either overnight at 14°C or for 
2 hours at roam temperature in SO mM tris-HCl pH 7.5,
5 mM MgC^, 5 mM DTT, 10 mM ATP, 0.1 - 0.3 units/pi of
T4 DNA ligase, with the DNA at a concentration of 10 - 100 ng/pl
(total DNA concentration).
Competent E coll DH1 cells were prepared and transformed as 
described in section 2B3. Since the vector preparation was rigorous, 
and preparations were only used when transformation backgrounds were 
less than 100 clones per microgranme, no screening of the subclones 
was requited, except by minimal restriction mapping. Important 
clones were confirmed by their subsequent use for sequencing.
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2H Ml3 cloning and dldeoocy sequencing
2H1 Cloning into Ml3
DNA fragments to be sequenced were excised from pBR322 with PstI 
and were gel purified. They were then digested, in separate
i
reactions, with Alul and Sau3AI. Ml3 mp8 (232) was cut with 
Smal and BamHI, for the Alul and Sau3AX products respectively.
Cleaved Ml3 DNA was dephosphorylated as described in section 
2B7, and gel purified. Vector DNA (100 ng) was mixed with 
10 - 100 ng of target DNA and ligated overnight at 14°C as 
described in section 2G. Competent E coli JM101 cells (233) 
were rendered competent as described in section 2B3, using the 
simple CaCl2 method. After the heat-shock, the cells were mixed 
with 3 ml of HTOP agar (1 X tryptone, 0.8 X NaCl, 0.8 X agar), 
containing 200 pg/ml BCIG, 190 pg/ml IPTG and a 1 in 15 dilution of 
log phase JM101 cells, and poured onto 1*1 plates (1.5 X agar,
10.5 g/1 l^HPO^ 4.5 g/1 K H ^ ,  1 g/1 (NH4)2S04, 0.5 g/1 sodium 
citrate, 0.01 X MgS04, 0.1 X glucose, 0.00025 X vitamin B^.
After overnight incubation at 37°C, white (recombinant) plaques 
were counted.
Single-stranded DNA was prepared from recombinant plaques by 
inoculating 2 ml cultures of JM101 cells (1 in 100 dilutions of 
stationary phase cultures) from plaques, and growing with 
vigorous shaking at 37°C for 5 - 6 hours in 2TY medien (1.6 X tryptone,
1 X yeast extract, 5 g/1 NaCl). The cells were removed by 
centrifugation and virus particles were precipitated by the addition of 
NaCl to 300 mM and polyethylene glycol 6000 to 2.5 X, with a 
10 incubation at room temperature. Phage particles were pelleted
in a  microfuge for 10 minutes, and resuspended in 100 pi of 10 mM
tris-HCl pH 8, 0.1 mM EDTA. After phenol extraction, DNA was 
precipitated with ethanol, dried, and dissolved in 25 pi of 
10 nM tris-HCl pH 8, 0.1 nM EDTA.
Most of the results presented were obtained with these libraries, 
though additional data were obtained with an Alul - Haelll 
double digest, cloned into Ml3 mp8 cut with Smal. Additionally, 
a library of DNase I - generated fragments was constructed as 
described in reference (234).
2H2 Dideoxy sequencing
Ml3 recombinants were sequenced by the dideoxy chain termination 
method, essentially as described by Sanger et al (235,236).
Five pi of single-stranded Ml 3 recombinant DNA was mixed with 5 pi 
of 20 mM tris-HCl pH 8.3, 20 raM MgCl2» 1 nM DTT containing a 
universal sequencing primer at 1 ng/pl. Initially the primer 
provided by BRL was used, but this was found to be unreliable - 
one batch produced overlapping sequencing ladders, and 'stuttering' 
was conmonly observed at the bottoms of the gels. Most work was 
done with the New England Biolabs primer, which anneals further from 
the insert than does the BRL product; no problems were encountered 
with this reagent. The mixture was heated to 95°C and cooled to 
room temperature over 30 - 40 minutes.
Each sequencing reaction was carried out by mixing 2 pi of the 
template-primer with 2 pi of a solution containing non-cognate 
dNTPs (other than dGTP) at 100 pM, dGTP at 1.7 pM, <X-(32P)dGTP 
at 0.3 pCi/pl, the cognate dNTP at 4.5 pM, the cognate 
dideoxy-NTP at 20 - 100 pM (exact concentrations were determined 
empirically), in 2.5 nM tris-HCl pH 8, 0.45 nM EDTA. In the G reaction, 
the concentration of dGTP was 1.7 pM. After a 15 minute incubation,
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2 pi of 0.5 raM dGTP were added, as a chase, and Che reactions were 
incubated for a further 15 minutes. At first, reactions were 
performed at roan temperature, but extensive premature termination 
of the G reaction was observed in sane 20 X of the clones.
Subsequent reactions were performed at 37°C, at which this problem 
. did not occur.
Reactions were terminated by addition of 4 pi of 90 % formamide, 
10 mM EDTA, 0.01 l each of bromophenol blue and xylene cyanol. 
and were heated to 95°C for 2 minutes. Gels were loaded with 3 - 5 pi 
per lane, and were run as described in section 2C6. For short 
runs, buffer gradient gels were used, and for long runs, 
simple 1 x buffer gels were used.
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21 Maxam and Gilbert sequencing 
211 Preparation of DNA fragments
Fragments labelled at one end with ( P) were prepared by three 
approaches. For labelling protocols, see section 2B7; for 
purification from agarose gels see section 2C6. For each set of 
reactions, 50 - 500 ng of DNA was used, giving exposures to 
X-ray film of 15 - 60 hours.
In the first approach, linear DNA fragments were produced by 
cleavage with restriction enzymes, and all termini in the mixture 
were labelled (or a fragment was gel-purified if appropriate) 
either with polynucleotide kinase or with the Klenow fragment of 
DNA polymerase I from E coli. The resulting labelled ends were 
separated by cleavage with a second restriction enzyme and were 
purified from agarose gels.
The second approach consisted of preparing linear DNA fragments 
which could be labelled with the Klenow enzyme in such a way that only 
one end was able to be labelled. For example, a fragment
terminating with BamHI and Hindi I sites can only label at the BamHI
32end with Klenow enzyme and « -( P)dGTP, while a fragment with 
TaqI and BamHI ends can be labelled at either end selectively: at the 
former with«-(32P)dCTP and at the latter with <x-(32P)dGTP.
Finally, a number of shorter fragments were prepared as 
single-stranded DNA: a double-stranded fragment labelled at both 
ends was denatured by heating to 95°C in 100 pi of 90 X formamide,
10 nM EDTA, 0.01 X each of bromophenol blue and xylene cyanol, 
and cooled on iced water.
3 2
- 79 -
The sample was applied Co a large slot in a 40 cm long, 1 mm 
Chick, 10 X polyacrylamide, 0.26 X bis acrylamide gel and run at 
40 V/cm until the xylene cyanol was two-thirds of Che way down Che 
gel. The gel was exposed wee Co X-ray film for 1 -2 hours, 
and radioactive bands were cut out. These were placed in a slot 
cut into a 1 X neutral agarose gel, sealed in with molten agarose, 
and eluted as described in section 2C6. This method of recovery 
was used in preference to direct elution from acrylamide gels 
because of speed and proven efficacy.
212 Modification and cleavage reactions
These were performed essentially as described by Maxam & Gilbert (237), 
though with slight modifications. The reaction times described 
below were for fragments greater than 200 bases in length; shorter 
fragment« were incubated for 2 - 5  times as long.
The purified end-labelled fragments were dissolved in 40 pi of 
water containing 5 pg of carrier sheared salmon sperm EHA 
(size 20 - 30 kbp). Ten pi of this were used for two-base reactions, 
and 5 pi for single-base reactions.
G reaction
Five pi of DNA were mixed with 200 pi of 50 mM sodium cacodyl ate 
pH 8, 10 mM MgC^, 1 mM EDTA and 1 pi of CMS was added. The 
reaction was not constructed on ice as recommended, as this was 
found unnecessary. Incubation was for 5 minutes at room temperature, 
after which the reaction was stopped by the addition of 50 pi of
1.5 M NaAc pH 7, 1 M 2-mercaptoethanol.
A +■ G reaction
Ten pi of DNA were mixed with 25 pi of 98 X formic acid and 
incubated at room temperature for 3 minutes. The reaction was stopped
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by addition of 200 pi of 300 nM NaAc pH 6.
C reaction
Five pi of DNA were mixed with 10 pi of 5 M NaCl and 30 pi of 
hydrazine. After 7 minutes at roan temperature, 200 pi of 
1 M acetic acid was added to terminate the reaction.
C + T reaction
This was done as the C reaction, except that 10 pi of DNA were used, 
and 10 pi of water were used in place of the NaCl.
A + C reaction
Ten pi of DNA were mixed with 100 pi of 1.2 M NaOH, 20 nM EDTA, and 
were incubated at 90°C for 10 minutes. The reaction was stopped by 
the addition of 150 pi of acetic acid.
Preparation of products for cleavage
Five pi of 1 pg/pl E coli tRNA were added to each terminated sequencing 
reaction, and products were precipitated with 3 volumes of ethanol 
at -80°C for 10 minutes. Modified DNA was recovered by centrifugation 
in an Eppendorf centrifuge in the cold for 10 minutes. After washing 
in 70 l ethanol, the DNA was redissolved in 200 pi of 300 nM NaAc 
pH 6 and reprecipitated with 3 volumes of ethanol. After pelleting, 
the DNA was again washed with 70 % ethanol. Finally, the samples 
were dried briefly in vacuo.
Cleavage reactions
All samples were redissolved in 100 pi of freshly diluted 1 M 
piperidine and heated to 90°C for 30 minutes. Piperidine was
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removed by lyophilisation, first of the reaction mixture, then from 
200 |il of water, and finally from 20 pi of water.
The resulting products were dissolved in 5 - 15 pi of 
90 X formamide, 10 mM EDTA, 0.01 X each of bromophenol blue and 
xylene cyanol, and sequencing gels were run as described in 
. section 2C5.
Buffer gradient gels were not used for Maxam & Gilbert 
sequencing, as the excessive spacing of bands in the lower part 
of the gel observed with dideoxy sequencing products was not 
found: presumably the fragments move more slowly when 
produced chemically, probably because of the much greater amounts 
of DNA and carrier RNA present.
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2J Primer extension 
2J1 Cloning of the primer
Primer extension was performed in order to estimate 
the length of sequence at the S' end of the mRNA not represented 
in the clones sequenced. A primer was prepared from one of the 
lectin clones (pRCL6), and subcloned into pUC8 - this approach 
was used because, in order to produce a primer fragment from the 
clone directly, difficult fragment separations would be required.
Fig 2J-1 shows a partial restriction map of clone pRCL6.
The 99 bp BamHI - Alul fragment (fragment A) was cloned into pUC8 
as follows: first, the BamHI-Bglll fragment (fragment B) was 
cleaved from clone pUC617 (a pUC8 subclone of pRCL6), and gel 
purified. This fragment was cleaved with Alul to generate the 
desired fragment, along with several others, including a 
110 bp Alul-Bglll fragment (fragment C). In order to prevent 
the cloning of this fragment, the mixture was digested with 
Hhal, which produces an incompatible terminus. In the 
resulting mixture, the only fragment with one blunt end and one 
end compatible with a BamHI site is the 99 bp target fragment, 
fragment A. pUC8 DNA was cleaved with BamHI and Smal, 
dephosphory 1 ated and gel purified. The two DNAs were mixed 
and ligated overnight, and E coli DHl cells were transformed with 
the products.
Plasmids were prepared from 10 of the colonies obtained, and were 
cleaved with EcoRI and BamHI to release any inserts. The cleaved 
samples were labelled with Klenow enzyme and *-(^ P^)dGTP to label 
at the BamHI site, and run on a neutral agarose gel. One of the 
10 plasmids (designated pPRIM8) contained an insert of the
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expected size: this was purified from a DNA sequencing gel 
(the band was cut out from this gel, placed in a slot in a neutral 
agarose gel, and eluted as described in section 2C6), and its 
identity was confirmed by Maxam & Gilbert sequencing.
2J2 Primer extension reaction
Annealing and synthesis were carried out after the method of Hall et al 
(238), except that SDS was emitted from the annealing stage.
After heat-denaturation of poly(A)+ nRNA, hybridisation was 
performed in 20 pi, containing 0.5 ng/pl of end-labelled primer 
(note that this contained 250 ng of E coli tRNA coprecipitant),
50 ng/pl poly(A)+ RNA, 50 nM HEPES-KOH pH 7.6, 450 nM NaCl,
1 nM EDTA and 25 X formamide. Incubation was at 43°C for 4 hours, 
the material was ethanol precipitated and thoroughly washed with 
70 X ethanol. Specificity of hybridisation was ascertained by 
running an annealing reaction on a 1 X neutral agarose gel, 
which was dried and exposed to X-ray film. In the absence of poly(A)+ 
RNA, only a band corresponding to unhybridised primer was visible, 
while in the presence of poly(A)+ RNA, an extra band appeared, 
corresponding in size to some 1500 - 2000 bases (exact size not 
determined), along with a smear of smaller material. This latter 
probably represented degraded RNA: the preparation used was an 
old one, and was from beans which had been stored for a long period.
The primer was extended by reverse transcription in 10 pi 
reactions containing 50 nM tris-HCl pH 8.3, 60 nM NaCl, 20 nM DTT,
6 nM NfeClj, 50 pM each of dCTP, dATP, dTTP, 4 pM dGTP, 1 pCi/pl 
«.-(^ PldGTP, and 0.4 units/pl of reverse transcriptase.
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The mixture was Incubated at 37°C for 30 minutes, and was then 
lyophilised. After dissolving in 5 pi of sequencing gel 
loading buffer, the products were denatured by heating to 95°C 
for 2 minutes, and were run on a sequencing gel, along with 
jeither dideoxy or Maxam and Gilbert sequence ladders.
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2K Nucleic acid transfer and hybridisation 
2K1 Southern blots (ref 239)
DNA samples were run on neucral agarose gels as described. Gels were 
soaked for 30 minutes in 10 volumes of 400 mM NaOH, 800 mM NaCl 
- to denature the DNA. The alkali was neutralised by soaking in 
300 mM tris-HCl pH 7.6, 1.5 M NaCl. The gel was then placed 
on a support covered with 3M*I paper running down into a tank 
containing 1 litre of 10 x SSC, to act as wicks, and a sheet of 
nitrocellulose (S & S type BA85/1), wetted with 10 x SSC, was 
placed on the gel. The edges were covered with Parafilm sealing tape, 
and 4 sheets of 3MM paper and a 6 inch pile of tissues were placed 
on top. After overnight transfer the stack was dismantled, and the 
filter was dried and baked in vacuo for 2 hours at 80°C.
Blots to be probed with oligonucleotides were prehybridised 
and hybridised and washed as described in section 2F1.
Other probes were labelled by nick translation, by the method 
of Rigby et al (240). Blots were prehybridised in 3 x SSC,
50 X formamide, 50 mM HEPES-NaOH pH 7, 5 x Denhardt's solution,
10 pg/ml sheared denatured salmon sperm DNA and 500 pg/ml total 
yeast RNA. . The filters were prehybridised for 4 hours at 43°C, 
and 106 cpm per ml of probe was added, and hybridisation was for 
16 hours at 43°C. Washes were: 3 times for 40 minutes each 
in 2 x SSC at room temperature, 10 minutes at 55°C in 0.2 x SSC, 
and a rinse in 0.1 x SSC at room temperature.
2K2 Northern blots
RNA samples on formamide agarose gels were prepared as described in 
section 2C3. RNA was transferred to nitrocellulose as above; 
prehybridisation, hybridisation and wash conditions were as above except 
that poly(U) was added to 20 pg/ml, and the stringent wash was at 
65°C in 0.1 x SSC.
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CHAPTER 3: RESULTS AND DISCUSSION 
3A Isolation and characterisation of mRNA
Castor beans at developmental stages D - E (81) were harvested and 
total RNA was extracted. After extensive washing with 3 M NaAc 
pH 5.5, the material was run on an oligo(dT)-cellulose column 
to purify the poly(A) - containing fraction. Typically,
150 - 200 mg of total RNA was obtained, of which 500 - 600 pg 
was polyadenylated (0.25 - 0.40 %). This compares with a 
proportion of 0.5 - 1.0 X obtained when castor bean mRNA was 
characterised previously (241).
The presence of mRNA species directing the synthesis of the
lectin precursors was shown by analysis of the products of
in vitro translation: Fig 3A-1 shows the time-course of
35incorporation of radioactivity from ( S)methionine into acid- 
insoluble products, and fig 3A-2 shows the SDS-polyacrylamide gel 
analysis of these products. In the total products of translation, 
a considerable number of proteins are synthesised, with a wide 
range of molecular weights. The imnunoprecipitated sample 
shows two bands, one at an apparent Mr of 60 kDal and the other 
with an apparent ^  of 34 kDal. These correspond respectively 
with the lectin precursor identified by Butterworth and Lord (45) 
and the castor bean albumin precursor previously thought 
to be the A chain precursor (44).
This poly(A)+ RNA was fractionated on the basis of size by 
sucrose density gradient centrifugation. Thirty fractions were 
collected, and the RNA in each was precipitated with ethanol, 
and a sample was translated in a rabbit reticulocyte system.
- 88 -
Fig 3A-1 : Time course for polypeptide synthesis in reticulocyte 
lysate supplemented with 40 pg/ml poly(A)+ RNA from maturing 
castor beans. 1 pi samples were removed from a 25 pi assay 
and hot TCA - insoluble material was determined by scintillation 
counting.
o - No added RNA 
x ■ Poly(A)+ mRNA added
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Fig 3A-2i Translation products of castor bean mRNA 
Lane 4 shows total products of in vitro translation of developing 
castor bean nRNA and lane 5 shows products lmmmoreactive with 
anti-agglutinin serum. The higher molecular weight products are 
the lectin precursor, and the lower molecular weight bands are 
the albumin precursor.
Lane 1 shows total products obtained in the presence of dog pancreas 
membranes; the reaction was fractionated by centrifugation and 
lmnunoreactive products are visible in lanes 2 (supernatant) and 3 (pellet). 
Compartmentalisatlon of the lectin precursor 1a evident, along with 
an increase in its apparent molecular weight as compared with the product 
obtained in the absence of membranes.
Markers as fig 3A-3
-  8 9  -
1 2 3 4 5
Fig 3A-2: Translation products of castor bean tnRNA 
Lane 4 shows total products of in vitro translation of developing 
castor bean mRNA and lane 5 shows products immunoreactive with 
anti-agglutinin serum. The higher molecular weight products are 
the lectin precursor, and the lower molecular weight bands are 
the albumin precursor.
Lane 1 shows total products obtained in the presence of dog pancreas 
membranes; the reaction was fractionated by centrifugation and 
imnunoreactive products are visible in lanes 2 (supernatant) and 3 (pellet). 
Campartmentalisation of the lectin precursor is evident, along with 
an increase in its apparent molecular weight as compared with the product 
obtained in the absence of membranes.
Markers as fig 3A-3.
Fig A3-3 shows the total products of translation of each fraction, 
and fig A3-4 shows the products immunoprecipitated with 
anti-RCA serum. The lectin precursor raRNA is predominantly 
present in fractions 25 - 27, while the albumin precursor is 
in fractions 16 - 19. The appearance of smaller species 
towards the bottom of the gradient is probably a result of RNA 
aggregation, even though the material was heat-denatured prior 
to loading on the gradient. Translational activity was fairly 
constant over the gradient, each fraction stimulating the 
activity of a lysate by a factor of 7 - 12 (data not shown).
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Fig 3A-3: Sucrose density gradient fractionation of mRNA.
RNA was recovered from fractions and translated in rabbit 
reticulocyte lysates in 25 pi assays. 3 pi of each assay 
were analysed by SDS-PAGE.
MW markers: carbonic anhydrase (30 kDal), ovalbumin (45 kDal), 
BSA (68 kDal) and phosphorylase b (92 kDal).
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Fig 3A-4s Sucrose density gradient fractionation of mRNA. 
Aliquots of the translation products shown in fig 3A-3 
were irmunoprecipitated with anti-RCA serum and analysed 
by SDS-PAGE.
3B cDNA synthesis
First strand synthesis reactions as described in section 2E1 
generally worked well, producing cDNAs of the expected size range: 
typically 1400- 2000 bases from RNA fractions 25 - 27.
Early attempts at second strand synthesis were less 
successful, as were those for the nuclease reaction.
Incubation of the second strand synthesis at 15°C, using
DNA polymerase I produced length increments over the first strands
of only 30 - 40 X, with enzymes provided by several colleagues.
The use of reverse transcriptase for this reaction did not result in 
any Improvement - nor did an attempt using the cDNA synthesis 
method of Land et al (242), in which homopolymer tails are added 
to the first strand reaction products, the second strand being 
primed with the complementary oligo(dN) (results not shown).
A fresh supply of DNA polymerase I from Boehringer produced 
products of the desired length: different temperatures were tried, 
30°C producing the longest second strands. However, it is known 
that at higher temperatures, many of the longer molecules are 
probably artefactual (243), so a compromise temperature of 20°C 
was subsequently used. Fig 3B-1 shows products of cDNA synthesis 
and Sj cleavage reactions, with the second strand reactions at 
15, 20 and 30 °C. Size markers are not shown here, but the 
second strands are approximately double the length of the 
first strands.
Fig 3B-2 shows the cDNA synthesis and Sj cleavage products 
which were used for the following cloning experiments.
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Fig 3B-ls cDNA synthesis.
Effect of temperature on second strand synthesis with ENA pol I 
Lanes 1 are two different first strand reactions. Lanes 2 are 
second strand reactions and lanes S are products of Sj cleavage 
Lanes a are at 15°C, b at 20°C and c at 30°C.
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Fig 3B-1: cDNA synthesis.
Effect of temperature on second strand synthesis with DNA pol I. 
Lanes 1 are two different first strand reactions. Lanes 2 are 
second strand reactions and lanes S are products of cleavage. 
Lanes a are at 15°C, b at 20°C and c at 30 C.
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Fig 3B-2s Synthesis of cDNA used for cloning.
Aliquots of the first strand synthesis with reverse transcriptase 
(lane 1), second strand synthesis with DNA pol I at 20°C (lane 2) 
and Sj cleavage reactions were analysed on a 1 l alkaline 
agarose gel.
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Fig 3B-2: Synthesis of cDNA used for cloning.
Aliquots of the first strand synthesis with reverse transcriptase 
(lane 1), second strand synthesis with DNA pol I at 20 C (lane 2) 
and Sj cleavage reactions were analysed on a 1 % alkaline 
agarose gel.
Double stranded cDNA cleaved with nuclease was tailed with 
dCTP and terminal transferase. The reaction was assayed by passing 
the products through a small column of Biogel P60; an 
aliquot of the excluded fraction was TCA precipitated and its 
radioactivity counted, and another aliquot was run on a 1 % 
neutral agarose gel and exposed to X-ray film. Such a gel is 
shown in fig 3B-3: lane 1 indicates that the untailed cDNA 
was labelled (during its synthesis), and that the tailed 
cDNA in lane 2 contains far more radioactivity.
The resulting tailed cDNA was annealed with Pst I-cut, dG- tailed 
pBR322 and transformed into E coll DH1 cells (see next section). 
Recombinants were identified by resistance to tetracycline and 
sensitivity to ampicillin, and small-scale plasmid preparations were 
carried out: only four of the 68 recombinants obtained were 
detectably larger than the vector plasmid, as judged by agarose gel 
electrophoresis. For this reason, the tailed cDNA was 
size fractionated on a sucrose density gradient. A mixture of 
restriction fragments of pBR322 were run on a parallel gradient as 
markers, and the cDNA gradient was loaded with 2.25 pg of material. 
21 fractions were collected, and pooled to form three final 
fractions:
(a) Small cDNA 600 - 1000 bp 25 % of input label
(b) Medium cDNA 1000 - 2200 bp 13 1 of input label
(c) Large cDNA greater than 2200 bp 3.5 X of input label
Results of transformation with these fractions are presented in 
the next section.
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Fig 3B-3: Tailing of cDNA.
Double-stranded cDNA labelled during synthesis (lane 1) was 
tailed with *  -<32P)dCTP and terminal transferase, and an 
aliquot was analysed on a 1 l neutral agarose gel (lane 2). 
Size markers are restriction fragments of pBR322.
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Fig 3B-3: Tailing of cDNA.
Double-stranded cDNA labelled during synthesis (lane 1) was 
tailed with « -(32p)dCTP and terminal transferase, and an 
aliquot was analysed on a 1 % neutral agarose gel (lane 2). 
Size markers are restriction fragments of pBR322.
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3C Construction of clones
Attempts to tail PstI - cut pBR322 with dG were of dubious success.
On no occasion did the incorporated counts indicate that more 
chan 1.-2 bases had been added per 3' terminus. The products of 
one reaction, in which some labelling was apparent, were digested 
with Haelll. This should produce two bands, one of 145 bp plus 
tail and one of 122 bp plus tail. Only one clear band was produced, 
corresponding to the larger of these, along with a number of faint 
bands of larger size. It is possible that significant amounts 
of tailing were taking place at single-stranded breaks in the DNA.
To avoid further problems, commercially prepared Pstl-cut, 
dG-tailed pBR322 was obtained from BRL.
Before recombinants were constructed, a transformation procedure 
was characterised, which gave good and consistent results.
Initially, a protocol in use at EMBL was tried, whereby competent 
E coli cells were prepared by two incubations on ice in 
100 nM CaCl2 pH 8, followed by a heat-shock. This was tried 
with E coli X1776 (244), HB101 (245) and DH1 (202). Although a 
wide variety of conditions were tried, the transformation 
efficiency never **n*»AeA same 2000 transformants per pg of 
supercoiled pBR322 DNA. Omitting the pH adjustment of the CaCl2
4improved the efficiency to around 5 x 10 per pg, but this was 
still considered inadequate. In all cases, cell viability was 
checked by taking control cells through the procedure and 
plating dilutions on antibiotic-free medium. Typically, there were 
some 0.2 - 2.0 x 106 viable cells per pi.
The procedure described in Methods section 2B3 (RbCl/MnCl2
method) was then tried, and has consistently given some 
7 810 - 10 transformants per pg of supercoiled pBR322 which is 
satisfactory.
The fractionated, tailed cDNA was then annealed with the vector 
as described and transformed using the above protocol. A total of 
1587 recombinants were obtained, of which 150 were examined on 
agarose gels to check for the presence of inserts:
cDNA fraction No of recombinants l with large inserts
Total (section 3B) 68 6
Large (this section) 52 40
Medium ( " " ) 672 72
Small ( " " ) 795 55
In this context, "large insert" means that the supercoiled 
recombinant plasmids were detectably larger than the vector. 
This is not an accurate measurement, but is adequate for the 
present purpose.
Thus a library of 1587 recombinant plasmids was obtained. 
All of these were subjected to screening for the presence of 
lectin - encoding insert sequences.
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3D Screening of the cDNA library
The first screening exploited the developmental regulation of lectin 
nRNAs: these species are translatable during stages D-F, but are 
absent during stages A-C (81). Polyadenylated mRNA was extracted 
from beans at stages A-C ("early") and from stages D-F ("late"). 
Aliquots of various preparations of these nftNAs were translated in 
rabbit reticulocyte lysates and the products were Inxunoprecipitated 
and analysed on SDS-polyacrylamide gels. This is shown in 
fig 3D-1, from which it is clear that the late nRNAs do indeed contain 
lectin nRNAs which are not present in the early nRNAs.
These nRNAs were reverse transcribed to produce single-stranded 
cDNA probes, using oligomeric calf thymus DNA as primer.
The library was grown up on nitrocellulose filters and the colonies 
were lysed. The filters were hybridised first with the "late" probe, 
then washed and rehybridised with the "early" probe. This order was 
used to avoid false positives which might have arisen if the 
"early" probe had been used first, by incomplete removal by washing of 
non-lectin cDNAs bound to clones of non-lectin mRNAs. Colonies 
of cells confa-tnlng pBR322 did not hybridise with either probe.
348 colonies were identified as developmentally regulated.
These were replated onto duplicate filters, one set being probed 
with each cDNA preparation. Fig 3D-2 shows an example: most of the 
colonies hybridise with the "late" probe, though some (arrowed) 
hybridise with both probes. A few, none of which are shown on this 
filter, hybridised only with the "early" probe.
At this time» an oligonucleotide probe was made available by 
Cell tech Ltd. This was designed from the published sequences of the 
ricin A and B chains: for details of design and determination of
Fig 3D-li Translation of early and late castor bean nRNAs 
Poly(A)+ nRNA was extracted from castor beans at the developmental stages 
A, C and D+E (Indicated above lanes) and translated In rabbit reticulocyte 
lysates. The first three lanes after the molecular weight markers 
show total products, while the remaining lanes shew products 
lamunoreactlve with anti-agglutinin aerun, each lane being from a 
different batch of nftNA. Developmental stages are defined in ref 81.
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Fig 3D-1: Translation of early and late castor bean mRNAs 
Poly(A)+ mRNA was extracted from castor beans at the developmental stages 
A, C and EH-E (indicated above lanes) and translated in rabbit reticulocyte 
lysates. The first three lanes after the molecular weight markers 
show total products, while the remaining lanes show products 
immunoreactive with anti-agglutinin serun, each lane being from a 
different batch of mRNA. Developmental stages are defined in ref 81.
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hybridisation and wash conditions see section 2F2. The probe was 
S' - end-labelled and used as described in Methods.
The Initial screening of the whole library with this probe 
identified 85 hybridising colonies, of which 23 produced only 
faint images on the autoradiograph. These were designated "possibles." 
All the positives, all the possibles, four negatives and cells 
containing pBR322 were rescreened: all but four of the positives 
hybridised again, and 13 of the possibles became positive.
All the negatives, and the pBR322 - containing cells, remained 
negative. Thus, 71 clones were finally identified. These were 
named pRCLx, where RCL stands for Ricinus communis lectin, and 
x represents the nunber of the colony designated for this 
experiment.
Fig 3D-3 shows the autoradiograph of the rescreening experiment: 
the sequence of the probe gives a range of predicted melting points 
of 52 - 60 °C (see section 2F2). The actual sequence to which the 
probe hybridised was later found to give a melting point 
of 56°C: it would be expected that all the oligomer would have 
just washed off at this temperature, but it clearly has not.
The rule is empirical and, evidently, not entirely accurate, given 
that the conditions were accurately maintained.
Comparison of these results with those of the differential 
screening reveals that 44 colonies were positive by both methods.
The differential screening thus missed 27 colonies, while the oligomer 
missed 304: these may be non-lectin developmental ly regulated 
sequences, or lectin-specific clones which lack the oligomer 
hybridising site. The 27 missed on the first screening could well 
be lectin clones containing the oligomer site, but not long enough 
to hybridise with the cDNA probe.
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Fig 3D-3: Rescreening with the oliganer.
Positive colonies and negative controls were replated in triplicate
and rescreened, stringent washes being at the temperatures indicated.
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Fig 3D-3: Rescreening with the ollgcmer.
Positive colonies and negative controls were replated In triplicate
and rescreened, stringent washes being at the temperatures Indicated.
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Fig 3D-3s Rescreening with the oligomer.
Positive colonies and negative controls were replated in triplicate
and rescreened, stringent washes being at the temperatures indicated.
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Small-scale plasmid preparations were performed on all the 
colonies which hybridised with the oligomer, and their sizes 
were crudely estimated by comparison with those of supercoiled 
pBR322 and pAT153. The eight largest plasmids were then 
rescreened by translation of hybridisation-selected taRNA.
The first step of this procedure involves linearisation of the 
plasmids with EcoRI. Fig 30-4 shows the products of digestion: 
plasmids pRCL 6, 17, 58 and 61 do not contain EcoRI sites 
within the insert, whereas pRCL 15, 52, 57 and 59 do. This was 
the first indication that two classes of cDNA clones had been 
obtained, and these were later shown to correspond to ricin and 
agglutinin clones.
The products of translation of the hybridisation-selected mRNAs are 
shown in fig 3D-5,. for plasmids pRCL 6, 15, 17, 58 and 59.
The other three were analysed on a separate gel (not shown).
All these plasmids select a mRNA encoding a protein of 
apparent 57 kOal which is imnunoreactive with anti-RCA sen®.
That no other proteins were synthesised by the selected mRNAs is 
shown in the lane containing non-immunoprecipitated products of 
the mRNA selected by clone pRCL15.
Thus, 8 plasmids with fairly large inserts were shown to
contain lectin - specific sequences
Fig 3D-4: EcoRI digests of plasmids prior to hybridisation with RNA. 
Lanes 1-8 are plasmids pRCL 6,15,17,52,57,58,59 and 61, cut with 
EcoRI.
Lane 9 is pBR322 cut with EcoRI.
Lane 10 in undigested pBR322.
Samples analysed on 1 X neutral agarose gel in TAE buffer system.
Fig 3D-4: EcoRI digests of plasmids prior to hybridisation with RNA. 
Lanes 1 - 8 are plasmids pRCL 6,15,17,52,57,58,59 and 61, cut with 
EcoRI.
Lane 9 is pBR322 cut with EcoRI.
Lane 10 in undigested pBR322.
Samples analysed on 1 % neutral agarose gel in TAE buffer system.
Fig 3D-5t Translation of hybridisation-selected nRNA 
nRNAs were selected by plasmids pRCL 6, 15, 17 , 58 , 59 and pBR322 
(indicated above lanes), translated in rabbit reticulocyte lysates 
and analysed by SDS/PAGE. Lanes marked + are lsmunoprecipitated with 
anti-agglutinin semn, while those marked - are run without 
immunoprec ipitatlon.
Lanes TP show products of translation of uRNA prior to 
hybridisation with plasmids, and lane R shows products encoded by 
cdRNA recovered from the hybridisation reaction.
Molecular weight markers are as fig 3A-3.
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Fig 3D-5: Translation of hybridisation-selected mRNA 
mRNAs were selected by plasmids pRCL 6, 15, 17, 58, 59 and pBR322 
(Indicated above lanes), translated in rabbit reticulocyte lysates 
and analysed by SDS/PAGE. Lanes marked + are imnunoprec ipitated with 
anti-agglutinin serum, while those marked - are run without 
Immunoprécipitation.
Lanes TP show products of translation of trRNA prior to 
hybridisation with plasmids, and lane R shows products encoded by 
mRNA recovered from the hybridisation reaction.
Molecular weight markers are as fig 3A-3.
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3E Characterisation of clones
The eight clones screened by translation of hybridisation-selected 
roRNA were cleaved with PstI and the sizes of the inserts were 
estimated on a 1 % neutral agarose gel, along with Alul and 
Hinfl digests of pBR322 DNA. The gel is shown in fig 3E-1, along 
with the results, and the sizes of four of the clones, which were 
later determined by sequencing. (The relative absence of vector DNA 
is because the samples analysed were aliquots of purified inserts.)
Since the original intention was to sequence in M13, no detailed 
restriction mapping was undertaken. However, the presence of two 
restriction classes identified by EcoRI digestion (see fig 3D-4) 
led to further investigation of restriction site heterogeneity.
First, the eight clones were digested with BamHI. The largest, 
pRCL52, produced four bands (fig 3E-2), indicating that this 
insert has three sites (the fourth one is in the vector, pBR322).
The bands were designated A - 0, in decreasing order of size;
the same fragments from the other clones are referred to by the same
letters, even if fewer or different bands are produced.
DNA from the BamHI digests was transferred from the gel to nitrocellulose 
and probed with the oligodeaxynucleotide used for screening the 
library. Fig 3E-3 shows the autoradiograph, which shows that in all 
plasmids which produce BamHI fragment D, this band hybridises.
It follows that fragment BamHI-D contains B chain sequences; its 
size is consistent with its containing most of the B chain: back- 
translation of the amino acid sequence Implies possible sites at 
amino acids 5-7 (one in two possibility) and at amino acids 
236 - 238 (one in eight possibility). This was later confirmed by 
sequencing.
Fig 3E- 2 also shows that pRCL6,15 and 52 contain BamHI fragment C, 
which was later shown to contain the whole of the A chain sequence,
and to precede fragment D in the clones. The BaoHI and sequence
Fig 3E-1: Insert sizes
Plasmids containing lectin-specific inserts were digested with PstI 
and the inserts (purified as part of another experiment) were run 
on a 1 l neutral agarose gel in TAE buffere system.
Lanes 1 - 8  are pRCL 6,15,17,52,57,58,59 and 61 respectively.
Lane A is pBR322 cut with Alul and lane B is pBR322 cut with Hinfl.
Plasmid _ Size from_gel_ (bp)_ _ _Size from sequenc ing_(b£> _ _
6 1650 1624
15 1650
17 1350 1287
52 1800 1688
57 1200 1171
58 1000
59 1300
61 1050
NB Sequencing sizes assime GC tails of 10 bp at each ends 
pRCL17 has a poly(A) tall of 27 residues.
- 109 -
Fig 3E-1: Insert sizes
Plasmids containing lectin-specific inserts were digested with PstI 
and the inserts (purified as part of another experiment) were run 
on a 1 X neutral agarose gel in TAE buffere system.
Lanes 1 - 8  are pRCL 6,15,17,52,57,58,59 and 61 respectively.
Lane A is pBR322 cut with Alul and lane B is pBR322 cut with Hinfl.
Plasmid _ Size from_gel_ (bp)_ _ _Size from sequencing^ b£) _ _
6 1650 1624
15 1650
17 1350 1287
52 1800 1688
57 1200 1171
58 1000
59 1300
61 1050
NB Sequencing sizes assume GC tails of 10 bp at each end; 
pRCL17 has a poly(A) tail of 27 residues.
The eight plasmids which were screened by translation of 
hybridisation-selected raRNA were digested with BaoHI and the 
products were run on a 1 X neutral agarose gel in TAE buffer system. 
Lanes 1-8 are pRCL 6,15,17,52,57,58,59 and 61 respectively.
Lane A is pBR322 cut with Hlnfl.
Lane B is pBR322 cut with Alul.
Fig 3E-2: Banfll digests
Bands A - D are defined in the text (pl08).
The eight plasmids which were screened by translation of 
hybridisation-selected mRNA were digested with BamHI and the 
products were run on a 1 % neutral agarose gel in TAE buffer system. 
Lanes 1-8 are pRCL 6,15,17,52,57,58,59 and 61 respectively.
Lane A is pBR322 cut with Hinfl.
Lane B is pBR322 cut with Alul.
Fig 3E-2: BamHI digests
Bands A - D are defined in the text (pl08).
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Fig 3E-3t Southern blot of BamHI digests
The gel shown In fig 3E-2 was blotted onto nitrocellulose and probed with 
the 20-mer ol lgodeaxynucleotlde vrtiich hybridises with sequences 
encoding residues 214-220 of the ricln B chain.
Lanes 1-8 are pRCL 6,15,17,52,37,58,59 and 61 respectively.
Lanes A and B are pBR322 digested with Hinfl and Alul respectively.
For definition of bands A,B and D see text (pl08).
Fig 3E-3: Southern blot of BamHI digests
The gel shown in fig 3E-2 was blotted onto nitrocellulose and probed with 
the 20-mer oligodeoxynucleotide which hybridises with sequences 
encoding residues 214-220 of the ricin B chain.
Lanes 1-8 are pRCL 6,15,17,52,57,58,59 and 61 respectively.
Lanes A and B are pBR322 digested with Hinfl and Alul respectively.
For definition of bands A,B and D see text (pi08).
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data, along with Sau96I digests of Insert preparations, were later 
used to determine the extents of all eight clones: see fig 3E-4.
The downstream Sau96l site Is present In all the clones, as Is the 
central BamHI site. The ends of the clones were estimated from the 
sizes of the Sau96I fragments, along with knowledge of the 
presence or absence of the downstream and upstream BamHI sites.
Sequencing of clones pRCL6,17,52 and 57 Implied the existence of 
another heterogeneity: the EcoRl’ clones contained a Bglll site 
in BamHI fragment 0, which was absent in the EcoRI+ clones.
In order to Investigate this In the other clones, all were cut 
with BamHI and PstI: those clones lacking a 'natural' BamHI-D 
fragment thus gain an analogous BamHI-PstI fragment. Half of each 
digest was then cleaved with Bglll, and all fragments In all the 
reactions were end-labelled, and analysed on agarose gels.
The autoradiographs are shown In fig 3E-5: In each EcoRI+ clone 
the BamHI fragment D lacks a Bglll site, while In each EcoRl~ 
clone, the site Is present.
Heterogeneity with respect to TaqI sites exists within BamHI 
fragments C and D. In fragnent C, clone pRCL6 contains two 
TaqI sites, and clone pRCL52 contains one (which Is at a different 
position from both of those In pRCL6). The only other clone 
having a BamHI fragment C Is pRCL15, which Is In the same EcoRl 
class as pRCL52. pRCT.15 was shown to contain only the TaqI site 
present In pRCL52. TaqI site heterogeneity in BamHI fragment D 
was not further investigated.
Thus, the eight clones can be divided Into two restriction 
classes in terms of EccRI, Bglll and TaqI sites. No variation 
with respect to BamHI or Sau96I was detected, and no clone had 
any sites for Hindlll, Sinai, Aval or Hindi! (data not shewn).
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Fig 3E-5: Belli sites In fragment BanHI-D
Recombinant plasmids (identified by pRCL no) were cleaved with BanHI 
and PstI (lanes a) to generate fragments analogous to BaoHI-D (see 
text for details). Half of each reaction was then digested with Bglll 
(lanes b), end-labelled and analysed on a 1 l neutral agarose gel.
Clones pRCL6, 58, 61 and 17 lack an EcoRI site, while clones 
pRCL 59, 57, 52 and 15 contain this site.
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Fig 3E-5: Ball I sites In fragment BaniHI-D
Recombinant plasmids (identified by pRCL no) were cleaved with BamHI 
and PstI (lanes a) to generate fragments analogous to BamHI-D (see 
text for details). Half of each reaction was then digested with Bglll 
(lanes b), end-labelled and analysed on a 1 % neutral agarose gel.
Clones pRCL6, 58, 61 and 17 lack an EcoRl site, while clones 
pRCL 59, 57, 52 and 15 contain this site.
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3F Subcloning into pUC8
The inserts of clones pRCL6 and pRCL52 were subcloned into pUC8, 
in order to facilitate the sequencing of their ends by Maxam and 
Gilbert sequencing, and for the construction of clones containing 
complete coding sequences. Clones pRCL17 and 57 were later 
shown to overlap with clones pRCL6 and 52 respectively, and were 
then also subcloned into pUC8.
The inserts were excised with PstI and gel purified, and 
ligated into suitably prepared vector, preparations of which were 
first shown to give very low backgrounds of transformation.
Same 30-50 colonies were obtained from the ligated material, 
compared to 1 - 2 from the vector. Small-scale plasmid extractions 
were performed: fig 3F-1 shows eight such plasmids from the 
cloning of the pRCL52 insert. All eight are of the expected size. 
The identities of the inserts were confirmed by limited restriction 
mapping, with BanoHI, Bglll and EcoRI, the orientations of the 
inserts being determined from the BaoHI digests. Fig 3F-2 
shows the BaoHI digests of recombinants in pUC8 containing the 
insert of pRCL6: Clones pUC611, 616 and 618 are in orientation A 
(see fig 3F-3), while pUC613, 614, 615 and 617 are in 
orientation B. Plasmid pUC612 failed to cut, as it comigrates 
with uncut pUC6l3 - this was not investigated further.
The orientations of the inserts in the pRCL52 subclones were 
determined by EcoRI digestion: pUC8 has a single EcoRI site, near 
the BamHI site shown in fig 3F-3, while the insert has a single 
site cutting it into fragments of approximately 1050 bp and 630 bp. 
Clones pUC521, 522, 523, 524 and 527 were in orientation A, while 
pUC525, 526 and 528 were in orientation B.
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3F Subcloning into pUC8
The inserts of clones pRCL6 and pRCL52 were subcloned into pUC8, 
in order to facilitate the sequencing of their ends by Maxam and 
Gilbert sequencing, and for the construction of clones containing 
complete coding sequences. Clones pRCL17 and 57 were later 
shown to overlap with clones pRCL6 and 52 respectively, and were 
then also subcloned into pUC8.
The inserts were excised with PstI and gel purified, and 
ligated into suitably prepared vector, preparations of which were 
first shown to give very low backgrounds of transformation.
Some 30 - 50 colonies were obtained from the ligated material, 
compared to 1 - 2 from the vector. Small-scale plasmid extractions 
were performed: fig 3F-1 shows eight such plasmids from the 
cloning of the pRCL52 insert. All eight are of the expected size. 
The identities of the inserts were confirmed by limited restriction 
mapping, with BamHI, Bglll and EcoRI, the orientations of the 
inserts being determined from the BamHI digests. Fig 3F-2 
shows the BamHI digests of recombinants in pUC8 containing the 
insert of pRCL6: Clones pUC611, 616 and 618 are in orientation A 
(see fig 3F-3), while pUC613, 614, 615 and 617 are in 
orientation B. Plasmid pUC612 failed to cut, as it comigrates 
with uncut pUC6l3 - this was not investigated further.
The orientations of the inserts in the pRCL52 subclones were 
determined by EcoRI digestion: pUC8 has a single EcoRI site, near 
the BamHI site shown in fig 3F-3, while the insert has a single 
site cutting it into fragments of approximately 1050 bp and 630 bp. 
Clones pUC521, 522, 523, 524 and 527 were in orientation A, while 
pUC525, 526 and 528 were in orientation B.
Fig 3F-1: Subcloning into pUC8.
The Insert of pRCL52 was cloned into pUC8. Plasmids were extracted 
from eight colonies and analysed on a 1 X neutral agarose gel.
Lanes 1 - 8  are plasmids pUC521 - 528.
Lane A is pUC8, B is pBR322 and C is pAT153.
Samples analysed on 0.8 X agarose gel in TAE buffer system.
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Fig 3F-1: Subcloning into pUC8.
The insert of pRCL52 was cloned into pUC8. Plasmids were extracted 
from eight colonies and analysed on a 1 % neutral agarose gel.
Lanes 1-8 are plasmids pUC521 - 528.
Lane A is pUC8, B is pBR322 and C is pAT153.
Samples analysed on 0.8 % agarose gel in TAE buffer system.
-  1 1 7  -
Fig 3F-2i Subcloning in pUC8.
The insert of pRCL6 was cloned in pUC8. Eight of the clones were 
digested with BaoHI and run on a 1 X neutral agarose gel.
Lanes 1-8 are clones pUC611 - 618 cut with BamHI.
Lane A is undigested pUC613.
Fragpoents A - D are explained in fig 3F-3.
Samplese were analysed on a 1 X agarose gel in TAE buffer system.
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Fig 3F-2: Subcloning in pUC8.
The insert of pRCL6 was cloned in pUC8. Eight of the clones were 
digested with BamHI and run on a 1 % neutral agarose gel.
Lanes 1-8 are clones pUC611 - 618 cut with BamHI.
Lane A is undigested pUC613.
Fragpients A - D are explained in fig 3F-3.
Samplese were analysed on a 1 % agarose gel in TAE buffer system.
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Fig 3F-3: Orientations of pUC8 subclones of pRCL6 insert.
Above: Location of BamHI sites in pRCL insert, cambered 
from beginning of insert, and assuming G-tails of 
10 bases. Arrowhead indicates 5' to 3' direction.
Below: Orientations in pUC8 with respect to the BaoHI site
of the vector. Boundaries of inserts are indicated, and 
correspond to PstI sites. Fragments A,B,C and D are the 
bands visible in fig 3F-2; band E is too small 
to see on the gel.
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3G Sequencing: introduction
3G1 Summary of results
Clones pRCL6 and pRCL52 were Initially selected for sequencing - that 
is, the largest member of each of the two restriction classes. 
Sequencing was at first carried out by the dideoxy method, after 
subcloning restriction digests of the inserts into M13 mp8; the 
remaining gaps were filled by Maxam and Gilbert sequencing.
The identities of the sequences obtained from each experiment 
were determined on the basis that the protein sequences are known: 
the 'translation' programme described in Appendix 1 was used 
to generate the coding capacity in all reading frames, which 
were aligned with the protein sequences manually. This approach 
was entirely satisfactory, and other programmes for aligning 
sequences were not used.
Both clones were found to contain seme 30 b of 5' non-coding 
region, followed by a putative signal sequence of 24 amino acids.
This was followed by sequences corresponding to the mature A chain, 
which was in turn followed by B chain sequences. A 12-residue linker 
was found between the two chains. Neither clone ran as far as the 
C-terminus of the B chain, clone pRCL52 being somewhat longer than 
pRCL6.
It was suspected, from restriction data (see section 3E) 
that clones pRCL17 and 57 overlap with clones pRCL6 and 57 
respectively, in such a way that the additional clones should 
contain sequences downstream of those in the clones originally 
sequenced. These two were therefore sequenced, entirely by the 
Maxan & Gilbert method: clone pRCL17 contained the whole 
3' - non-coding region, including the poly(A) tail, whereas
pRCL57 terminated within the 3' - non-coding region. Throughout the 
overlapping parts, no differences existed within the two pairs of 
clones.
However, pRCL17 contains an extra fragment: the greater 
part of its insert consists of sequences encoding the end of the 
A chain, the linker, the whole B chain and the 3' - non-coding 
region. Preceeding this, and in the other strand, there is a 
small fragment encoding part of the B chain. As will be discussed 
at the end of this section, this is probably a cloning artefact.
Since the two castor bean lectins are believed to be extremely 
similar, both inmunologically (3) and in terms of the N-terminal 
sequences of both chains (31), there is a need to identify the 
coding sequences of the two sets of clones with the two lectins.
This was approached by comparing the sequences determined here with 
those published for the ricin chains. Fig 3G-1 shows plots 
indicating the locations of differences between the sequences 
deduced from the cDHA clones and the published sequences. It is 
clearly apparent that the sequence of clones pRCL6 and 17 
is far more similar to the published amino acid sequences than 
is that encoded by clones pRCL52 and 57. The similarity of the 
clone pRCL6 and 17 sequence to the published one may well be much 
greater than indicated here, as will be shown later.
The two sequences were tentatively identified as ricin (clones 
pRCL6 and 17) and RCA (clones pRCL52 and 57) on this basis.
It is of note that the cDNA data indicate that the two B 
chains are of very similar length - although EndoH digestion of 
ricin and agglutinin B chains indicates that the latter is longer (45), 
more recent evidence obtained in the presence of tunicamycin
indicates that they are indeed of similar length (JM Lord,
A chain
_LI_ 6/17
( Li i_____ L_i L_i___ 1— i— u 11 U-J------------------------- LL-iX—j 5 2 /5 7
|-------1— I----- 1--------1-----Ul--------------11—1-------U ___IllJ______ I I r i i j
I--------1U1----UJ1__ ■  m ill I___I___II I I III___III! Ill I I I  «11^
B chain 
6/17
52/57
Fig 3G-1
Differences between the deduced amino acid sequences and those determined 
by Funatsu’s group. Each vertical line represents an amino acid 
difference, deletion or insertion.
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personal conmunlcatlon).
Final identification cannot be made on these grounds alone, 
however, because the sequences obtained here may be genuinely 
different from those of Funatsu, due to heterogeneity within and 
between beans of different sources. Since only eight clones 
have been considered in any detail at all, it is possible that 
the present library contains sequences even more similar to those 
of Funatsu than that encoded by clones pRCL6 and 17.
For the purpose of further identification of the cloned 
sequences, subclones containing the whole coding sequence 
of clones pRCL6 and 17 have been constructed (LM Roberts and 
the author, data not shown). This will be subcloned into 
vectors containing the SP6 promoter sequence (246), and will then 
be transcribed. The resulting RNA will be translated and the products 
identified by imnunoprecipitation with sera specific to each 
lectin - provided by Dr P Thorpe. The specificity of these 
has been confirmed (JM Lord, personal conmunication).
However, the success of this approach relies on the maintenance of 
the Immunological distinction between the two lectins in so 
artificial a system. If the antigenic properties of the proteins 
depend to any great extent on the correct three - dimensional 
folding of the chains, then even specific sera may be unable to 
distinguish between them.
Another approach relies on the differences in the functions 
of the subunits of the two lectins. If the cDNA sequences can 
be expressed in such a way as to produce toxic A chains or 
sugar-binding B chains, then quantitative assay of A chain function, 
or determination of sugar specificity of B chains should assist 
in final identification. Towards this end, the clones 
containing the whole ricin coding sequence will be subcloned into.
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Che yeast expression vector pMA91 (247).
Clone pRCL17
As mentioned above, this clone appears to contain a cloning 
artefact. A map Is shown In fig 3G-2, and the sequence 
surrounding the junction Is shown In fig 3G-3.
The origin of this anomaly is unclear. The three 
G residues (encoding Che first glycine residue of the additional 
fragment) might suggest an origin during annealing: this 
hypothesis requires that the end of one molecule failed to tail, 
such that these G residues were left overhanging, subsequently to 
hybridise with the C tails on another molecule. However, 
this model implies that the G residues would be at the 3' end 
of a DNA strand; they are, in fact, at the 5' end.
The E coll strain used was DH1, which is recA~ (202).
However, a scenario for a recombination event can nonetheless be 
constructed, based on the findings of Conley & Saunders (248), who 
report the transformation of E coll with linearised pBR322 DNA 
into a variety of reccmbinational backgrounds, including recA~.
They find that, although the efficiency of transformation is low 
with linear molecules, the transformants which do arise generally 
contain deletions, implying a recombination event. It is suggested 
that most transformants in these experiments arose through 
recombination of homologous sequences, rather than by annealing 
of sticky restriction ends. In support of this, they transformed 
cells with linear dimers of pBR322, and obtained perfect 
monomeric plasmid DNA from transformants.
It is possible that some similar event has occurred in 
clone pRCL17: if a single cell were transformed with two

-  125 -
co
18 § 
SU 8 
-Jë s
•h a> <  H
i
U
g  | .s a  - -8
SIg g s 1«
y §£*
H
S r<n 
'tt o
g ^
y Sa
8 g£ °  Sfi in
1 a
8 es <7S -5•• ü
g  ^ A 1i i 
un en Bel
ow 
thi
s i
s t
he 
com
ple
men
tar
y s
tra
nd.
 
Num
ber
s i
ndi
cat
e p
osi
tio
ns 
in 
the
 pr
epr
ori
cin
-  126 -
recombinant molecules, each containing ricin sequences, then a 
recombination - deletion event may have occurred, parts of one 
or both of the original molecules being deleted in the process. 
However, this should imply some homology surrounding the 
recombination site, but a search of this region, comparing 
regions upstream and downstream of both termini at the junction, 
revealed no detectable homology. The search was conducted by 
the generation of a dot matrix (249) using a simple computer 
programne (results not shown).
3G2 Ml3 cloning and dideoxy sequencing
The inserts of clones pRCL6 and 52 were initially sequenced in 
Ml3 subclones, generated from Sau3AI and Alul digests of their 
inserts. In each case, libraries of 300 - 400 Ml3 recombinants 
were obtained. Sequencing of many of these, along with screening 
of the rest by T-tracking, showed that not all of the target 
sequence had been represented in the libraries. Fig 3G-4 shows 
the extent of the Sau3AI and Alul libraries for both clones, 
as well as a Haelll - Alul double digest library subsequently 
made from pRCL6. The sites for these enzymes are also shown, as 
determined from the completed sequences.
In each case, there are gaps - these are in similar regions 
of each clone. Although the large region lacking Alul sites 
might be understood not to have cloned very efficiently in the 
presence of smaller fragments, there are several Sau3AI sites 
in this region, which would be expected to have cloned.
Non-random distribution of Ml3 clones has previously been 
reported (235), and it may be relevant that Drouin (250) found that 
certain Mbol fragments were difficult to clone in pBR322.

A further clone bank of about 100 clones was constructed by a 
DNase I. cleavage method (234). Limited analysis of this bank 
by sequencing and T-tracking indicated that most of its members 
contained sequences from the regions already represented in the 
previous libraries. Although size fractionation was not 
performed here, it would still be expected that the clones should 
have a random distribution.
An attempt was also made to clone the whole inserts of 
pRCL6 and pRCL52 into Ml3 cut with PstI: although large mmbers 
of white plaques were obtained, these were very small, and the 
virus failed to grow in liquid culture. Instability of 
large (greater than 2000 bp) inserts in Ml3 has been reported (235). 
The failure may be due to excessive slowing of virus replication, 
with the result that uninfected cells outgrow those containing 
the desired recombinants.
A recognised problem with M13 cloning is the risk of 
generating clones with multiple inserts (235), this occurring 
during ligation of the mixture of target fragments with the vector. 
This is not usually a serious problem when restriction digests 
are used to fragment the original DNA sequence, as its occurrence 
can be detected by the presence of the appropriate restriction 
site in the Ml3 recombinants. This phenomenon was found in two 
of the present Ml3 clones, both in the Alul library derived from 
pRCL52. In one case the two fragments were from adjacent regions 
of the starting sequence, and in both cases the fragments were 
in opposite strands.
Another potential problem is the location of the determined 
sequences with respect to the starting sequence: since the 
protein sequences were known, no computer programmes for aligning
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these sequences were used. No problems of this type were found 
during this work, but it is suspected that if pRCL17 had 
been sequenced in Ml 3, some confusion would have arisen from the 
duplication within this clone.
Some of the difficulties associated with these techniques were 
not encountered here, such as band compression (251).
However, a fairly frequent problem was that of non-specific termination 
of synthesis of the new DNA strand. Regions of sequence which were 
difficult to determine because of this were obtained by 
sequencing Ml3 clones containing the same fragment in the opposite 
orientation, and by Maxam & Gilbert sequencing.
Because of the incompleteness of the Ml3 results, the 
remaining sequence was determined by the Maxam & Gilbert 
chemical method, as described below.
3G3 Maxam & Gilbert sequencing
Very few problems were encountered with this technique.
Occasionally, gels would smear, or bands would appear diffuse, 
these problems probably arising from poor fragment preparation.
In one or two cases, non-specific bands were observed, but these 
did not reappear on repetition of the experiment.
The most important difficulties occurred when sequencing from 
Aval sites and from Hindlll sites. In the former case, the site 
in pUC8 which was labelled has two adjacent C residues. In the 
simple labelling protocol, one or both of these may be labelled - 
giving overlapping sequence ladders. This was easily overcame 
by following the labelling reaction with a chase of dCTP at 
much higher concentration than that of the labelling reaction.
Hindlll sites mostly produced unreedable ledders, with badly
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overlapping sequences, chough sane such experiments worked 
well. Even if chis enzyme can cue at either of Che A residues 
in its recognition sequence (A/AGCTT), this should have no 
effect, as the reaction was performed in the presence of 100 pM 
cold dATP, and radioactive dGTP - only one postion should label. 
The reason for this problem thus remains unknown.
The fragpents sequenced are shown in figs 3G5-3G8, 
for clones pRCL6, 17, 52 and 57 in that order.
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In tMs and the following sections, the cDNA sequences encoding 
rlcin and the agglutinin (in their prepro- forms) are presented 
and described. Further details will be discussed in 
subsequent sections.
Fig 3H-1 shows the complete preproricin cDNA sequence, as 
determined from clones pRCL6 and 17. The deduced amino acid 
sequence Is below the cDNA sequence, and when this differs from 
those obtained by Funatsu, the latter's data are placed below the 
deduced data. Amino acids missing from Funatsu' s data are 
indicated by dashes, whereas those present In Funatsu, but absent in 
the deduced sequence, are Indicated by asterisks. Potential 
sites for N-glycosylation are enclosed In boxes.
Clone pRCL6 contains bases -102 to 1512, and pRCL17 contains 
bases 733 to 1782, along with the poly(A) tail (but see also 
section 3G1 for discussion of pRCLL7). The 5' non-coding region 
consists of 30 bases, although the nsRNA probably contains another 
80 bases, as will be shown In section 3L. This Is followed by 
an ATG codon (not the first one) which opens up a reading frame 
containing, after a 24-residue signal sequence, the whole ricin 
A and B chains. The A chain Is 267 residues long (Funatu's sequence 
was 265), and Is followed by a linker of 12 amino acids. This Is 
in turn followed by a B chain sequence of 262 residues (Funatsu's 
sequence contained 260). The coding sequence Is terminated by 
a ISA stop codon, which begins a 3' non-coding region of 
156 bases.
3H The preproricin sequence
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• 'H , - I »
S -AAAOOKGAC GAAATACTAT TCTAATATGG ATC TAT OCA GTC OCA ACA TOC CIT TCT T ÏT OCA TOC AOC TCA OOC TOC TCT TTC ACA TTA GAG
•« »i
AAC ATA
Mat Tyr Ala Val A la  Thr Trp Leu Cya Pha G ly Sar Thr Ser C ly Trp Ser Pha Thr Lau Glu
CAT AAC TTC OOC AAA CAA TAC d en ATT OCT O K
V
ACT CAA AOC TAC ACA AAC TTT ATC AGA OCT
Aap Aan Aan l ia Pho Pro Lya Cln Tyr Pro 11« G ly Ala Thr Val Gin p r i y r Thr Aan Pha I I « Arg Ala
1» * *
CTT OOC OCT OCT ITA ACA ACT OCA OCT GAT CTG ACA CAT GAT ATA OCA CTG TIC OCA AAC AGA CTT OCT TTC OCT ATA AAC CAA O K TTT
Val Arg G ly  A rt Leu Ih r  Ih r C ly Ala Aap Val Arg I IU  Aap 
-  G lu
11« Pro Val Lau Pro Aan **» Val G ly Lau Pro 11« Aan Gin Arg Pha
•t» » r
ATT ITA CTT GAA ere TCA AAT CAT OCA GAC c rr TCT CTT ACA TTA OCC CTC CAT CTC AOC AAT OCA TAT CTC CTC O K  TAC OCT OCT OGA
11« Lau Val G luM Lau Sar AanCln
IIU Ala Clu Lau Sar Val Th r Lau Ala Lau
Î ?
Val Thr A«n Ala S r v . 1 Val C ly  T y r Arg Ala G ly
«!•
AAT AOC OCA TAT TTC IT T  CAT CCT GAC AAT CAC GAA GAT OCA GAA OCA ATC ACT CAT CIT TTC ACT GAT CTT CAA AAT OCA TAT ACA TTC
Aan Sar A la  T y r Pha Iha IIU Pro Aap Aan Cln C lu  Aap A la Glu Ala 11« Thr H U Lau Pha Thr Aap Val Cln Aan Arg Ty* Thr Pha
GOC IT T OCT OCT AAT TAT GAT ACA CIT GAA CAA c r r  o c r  O er AAT
T
CTC AGA CAA AAT ATC GAC TIC OCA AAT OCT OCA CTA GAC GAG OCT
Ala Pho « y  G ly Aan Tyr Aap Arg Lau Clu Cln Lau Ala C ly Aan Lau Arg Glu Aan 11« C lu Lau GJy Am G ly Pro Lau Glu Clu Ala
f
ATC TCA OCG CTT TAT TAT TAC ACT ALT OCT OOC a c t  cao c r r OCA ACT CTG OCT OCT TOC TTT ATA ATT TOC ATC CAA ATC ATT TCA GAA
11« Sar A la  Lau Tyt T yr Ty r Sar Thr G ly G ly I h r  G in Lau Pro Thr Lau Ala Arg Sar Pha 11« 11« Cya I I « G in Hat 11« Sar Clu
T
OCA OCA AGÀ TTC CAA TAT ATT GAG GUA GAA ATU OOC AOC AGA ATT A K  TAC AAC OOC AGA TCT OCA OCA GAT OCT AUC CTA ATT ACA CTT
Ala Ala Arg Pha Gin T yr 11« Clu G ly Glu Hat Arg Thr Arg 11« Arg Tyr Aan »r g Arg Ser Ala Pro Aap Pro Ser Val I I « Thr Lau
GAG AAT ACT TOC OOC Aga c r r TOC ACT GCA ATT CAA GAG TCT AAC CAA oca OOC IT T OCT ACT OCA ATT CAA CAA AGA OCT AAT OUT 
(Aan U ly  
«»P
Clu Aan Sar Trp G ly Arg Lau Ser Thr Ala Ile Cln Glu Sari » Aan Cln C ly Ala Pha Ala Sar Pro Ila  Gin Lau Gin Arg Arg
. . .
TOC AAA 
Sari Lya
TTC ACT CTC TAC CAT CTG ACT ATA ITA ATC OCT ATC ATA OCT e ie ATC CTC TAT AGA ICC oca ccr OCA OCA TOG TOA CAC TTT
Pha Sar Val Tyr Aap Val Sar 11« Leu I la  Pro I la  
Lau
11« Ala Lau Hat Val Tyr Arg Cya J U  Pro Pro Pro Sar Ser G in Pha
TCT TIC c r r  ata AOC OCA GTC CTA OCA AAT IT T AAT OCT GAT CTT
•f*
TCT ATC GAT OCT CAC O K ATA ere Oc t ATC CTA OCT OGA AAT OCT
Sar Lau Lau I la * * Pro Val Val Pro Aan Pha A «  M .  tap Val Cya Hat A«P Pro Glu Pro 11« Val Arg 11« Val C ly Arg Aan G ly
'  . •1*
CTA TOT GTT CAT CTT AOC CAT OCA AGA TTC CAC AAC OGA AAC OCA ATA CAC TIC TOC OCA TOC AAC TOT AAT ACA GAT ÒCA AAT CAC ere
Lau Cya Val Aap Val Arg Aap G ly  Arg Pho Hla Aan G ly  Aan Ala 11« Gin Lau Trp Pro Çya l y » Sar Aan Thr Aap Ala Aan C ln Lau
Aan IIU. . . . .
TOC ACT TIC  i__ _____
Trp Thr Lau Lya Arg I
r ACT i r OQA TCT AAT OCA t
i  Ih r  I I «  Arg Sar Aan Gl y  Lya Cya Lau Ih r  Ih r  T y r  C ly  T y r  !
r TTA ACT ACT TAC GQ0 TAC ACT O K  OGA (TIC TAT CIC A1C ATC TAT
Tro Sor
> C ly  Val Tyr Val : I la  T y r
GAT ICC AAT ACT OCT OCA ACT GAT GOC ACC O K  TOC CAA <
p Cya ¿jjn Th r Ala Ala
Thr
Ala Thr Arg T rp  G in  l i a  T rp  i
• O lu  i
T  AAT OCA ACC ipBBGüB ATC ATA AAT OOC ACA TCT ACT CTA CTT TTA OCA|lla I I «  Aan Pro Arg Sor ! i Val i A la
OOC ACA TOA OOC AAC ACT CCT ACC ACA CTT ACC GTC CAA ACC AAC ATT TAT OOC C ÏT ACT CAA COI TOO CIT OCT ACT,
Ala Thr Sar C ly  i r C ly  Ih r  Thr I r Val C ln  Th r Aon 11« Tyr A la  Val 8or G in  C ly  Trp  Lau Pro Thr
AAT AAT ACA d  
LA>n Aon Thr K=1
OCT TTT CTT ACA AOC ATT CTT OOC CTA TAT OOT CIC TOC TTC CAA OCA AAT ACT OCA CAA CTA TOC ATA GAG GAC TCT AUC ACT CAA AAC 
Pro Pha Val Thr Ih r  I I «  Val C ly  Lau T y r C ly  Lau Cya Lau G in Ala Aan Sar G ly  G in Val Tra  I la  G lu Aop Cya Sar Sar C lu Lya 
T rp  *** Val Sar Cya
OCT CAA CAA GAG TOO OCT C IT TAT OCA GAT GOT TCA ATA OCT OCT CAO CAA AAC OCA CAT AAT ICC CIT ACA ACT GAT TUT AAT ATA OHG
9 G in Gin iArg i Cya i i Ih r  Sar .A la C lu G in  G in T rp  Ala Lau Ty r A la Aap G ly Sar ]£ «  Arg I 
CAA ACA CTT C IT  AAC ATC CTC TCT TCT OOC OCT OCA TOC TCT OOC CAA OCA TOG ATC ITC AAC AAT GAT ÜGA AOC ATT TTA AAT ‘
i 11« Arg
Clu Ih r  Val Val Lya I la  I r Cya C ly  Pro Ala Sar Sar G ly  G in Arg Trp  
Clu
i Lya Aan top C ly Thr I I « i Aan I i  Ty r
ACT OCA T IC  CIC TTA CAT CIC AGO OGA TOO CAT COO AOC C IT  AAA CAA ATC ATT CTT TAC OCT CTC CAT OCT GAC OCA AAC CAA ATA TOG
Sar C ly  Lau Val
TTA CCA TTA
» Val Arg Arg 
Ala
Cln I la  I la  1 i  T y r I i  Illa G ly  < 
«C ly  IIU
i C ln I I «  f r p
K TAGACAGATT ALT LTCTTOC ACTCTOTAIC TOCTOOCATC AAAATACATC OCTTAAATAA AAACGACATT CTAAATTTTG TAACTGAAAG
(»N
GACÂOCAACT TATTOCACTC CAGTATCTAA TAAUAGGACA ACTATTGTCT TCIGCATTCT AAATTT -  Poly(A ) -  C -ta ll
Fig 3H-1: The praproricin cDNA »aquatica
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5 -AAACOGGGAC GAAATACTAT 1UTMTAT0C ATC TAT OCA CTC OCA ACA TOG CIT TCT n r UGA TOC AGC TCA GOC TOC TCT TIC ACA TTA GAR
Hat T y r Ala Val A la  Th r T rp  Lau
• M c y .
Pha O ly Sar Thr Ser G ly Trp Sar Pha Thr Lau Glu
GAT AAC AAC ATA n e CGC AM CM TAC GCA A n ATA AAC T IT  MX ACA GOC GCT GOC
V
ACT CTG CM AOC TAC ACA AAC T IT ATC ACA GCT
Aap Aan Aan I I « Pha Pro Lya Gin Tyr Pro i i « UalAan Ria Thr | lh r  Ala O ly Ala Thr Val Gin & r  * * Thr Aan Pha I I « Arg Ala
*!•
CTT GOC GCT GCT TTA ACA ACT GCA GCT GAT CTG ACA GAT GAT ATA GCA CTC TTC OCA AAC ACA CTT oe r n e 0CT ATA AAC GM GOC TTT
Val Arg C ly  A r« Lau I h r  Ih r C ly A I« U p Val Arg IIU  Aap 
-  G lu
11« Pro Val Lau Pro Aan U g Val G ly  Lau Pro 11« Aan Gin Arg Pha
» r
ATT TTA CTT GM CIC TCA M T CAT OCA GAC CTT TCT CTT ACA m OCC CTC CAT CTC AGC M T GCA TAT GTG CTC GOC TAC GCT GCT GGA
11« Lau Val G lu
M
Lau Sar Aan
Gin
IIU Ala Glu Lau Sar Val Thr Lau A l«  Lau U P
Sar
Val Thr Aan Ala
Ï T  V a l
Val C ly  Tyr A r« Ala G ly
*!•
M T  AGC OCA TAT TTC TTT CAT GCT GAC M T CAC GM GAT OCA GM GCA ATC ACT CAT CTT TIC ACT GAT CTT CM M T ¿ca TAT ACA TTC
Aan Sar Ala T y r Pha Pha IIU Pro Aap Aan Gin G lu  M p Ala Glu Ala  11« Thr H U Lau Pha Thr Aap Va l Gin Aan Arg Tyr Thr Pha
GOC IT T GCT GCT M T TAT GAT AGA CTT GM CM CTT GCT GCT M T
• r
CTC AGA GM AAT ATC GAC TIC GGA M T GCT OCA CTA GAC GAC GCT
Ala  Pha G ly  G ly Aan T y r M p Arg Lau Clu Gin Lau Ala C ly Aan Lau Arg Glu Aan 11« Glu Lau G ly  Aan O ly Pro Lau Glu Glu Ala
f* T
ATC TCA GOC CIT TAT TAT TAC ACT ALT GCT GOC ac t  gag e n OCA ACT CTG GCT GCT TOC T IT ATA A n  TOC ATC CM ATC A n TCA GM
I I «  Sar Ala Lau T yr T y r  Tyr S«r Ih r G ly C ly Ih r  G in Lau Pro Thr Lau Ala Arg Ser Pha 11« 11« C y« I I « G in Nat I I « Ser Glu
f
GCA GCA ACA TIC CM TAT ATT GAR GGA GM ATC GOC AOC AGA A n AOC TAC AAC GOC AGA TCT GCA OCA GAT GCT AGC CTA A n ACA CTT
Ala Ala Arg Pha Gin T y r 11« Glu O ly Glu N at Arg Ih r  Arg i i « A r« Tyr Aan Arg Arg Ser Ala Pro Aap Pro Sar Val 11« Thr Lau
T*
GAG M T ACT TOG OGG acá e r r TOC ACT GCA A n CM GAG TCT AAC c m  oca GOC T IT GCT ACT OCA ATT C M CTG CM AGA OGT AAT OGT 
(fen G ly
fep
G lu  Aan Ser Trp G ly Arg Lau Sor Thr Ala 11« Gin G£u Sar Aan Gin G ly Ala Pha Ala Sar Pro I la  G in Lau Gin Arg Arg
*!•
TOC AM 
Sari Ly«
TIC ACT GTG TAC GAT GTG ACT ATA TTA ATC GCT ATC ATA GCT CTC ATC CTG TAT AGA TOC OCA CCT OCA OCA TOG TCA CAG TTT
Pha Sar
IM
Val T y r  U p Val Sar 11« Leu 11« Pro 11« 
Lau
11« Ala Lau Net Val Tyr U g Cy. A U  Pro Pro Pro Ser Sar Gin Pha
TCT TIC C IT ATA AGC OCA GTG CTA OCA AAT TCT M T GCT GAT CTT TCT ATC GAT GCT GAG GOC ATA GTG OGT ATC CTA OGT GCA M T GCT
Sar Lau Lau 11« A r» Pro Val Val Pro Aan Pha Val Cya Nat *H> Pro Glu Pro 11« Val A rg 11« Val G ly Arg Aan G ly
CTA TCT CTT GAT GTT AGC GAT GGA AGA ITC GAC AAC OCA AAC GCA ATA CAS n e TOG OCA TOC AAC TCT M T ACA GAT GCA M T CAC e ie
Lau Cya Val Aap Val Arg Aap G ly  Arg Pha H l« Aan G ly  Aan Ala 11« Gin Lau Trp Pro cy« Lya Sar Aan Thr Aap Ala Aan Gin Leu
Aan Aan IIU
m p . • . .
TOG ACT TIG AM AGA GAC M T ACT A n  GGA TCT M T OCA AAC TCT m  ACT ACT TAC GOC TAC ACT COG GGA CTC TAT CTC ATC ATC TAT
T rp  I h r  Lau Lya Arg Asp Aan Ih r  I I «  Arg Ser Aan C ly  Lya Cya Lau Ih r  I h r  Ty r G ly  Ty r Sar Pro C ly  Val Tyr Val Nat I I «  Tyr
—  Pro Sor• <y* , . . .  "p .
GAT TOC M T  ACT OCT OCA ACT GAT GOC AGC O R  TOC CAA AIA TOC CAT AAI OCA ACC ATC ATA AAT CGC AGA TCT ACT CTA GTT ITA  GCA
Aap Cya Aan Ih r  A la  A la  Ih r  Aap Ala Ih r  Arg T rp  G in 11« T rp  AaplAan G ly Ih r l i la  I la  Aan Pro A rg  Sar Sar Lau Val Lau Ala
m  Ih r  Aap —  G lu  Aan ■"
GOC ACA TCA GOC AAC ACT GCT AGC ACA CIT AGC GTG CM ACC AAC ATT TAT GOC GTT ACT GM OCT TOG CTT CCT ACT M T M T ACA CM
Ala  Ih r  Sar G ly  Aan Sar G ly  Ih r  Ih r  Lau Ih r  Val G in Ih r  Aan I la  T y r  A la Val Sar Gin G ly  T rp  Lau Pro ThrlÄan Aan I h r lOln
Pro Pha. . . 'f
GCT TTT G IT  ACA AOC ATT G IT  GOC CTA TAT GCT CTG TOC TTC GM  OCA M T  ACT GGA GM GTA IOC ATA GAG GAC TUT AGC ACT GM AAU
Pro Pha Val Ih r  I h r  I la  Val G ly  Lau Tyr G ly  Lau Cya Lau G in Ala Aan Sar G ly  G in Val Trp  11« G lu  Aap Cya Sar Sar Glu Lyn
T rp  7 / 7 /   ^ Val S ir  Cya
GCT GM  CM GAG TOC GCT CTT TAT GCA GAT GUT TCA ATA GCT GCT GAC CAA AAC OCA GAT M T TUC C IT ACA ACT GAT TUT M T  ATA GRU
Ala  G lu  Gin G in T rp  Ala Lau Ty r A la  Aap G ly  Sar I I «  Arg Pro Gin Gin Aan Arg Aap Aan Cya Lau I h r  Sar Aap Sar Aan I I «  Arg
Sar Aan Aan Arg
GM  ACA C IT  GTT AAG ATC CIC TCT TUT GOC GCT OCA TOC TUT GOC CM OCA TOC ATU TTC AAC M T GAT GGA AOC ATT TTA M T TIC TAT
G lu  I h r  Val Val Lya I I «  Lau Sor Cya G ly  Pro Ala Sar Sar G ly  G in Arg T rp  Hat Pha Ly« Aan Aap C ly  Ih r  H a  Lau Aan Lau Tyr
**• ( G lu "• w
ACT OCA TIC CTG TTA GAT CTG AOC OCA TOC GAT CGC AGC C IT  AM  CM ATC ATT CIT TAC GCT CTC CAT GUT GAC OCA AAC CM ATA TUG
Sar G ly  Lau Val Lau Aap Val Arg Arg Sar Aap Pro te r Lau Lya Gin I I «  I I «  Lau T y r Pro Lau lila  G ly  Aap Pro Aan G in 11« Trp
Ala "*  *Cly H U   ^ *
TTA CCA TTA T IT  TCA TACACAGATT ACT LTCITOC ACTCTUTAIC TOCTOCCATO AAAATAUA1C GCITAM TM  AAAOGACATT G TAM Tm C TAALTGAAAC 
Lau Pro Lau Pha ***
GACAGCAACT TATTOCACTC CACTATCTM TAAGAGCACA ACTÀTTCTCT TCTOCATTCT AAATTT -  Poly(A) -  C -ta ll
Fig 3H-1: The praproricin cDMA aaquanca
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The preproagglutinin sequence is shown in fig 31-1, compared with 
Funatsu's ricin A and B chain sequences. The format is as fig 3H-1.
The overall structure of the sequence is the same as that 
of the preproricln sequence, but the A chain is three bases 
shorter, corresponding to deletion of ricin's alanine at position 130. 
An additional potential N-glycosylation site is located at 
residues 357 - 359, in the B chain, and the A chain contains two 
cysteine residues, at positions 84 and 156, which are absent in 
the ricin sequence.
Both sequences begin at the 5' end at the same nucleotide: this 
may reflect homology extending towards the 5' terminus, resulting 
in identical nuclease cleavage points for both sequences.
The preproagglutinin sequence contains only 69 bases of 
3' non-coding region, and these are Identical to their counterparts 
in the preproricin sequence.
There are nmerous differences in the coding regions, which will 
be discussed in detail in following sections.
Clone pRCL52 contains bases -102 to 1566, and clone pRCL57 
contains bases 538 to 1689, though not all of this clone has 
been sequenced. No differences were found in the overlapping 
regions.
31 The preproagglutinin sequence
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3J1 Comparison with protein-determined sequences 
The molecular weights of the deduced sequences are shown in fig 
3J-1, along with those calculated from Funatsu's data. Values for 
the ricin chains are close to those of Funatsu; the RCA chains 
are of similar sizes to those of ricin.
The comparison of the two deduced sequences with the 
protein-determined data already presented (fig 3G-1) includes 
all differences, regardless of cause. As will be shown, many of 
these may result from errors in the protein sequence data, though 
it most be borne in mind that seed proteins do tend to be 
heterogeneous, and that some of the differences which might be 
explicable on these grounds may in fact be genuine differences.
It must also be remembered that cDNA synthesis does not always produce 
absolutely faithful copies of an mRNA sequence (232,253), 
so that some of the differences may be errors in the cDNA.
Fig 3J-2 lists all the differences between the sequence 
determined by Funatsu and the deduced ricin sequence, and classifies 
them into those explicable by transposition of residues, those 
due to mis identification or missing of tryptophan, and 
those involving confusion with anidated residues. Those lacking 
conments are assumed to be inexplicable by any obvious problem 
In protein sequencing. These remaining differences are plotted 
in fig 3J-3, which shows that the two sequences assvxne a much greater 
degree of similarity than is at first apparent.
Funatsu's sequence data were obtained from A and B chains 
isolated either by performlc acid oxidation of native rlcin, or 
by reduction with 2-mercaptoethanol (51). In the case of the A 
chain, much of the sequence was determined solely on
chains (33,34), while the B chain was determined both on
3J Analysis of protein sequences
Fig 3J-1: A m in o  acid compositions and molecular weights
Riein A Riein B RCA A RCA B Signal Linker
Ala 24 14 23 12 2 -
Cys 2 9 4 9 1 -
Asp 9 17 10 14 1 -
Glu 14 5 15 6 1 -
Phe 14 4 15 6 2 1
Gly 17 20 15 20 2 -
His 4 2 5 2 - -
He 22 18 22 18 - 1
Lys 2 7 2 11 - -
Leu 23 24 21 23 2 2
Met 3 3 4 3 1 -
Asn 17 21 15 21 2 2
Pro 15 13 15 13 - 2
Gin 14 15 13 16 - -
Arg 21 14 19 13 - 1
Ser 19 20 21 19 3 1
Thr 17 21 18 22 3 -
Val 15 17 16 19 1 2
Trp 1 9 1 10 2 -
271_____ 14 9 12 5 1 -
Total 267 262 266 262 24 12
29399 28531 29261 28584 2670 1309
Funatsu 29172 27944
MW of preproricin is 61855 Dal.
MW of preproaggluCinin is 61779 Dal.
a t  3J-2: Amino acid differences
List of amino acid differences between the ricin sequences according 
to Funatsu's group and that deduced from the cDNA. Numbering is 
from fig 3H-1; a + following a number indicates position of a 
residue in Funatsu's sequence which is absent in the cDNA-derived 
sequence.
Position cDNA Funatsu
A 41 Asp Glu
63 Ser Gin
75 Asp Ser
235 Arg —
236 Asn Asp
249 He Leu )
254 Leu ... j
B 301 Asp Asn
308 His Asn )
309 Asn His )
328 Trp —
349 Ser Pro \
350 Pro Ser )
365 Asp Thr 1
367 Thr Asp )
369 Trp —
370 Gin Glu
410 Trp Pro
412 Pro Phe !
419 Phe Trp
439 Trp Val
443 Cys Ser )
444 Ser Cys )
457 Asp Ser )
459 Ser Asn )
461 Arg Asn )
465 Asn Arg )
493 Gin Glu
Comments ________________
Alternative acid
Misinterpretation of Arg-Arg as Arg 
Acid-amide
Transposed Leu plus missed He
Acid-amide
Transposition
Missed Trp 
Transposition
Transposition
Missed Trp 
Acid-amide
Complex transposition
Mia identification of Trp? 
Transposition
Transposition plus acid-amide
Transposition
Acid-amide
Continued....
Fig 3J-2 (continued)
Position cDNA Funatsu
B 516 Arg Ala
529+ — Trp
530 His Gly )
531 Gly His )
535+ — Leu
537 Trp —
540 Leu —
Comments________________
Incorrect position of Trp-537 
Transposition
Incorrect position of Leu-540 
Correct position of Trp (529+) 
_Correct_posl.tl.oo of_Leu_( 535+2
For further details and commenta see text
»« 3J-3
Differences between deduced ricin sequences end ricin sequences 
determined by Funatsu’s group, ignoring differences which may be due 
to protein sequencing errors.
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oxidised material and on reduced, carboxymethylated chains (35,36). 
Perforale acid treatment of proteins is not entirely specific 
for modification of cysteine residues - it is well-known that 
tryptophan residues are largely degraded to kynurenine and 
other products (254); tyrosine and histidine residues may also 
be modified and degraded (254). Serine and threonine residues 
may undergo acyl shifts - that is, the peptide bond is converted into 
an ester linkage - though this reaction is reversible and its 
significance to sequencing studies is unclear (254). Methionine 
is also modified, almost quantitatively, to the sul phone, but this 
derivative presents no problems. Funatsu (34) cooments that methionine 
was indeed converted to the sul phone (or the sulphoxide), that 
cysteine residues were partially converted to cysteic acid, but that 
no modification of tyrosyl or histidyl residues was observed.
In the case of the A chain, tryptophan residues were checked by 
cleavage with N-chlorosuccinlmide, followed by N-terminal analysis 
of the product mixture - this confirmed that the A chain contains only 
one tryptophan. No such analysis is reported for the B chain, possibly 
because it contains several tryptophan residues and the products 
may have been complex. This is unfortunate, as several of the 
possible errors in the B chain concern tryptophan residues.
Reduction and carboxymethyl at ion of the chains may also result 
in sequencing problems, in that reports suggest that seme 
2 X of lysine residues may be carboxymethyl ated, and that up to 10 X 
of methionine residues may be degraded (254). However, the low 
proportions are unlikely to have a very great effect, and appear 
not to have caused Funatsu any difficulty.
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The differences between the amino acid sequences determined 
by Funatsu's group and those deduced from the cDNA will now be 
discussed in more detail.
The C-terminus of the A chain was only sequenced in one 
fragment by Funatsu (33,34): a peptic peptide of 18 residues, 
designated fragment T-23. Part of this fragment was also 
examined by determination of the amino acid composition of a 
small (6 residue, according to Funatsu) peptic fragment 
derived from a large cyanogen bromide fragment (designated 
CBII-P2):
S K F S V Y D V S  I L L P  I I A - M V Y R C Ai iS K F S V Y D V S I L I P I I A L M V Y R C A
.-- --------------------------- - T-23
•---------- - CBII-P2
The composition of CBII-P2 is given as Pro Ala Ilej Leu Hse
(Hse - homo serine, product of cyanogen bromide action on methionine).
It appears that the leucine in fragment T-23 has been misplaced, 
and that the failure to detect the extra isoleucine in the 
composition analysis of CBII-P2 has resulted in this not being 
corrected. It is noteworthy that both apparent errors are 
contained within both fragments.
The next region to be discussed is that which starts at residue 
355 - following this residue there is a transposition, an omitted 
tryptophan and a possible asparagine-aspartic acid confusion.
The fragments used by Funatsu are shown below, along with the
HaAiffri sequence, and the sequence obtained by Li's group (50):
Funatsu (33,34): 
cDNA:
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M I Y D C N T A A T T A D R - E I W N Ni i i  •M I Y D C N T A A T D A T R W E I W
M I Y D C N T A A T D A T R W E I W D N
*------------ 1 CBI
________ C8I-I4 CBI-T1
._________CBI-P11 CBI-P3
Of Che first fragment, CBI, only Che first 5 residues were sequenced.
Its subfragment CBI-T4 was completely sequenced, though the fragment Pll 
was not sequenced (its composition is given as Asp2 Thr2 
Ala2 He Tyr, ie 8 amino acids, though Funatsu draws it as 9 residues 
in length). However, the region containing the transposition 
was sequenced twice (in CBI-T4 and in CBI-P3). Similarly, the 
region with the missing tryptophan and the acid-amide confusion 
was also sequenced twice (in CBI-T1 and in CBI-P3). Note that 
the transposition was never split over two fragments. Li's group 
also sequenced the cyanogen bromide fragment corresponding to 
Funatsu ' s CBI and obtained a sequence identical to that from the 
cDNA sequence (50), which supports the possibility that Funatsu 
is in error in this region.
The 'complex transposition' indicated in fig 3J-2 occurs at 
residues 410, 412 and 419. This region was sequenced twice by Funatsu:
Funatsu (36): T N I Y A V S Q G P L F T N N T Q P W V T T I V GI I I
cDNA: T N I Y A V S Q G W L P T N N T Q P F V T T I V G
I .. .....  -  i CBI-T8-C1
Funatsu (35,36): 
Li (50): 
cDNA:
CSI-P2
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It Is notable that both fragments gave the same sequence. As In the 
above case, the residues involved in the transposition were never 
examined on different fragments - errors would be less likely if the 
data overlapped more. Another fragment covering part of this 
region was examined by determination of its amino acid composition, 
giving results consistent with the sequence results - the fragment 
contained two of the transposed residues, but not the third.
However, the identity of a Glx residue in this fragment is 
unclear - the composition gives glutamic acid, while in the sequence 
it is presented as glutamine (vdiich agrees with the cDNA).
In the sequences of the two fragments shown above, this residue 
is presented as Glx. What has happened at this point is unclear.
The situation at the end of the B chain is more complex, involving 
residues misplaced, mis identified and transposed:
At the end of the B chain, there are three differences between 
Funatsu's sequence and that deduced from the cDNA: two misplaced 
residues, and a transposition:
The amino acids His-Gly at 530-531 are transposed. The tryptophan 
residue which Funatsu places after Leu-529 should be at position 537, 
and the leucine which Funatsu places after Gln-535 should be at 
position 540.
Funatsu: K Q I I L Y P L W G H D P N Q L I - L P - Fit: i • •
cDNA: K Q I I L Y P L - H G D P N Q - I W L P L FS2J 530 54
CBIII-T3
CBIII-P4 C8III-P6
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As can be seen from fig 3J-2, three differences between the 
Funatsu and the cDNA-deduced sequences remain, two in the A chain 
sequence and one in the B chain sequence. A similar analysis 
has not been performed for the putative agglutinin sequence, 
because this differs much more from the Funatsu sequences.
It must once again be emphasised that some of the apparent errors 
in Funatsu's data may not be errors, but may reflect 
heterogeneity between different castor bean varieties. The beans 
used in this study are not of defined lineage, and may possibly 
contain other nRNAs encoding proteins more closely related to 
those sequenced by Funatsu's group than the ones which were 
cloned here.
The deduced ricin A chain sequence contains one potential 
N-glycosylation site absent from Funatsu's sequence, caused by 
the presence of an asparagine residue at position 236, where 
Funatsu's sequence has aspartic acid. This is in accord with 
recent results, which indicate that the ricin A chain does carry 
two oligosaccharide moieties (B Faxwell, personal coranunication).
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3J2 Comparison of deduced amino acid sequences
The two deduced amino acid sequences are presented in fig 3J-4,
differences between them being indicated by vertical lines.
The signal and linker peptides have identical sequences; the A chains 
are identical at all but 18 positions, and are thus 93.3 X 
homologous, while the B chains differ at 41 positions and are 
84.4 X homologous.
The differences between the sequences are listed in 
fig 3J-5, along with their codons. 45 changes are due to 
single base substitutions, 10 involve alteration of two bases 
within a codon, while three changes result from complete replacement 
of codons. One codon present in the preproricin sequence is absent 
in the preproagglutinin. The reversal of lysine and arginine at 
positions 330 and 331 may be a cDNA synthesis artefact, since it 
involves displacement of a G in a run of A's (the agglutinin has 
AGA-AAA and ricin has AAA-AGA). Clearly, several changes could be 
explained as cENA synthesis errors, which are known to occur (252). 
However, the number of changes is far too high for many to be 
due to such errors - the rate of misreading by reverse transcriptase 
has been estimated as one in 600 bases (253). Confirmation of 
rh«ngp« can only be achieved by sequencing more clones for both 
sequences.
Of the total of 59 amino acid differences, 22 might be expected not 
to alter the properties of the protein significantly, as in these 
cases the amino acids in both proteins are of similar 
characteristics (that is, they are members of the same groups as 
defined by von Heijne (263) - eg hydrophobic, aromatic etc). These
«re marked with asterisks in fig 3J-5. A further four changes
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fit 3J-5: Amino acid differences
Amino acid differences between the two deduced sequences are listed, along 
with their codons. Numbering is according to the preproagglutinin 
sequence. One asterisk indicates that both residues shown are of 
similar properties (see text), while two indicate an amidated residue 
change. Residue 129+ is an extra amino acid in the preproricin sequence 
which follows residue 129 of the preproagglutinin sequence.
Position Aggl Ricin Aggl Ricin
(A) 15 Asp Gly GAT GGT
19 ’ Glu *★ Gin GAA CAA
30 - Ser Gly AGT GGT
31 His Arg CAT 0GT
41 Glu * Asp GAA GAT
54 Ser Asn AGC AAC
84 Cys Tyr TGC TAG
114 Ser Arg TCA CGA
115 Phe k Tyr TTT TAT
129+ — Ala — GCT
131 Gly Asn GGT AAT
140 Thr Asn ACT AAT
145 Asp k Glu GAC GAG
156 Cys Gly TGT GGT
160 He * Leu ATT err
168 Met k He A7G ATA
169 Val * He GTT ATT
240 Asn Ser AAT AGT
(B) 302 Thr Arg ACA AGG
303 Gly Asp GGT GAT
304 Glu Gly GAA GGA
305 Glu k Arg GAA AGA
307 Phe * His TTC CAC
308 Asp ** Asn GAT AAC
311 Pro Ala OCA GCA
323 Trp Ala TGG GCA
330 Arg ★ Ly. AGA AAA
331 Lys k Arg AAA AGA
AGC AAT
Continued....

Involve amidated residues, and are indicated in fig 3J-5 by double 
asterisks.
The effects of the differences in sequence were examined by 
generating hydropathy plots of the A and B chains, using the 
progranme described in Appendix 1. Hydropathy values determined by 
Kyte and Doolittle (255) were used: these are averaged over a number 
of residues (the span), and plotted against position in the protein. 
Kyte and Doolittle noted that spans of 7 - 11 residues gave the 
most meaningful results in terms of signal-to-noise ratio, and best 
correlation with structural features determined by X-ray diffraction. 
That is, hydrophilic regions tend to be located on the external 
surface of the molecule, while hydrophobic regions are buried in 
the interior.
The resulting plots are shown in figs 3J-6 (A chains) and 
3J-7 (B chains); the latter also shows the positions of the 
disulphide bridges. The cysteine residues, and consequently, 
the disulphide bridges, are conserved. The bridges tend to occur 
at the limits of hydrophobic regions - these may thus represent 
polypeptide loops associating together in the inside of the molecule, 
a feature which may be required to construct the sugar-binding sites 
by bringing together different parts of the chains at the surface.
Fig 3J-8, a difference plot for hydropathy, shows that the 
region of greatest difference coincides with the second hydrophobic 
loop; the agglutinin has a less hydrophobic loop than does ricin.
The agglutinin loop may be less deeply buried than that of ricin, 
with the possible result that different residues are exposed at the 
surface - causing different sugar specificity. Differently 
mtpossd residues may also participate differently in intermolecular 
interactions, allowing the agglutinin to form its dimers of
154 -
Fig 3J-6: Hydropathy plots of A chains.
The ricin A chain hydropathy plot is shown above, and tha 
agglutinin below. Both ware determined with span - 9 residues.
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Fig 3J-8s Hydropathy difference plots 
Hydropathies over a span of 9 residues were determined 
simultaneously for both sequences, and the difference was plotted. 
Positive peaks indicate that rlcin is more hydrophobic than 
the agglutinin at the region of the peak, and vice versa.
The A chains are shown above, and the B chains below.
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ricin-like species.
Secondary structures were predicted by the method of 
Gamier et al, as described In Appendix 1. No gross differences 
emerged between ricin and the agglutinin, though an alpha-helical 
region around residue 100 of the A chain was marginally longer 
in the agglutinin, and a region of alpha helix was predicted 
in the agglutinin B chain which was not predicted in the 
corresponding ricin position. The region containing this latter 
feature coincides with the first hydrophobic loop.
The conclusions presented here are necessarily extremely 
tentative, and resolution of these questions will have to await 
the availability of good X-ray diffraction data.
The a g g lu t in in  B chain has one glycosylation site not present 
in the ricin B chain, located at residues 357 - 259 (Asn-Cys-Ser 
in the agglutinin). It is possible that this also plays a role in 
the quaternary structure of the agglutinin. Also, the agglutinin 
A chain has two cysteine residues absent from the ricin A chain, 
at positions 84 and 156.
avid r*cA MEfei
A s
-  158 -
3J3 The signal and linker peptides
The cDNA sequences predict the presence of 24 amino acids 
preceeding the N-terminus of the mature lectin A chain, these 
being the same for both proteins. These are presumed to represent 
signal sequences involved in the cotrans1ational segregation of the 
nascent polypeptides, and have been observed in all protein 
body proteins thus far investigated (eg refs 87,95,256-262).
It is unlikely that the signals play any role in the topogenesis 
of protein body proteins other than cotransiational segregation, 
since they are cleaved cotranslationally, though it is conceivable 
that they may direct the proteins to a receptor which carries them 
to their ultimate destination.
The signal sequence of the castor bean lectins Is:
M Y A V A T W L C F G S T S G W S F T L E D N N  - mature A chain
The hydrophobic properties of this sequence were examined by 
producing a hydropathy plot as described in section 3J2.
Fig 3J -9 shows the results obtained with spans of 1 and 5 residues. 
The former shows hydropathies for Individual amino acids; the 
span of 5 was used because the wider spans previously used are 
Inappropriate for so short a sequence.
The lower plot (span - 5) indicates that the first 10 residues 
are in general hydrophobic, though the upper plot (span - 1) 
reveals the presence of hydrophilic residues among them.
This Is not entirely characteristic of signal sequences - they 
usually have a hydrophobic core, rather than a hydrophobic beginning, 
and usually terminate with a small uncharged residue (263).
-  1 5 9  -
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:
Fig 3J -9: Signal sequence hydropathy plots.
Plots were constructed as described In the text, with span
(above) and span - 5 (below).
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Von Heijne examined 78 eukaryotic signal sequences (no plant 
signals were included) and formulated a set of rules for predicting 
the cleavage site (263): starting from the N-terminus, a search 
is carried out for a group of four residues, three of which are 
hydrophobic. This opens up a 'processing window' a number of 
residues downstream, and the site of cleavage is predicted in detail 
within this window. The hydrophobic residues are phenylalanine, 
isoleucine, leucine, methionine and valine: no quadruplet 
containing three from this group is found within the present signal 
sequence. The same study found that aspartate residues are never 
present in position -3 (with respect to the cleavage site), and in 
only one case was an asparagine or a glutamine found at position -1.
The present sequence is unusual in having both of these features.
Since von Heijne excluded plant signal sequences, a small 
group are shown in fig 3J-10. Note that all except the castor bean 
lectins obey the '-3, -1' rule, in that the -1 position is always 
occupied by an alanine or a serine residue, and no forbidden residues 
are found at the -3 position (270) and that proline does not occur 
between -3 and -1.
Von Heijne suggests (270) that selection of residues in this region 
is to offer a single site to signal peptidase, other
potential sites being blocked by the presence of forbidden residues.
The unusual nature of the castor bean cleavage site may perhaps 
be explicable by an unusual signal peptidase: the -1 position 
is occupied by asparagine, which may be associated with precursor 
processing sites (see later in this section).
Although one study (271) suggested that only entirely 
non-polar signals can interact with the receptor, several 
signals do contain polar residues, in the hydrophobic core (263).
The hydrophobic region of the castor bean lectin signal may thus 
represent a more extreme case of this observation.
Cleavage site Reference
Thaimatin II TLSRA/ATFE 264
Zein clone A30 SAASA/TIFP 265
Zein p22.1 SATNA/FIIP 276
Phaseolus lectin SHANS/ATET 266
Phased in SASFA/TSLR 258
Pea legunln GGCFA/LREQ 267
Pea vicilln VCVSS/RSDQ 268
Pea seed lectin FKVNS/TETT 262
Napin LLTNA/STYR 95
Wheat gliadin TATTA/VRFP 269
Barley amylase GALAS/GHQV 275
Soybean seed lectin SKANS/AETV 262
LEDNN/IFPK Present work
Fig 3J-10: Plant signal sequence cleavage sites
Cleavage sites shown were determined by comparison with mature
proteins, or are most likely sites - by a variety of criteria,
for which see references cited.
I
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Between the C terminus of the A chain sequence and the N terminus 
of the B chain, the cDNA precursor sequence reveals a 12 amino acid 
linker peptide, which is the same for both lectins. This Is shown 
below, along with the termini of the chains:
A chain - P P P S S Q F / S L L I R P V V P N F N / A D V C M - B  chain
Linker peptides from a few other proteins have also been sequenced: 
that of napin (95) is 19 or 20 residues long, depending on 
heterogeneity, while that of pea seed lectin Is 6 residues (94), 
though identification in this case is not final. By analogy, lentil 
lectin, which is homologous to pea seed lectin, may have a 
tetrapeptide linker, while conA, which is otherwise homologous to 
these two lectins, is not cleaved - and Is divergent at the 
processing site (94). An analogous situation has been found to 
apply to pea vie 11 in: the 47 kDal variant is processed by a single 
endoproteolytic cleavage, while the 50 kDal species is not (268).
The proteins are homologous except at this region, in which a 
number of cDNA base changes occur, and two small deletions are 
quite close. Pea legumin also appears to be processed by a single 
cleavage (267), thus not having a linker. Soybean glycinin has a 
4 - residue linker (272). The sequences surrounding these 
processing sites are shown in fig 3J-11.
The conmon factor which emerges from these is the asparagine 
residue at the C-terminus of the linkers. This may have seme 
bearing on the asparagine residue at the end of the castor bean 
lectin signal sequence, if the signal peptidase is related to the 
processing enzyme.
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The mammallan protein insulin Is also synthesised as a 
heterodimer precursor, and has a linker (or connecting peptide) 
of 33 residues, accounting for more than one third of the 
precursor (96). Both ends of the linker have dibasic 
sites, which Is not observed in the plant linkers.
Haptoglobin Is also synthesised as a precursor, and in this case 
has a single arginine residue as its linker, this not being 
part of a dibasic site (274).
The enzymes responsible for processing heterodimer 
precursors have as yet received little attention. However, 
the castor bean lectin processing enzyme has been located 
within the protein bodies, and has been shown to cleave the 
lectin precursors to products of the expected sizes, with a 
pH optimum of 4: this Is consistent with processing taking 
place In protein bodies (S Harley and JM Lord, personal communication).
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3K Analysis of nucleotide sequences
3K1 Comparison of preproricin and preproagglutinin sequences 
Both cDNA sequences are shown in fig 3K-1; the agglutinin sequence 
is above the ricin sequence. The agglutinin deduced amino acid 
sequence is presented above its cDNA sequence, while only those 
residues which differ are shown for ricin, below the sequence.
Throughout the overlapping part of the sequences there are 
114 base differences, giving identity at 93.25 l of positions.
The B chains diverge more than do the A chains, having homologies 
of 90.5 X and 95.4 X respectively. It is curious that the protein 
sequences appear to be less conserved than the cDNA sequences, 
the B and A chains having homologies of 84.4 X and 93.3 X 
respectively. One would expect the DNA sequences to diverge more, 
since many base changes do not affect the coding properties.
However, of 96 codons containing nucleotide alterations, only 37 
fail to alter the amino acid encoded. Similarly, it is unexpected 
that the 5' and 3' non-coding regions are identical - in the absence 
of selective pressure acting upon them, they should change more 
than the coding sequence.
The absence of one codon in the agglutinin A chain as compared 
to the ricin A chain might possibly be a cloning artefact, though 
similar deletions have previously been observed, for example, in 
cDNA sequences encoding pea vicilin (268), in which a single codon 
deletion and a three codon deletion occur close together.
The majority of base changes in the present sequences are 
transitions (64.5 X); 35.2 X of these are silent, whereas
28.2 X of the transversions are silent. This might be expected 
since doublet codons have either purines or pyrimidines in the
third position. Nonetheless, the high frequency of A-G 
transitions (43.6 X of all base changes) is curious.
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ns. 3K-1: Preproagglutinin and preproricin sequences 
Figure appears on Che next page.
The upper nucleotide sequence is that of Che preproagglutinin cDNA, 
with its deduced amino acid sequence above it. The lower 
nucleotide sequence is Che preproricin cDNA; only when its 
amino acids differ from those of preproagglutinin are they 
shown, below Che sequence.
The first amino acid in each row is numbered at left, and Che 
last nucleotide in each row is numbered at right (numbers correspond 
Co positions in Che preproagglutinin sequence).
The ends of various parts of the sequences are indicated by 
arrows; S - signal sequence, A « A chain, L - linker peptide, 
and B - B chain.
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Base 5’ NCR CR 3' NCR Total
A 195 (12) 4945 (494) 987 (53) 6127 (559)
T 127 ( 7) 4232 (486) 1105 (51) 5464 (544)
C 149 ( 3) 4702 (347) 501 (24) 5352 (374)
C 66 ( 8) 4164 (368) 607 (31) 4837 (407)
A-T (l> 60.0 (63.3) 50.9 (57.8) 65.4 (65.4) 53.2 (58.5)
c*c (i) 40.0 (36.7) 49.1 (42.2) 34.6 (34.6) 46.8 (41.5)
No of aeqi 13 21 22 22
FU 3K-2t i m  composition
Data war* collected fron eh* rumbar of aaquancas Indicated; data for 
cha praprorlctn cOMA sequence ara praaancad In brackaca.
Baverai of cha publiahad sequences lackad 5' non-codIn* ragiona.
References; 95. 262, 264-269,276,276-287
A T C G
A 140 152 99 102
T 118 136 93 138
C 134 98 75 40
C 101 99 80 88
Fig 3K3« Dlnucleocide frequencies
Th* flrac b i M  Is In the col a m  it lefc, and che second base la 
Indicated at cha cop. Tha analysis la of che preprorlcln sequence, 
Including non-coding regions.
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1 U 1 C 1 A 1 G
u 1 U 12 Phe l U 11 Ser 1 U 15 Tyr 1 U 6 Cys
1 c 9 Phe , c 5 Ser | C 9 Tyr 11 c 6 Cys1 A 11 Leu * A 7 Ser 1 A 0 *** 1 A 0 irk-k11 G 9 1Leu | G 2 Ser [ G 0 *Vrfr 11 G 12 Trp
j _
c 11 U 16 1Leu | U 11 Pro j U 5 His 11 U 6 Arg1 c 5 Leu 1 c 3 Pro 1 c 1 His 1 c 3 Arg
1 A 4 Leu | A 14 Pro j A 22 Gin 11 A 6 Arg1| G 5 Leu 1 1 G 2 Pro 1 1 G 7 Gin 1| G 3 Arg
-1
A 1 U 14 He 1 U 14 Thr 1 U 28 Asn 1 U 14 Ser
1 c 12 lie | C 9 Thr | C 14 Asn 11 C 5 Ser11 A 16 lie 1 | A 15 Thr 1 A 4 Lys 1 A 14 Arg
11
G 7 Met |
1
G 2 Thr |
1
G 5 Lys 11
G 4 Arg
G 11 U 14 1Val | U 12 Ala | U 23 Asp 11 U 16 Gly1| c 3 Val 1 c 6 Ala 1 1 C 4 Asp 1 c 3 Gly
1 A 4 Val | A 19 Ala | A 10 Glu 1 A 14 Gly1 G 14 Val 1 G 3 Ala 1 G 10 Glu 1 G 6 Gl£
Fig 3K-4: Codon usage.
First base is at left, second at Cop, and third in centre. 
Data are for preproricin sequence, excluding the stop codon.
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There are 153 amino acids in the sequence which can have codons 
ending with OG, but only 12 such codons are used. This accounts 
for 30 CG dinucleotides altogether, leaving the remaining 10 to be 
distributed between codons rather than within codons.
Grantham (277) points out that mannalian tnRNAs contain several 
times as nuch degenerate G than A, with the result that the 
sequences prefer the codons CUC and CUG for leucine,
GCC for alanine, AAG for lysine and CAG for glutamine. The 
preproricin sequence contains more than twice as much degenerate 
A as G (T being the most frequent), the result being that these 
codon preferences are not observed here. This has previously 
been noted for a number of plant mRNAs (291). The avoidance by 
plant mRNAs of the UUA leucine codon (291) is not observed here.
In spite of the manmalian preference for degenerate G, 
Grantham (277) notes that the more abundant mRNAs tend to prefer 
C and U in the third position. The preproricin mRNA produces an 
abundant protein, and has 57.5 % of the degenerate third bases 
being C or U, and may thus fit the hypothesis.
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3K3 The 5' non-coding region
Thirty bases of 5' non-coding region are represented in both the 
preproricin and preproagglutinin sequences. These are identical in 
both sequences, and both begin at exactly the same nucleotide.
This probably indicates continuation of the homology to the very 
5' terminus of the mRNAs, since the hairpin loops of the cDNA 
produced by the first strand synthesis apparently end in the same 
position (222).
Primer extension (see section 3L) indicates that seme 80 bases 
are missing from the clones; only one band was seen, implying that, 
the two mRNAs are of the same length (assuming a similar abundance 
for both).
In the following discussion bases are numbered from the 
first base of the codon for the first residue of the mature 
A chain.
The first AUG codon occurs at position -76, and is followed by 
a short reading frame of 23 amino acids (including the initiator 
methionine), which ends at the termination codon TAA at -7.
A second AUG is found at position -72, which opens up a reading frame 
which goes on to include the whole coding sequence of the A and 
B chain precursor. Fig 3K-5 shows a Maxam & Gilbert sequencing 
gel from which this part of the sequence was determined. One of the 
pUC8 subclones of pRCL6 was cleaved with Aval and Hindlll and the 
insert was purified on an agarose gel. The Aval end was 
selectively labelled and the fragment was sequenced. The region 
of the gel showing the two AUG codons is marked, as is the part 
containing the beginning of the mature A chain sequence. It is clear 
from this gel that it is indeed the second AUG which opens the 
correct reading frame. It is remotely possible that this region 
became altered during subcloning into pUC8, but the same sequences 
were obtained from both of the original clones (pRCL6 and pRCL52) 
by labelling at the BamHI site located at position -42, that is, 
within the signal sequence. It is also possible that these
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O U •“ 
+  a  ♦  O < < U
5' 3'
CCC
cTTA
Pro
Phe
3' 5
End of dC-tail
Fig 3K-5: 5' terminal sequence of preproricin clone
Maxam & Gilbert gel showing the 5' non-coding region, the 
signal sequence and the beginning of the A chain. See text 
for further details.
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formed during cDNA synthesis: it is known that the 5' ends of 
cDNAs are less faithfully synthesised than are the other regions 
(285). However, it is unlikely that the same artefacts would be 
obtained in two different clones, which were annealed and transformed 
at different times.
Since initiation at a second AUG is unusual, the evidence 
favouring initiation at the first will be briefly reviewed, and a 
small survey of plant mRNAs will be presented.
The currently favoured model of translation initiation is the 
scanning model proposed by Kozak (292), in which the 40 S ribosomal 
subunit is believed to bind to the 5' end of a mRNA, and then 
to migrate downstream until it encounters an AUG codon. At this 
point, migration stops, presumably because of an interaction between 
the initiator codon and the met-tRNA^  which is already bound to the 
40 S subunit. Peptide bond formation then ensues, and continues 
until a stop codon is reached. The model was inspired by the 
observation that the vast majority of mRNAs then sequenced 
(mostly from animal sources) had no AUG codons in the 5' untranslated 
region. The few exceptions known at that time were explained away 
with a variety of arguments. For example, one upstream AUG was 
imnedlately adjacent to a 5' cap structure, while another was 
involved in a stable secondary structural formation and, it was 
suggested, unavailable to the 40 S subunit. Presumably in this case 
the 40 S subunit was supposed to migrate past the bottom of 
the stem-and-loop structure.
Under certain abnormal conditions (for example in the presence 
of edeine, or in low Mg^ + concentrations), it was found that the 
40 S subunit could migrate right through an initiator AIX*. and on 
this basis the model was modified (293). It was now proposed that
if the upstream AUGs were 'weak' Initiators, then the 40 S subunit 
was able to ignore them, perhaps initiating with decreased efficiency 
at subsequent initiator codons. In support of this, one set of 
experiments involving the introduction of extra AUGs in the 
5' non-coding region of a Herpes simplex thymidine kinase gene, cloned 
in a retrovirus vector, indicated that the more upstream AUGs there 
were, then the less efficiently was translation initiated at the 
correct codon (294). Similar experiments in a different system (295) 
found that if the upstream AX was an efficient one, then 
reinitiation at a subsequent AX would only occur if the reading... 
frame already started were terminated before the ribosome 
arrived at the correct reading frame.
Sequencing of three procollagen genes (296) indicated that in each 
one there were two or more upstream AXs - all encoded short 
reading frames of the type described above. However, the functional 
AX was in each mRNA involved in a stem-and-loop structure, apparently 
invalidating the supposition that AX codons could be 'hidden' from the 
40 S subunit by secondary structure. This work also suggested that 
the function of the short peptides initiated by the upstream AXs 
was in the regulation of translation: it is known that N-terminal 
oligopeptides of the gene product (preprocollagen) inhibit 
translation of the mRNA species concerned (296). Also noteworthy is 
hamster 3-hydroxy-3-methylglutaryl-coA reductase cDNA, which contains 
an AX codon 160 b upstream of the correct initiation site.
Its reading frame overlaps the correct frame, and it has a 'better' 
initiation environment than the correct AX (297).
The 'quality' of an AX has been investigated by searching for 
similarities in sequences flanking initiator AX codons in many mRNAs. 
The initial study (298) found a consensus around the AX of 
AqXXAUGG(X - any nucleotide). The significance of this result was
- 177 -
supported by the finding that the presence of a purine in positions 
-3 and +4 enhanced the binding of AUG-containing oligonucleotides 
to wheatgerm ribosomes. More rigorously, a variety of preproinsulin 
cDNA - containing plasmids were constructed with different 
nucleotides in the -3 and +4 positions (299). At -3, the base A gave 
the most efficient initiation, while G was better than C or T.
At the +4 position, G was better than A.
A later survey (300) of 211 mRNAs (of which only 8 were of 
plant origin) enlarged the consensus sequence to CC^ CCAUGG.
Only six of the sequences had a pyrimidine at -3, and 1J of these 
were from plants (the 'i' is a result of a sequence which 
Kozak treats as one sequence, but is in fact two mRNAs, one of which 
has A, while the other has C). As far as the first four bases of 
this consensus are concerned, more than half the mRNAs had 
three or four nucleotides in common with the consensus, and only 
10 were perfect matches.
On the basis of 20 sequences of plant origin, Messing (301)
rsuggested that the plant initiation environment was qAAXXADGG, 
where X is any base. Note that of the 16 sequences for which this 
region is given completely, 8 are zein variants and 5 are 
soybean leghaemoglobin variants.
A number of plant translation initiation sequences are given 
in fig 3K.-6 and in fig 3K-7 these are used to determine
Aanother consensus sequence: ACAA^ A AUG G. The validity of 
including several closely related sequences is dubious - ie the zeins 
and the soybean leghaemoglobins - since these are likely to be 
conserved for reasons other than singularity of function.
In fig 3K-8 the sequences are relisted, omitting all members of 
these two families, and two sequences whose functional AUGs are
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In the column labelled 5' NCR, complete Indicates that the data are 
derived from genomic clones; incomplete implies cDNA clones, in 
which case AUGs not shown in reports could exist upstream (as also 
applies to the sequences for the castor bean lectins).
If the 5’ non-coding region is very short, then its length is 
found in the comments column. The presence of any upstream AUGs 
is also noted here.
Fig 3K-6: Explanation and notes
Note 1
The AUG codon for Phaseolus lectin is predicted on the basis of 
opening the correct reading frame and having the best surrounding 
sequence. The upstream AUG shown in the table has a less favourable 
environment, and there are two more AUGs out of phase:
AUGAAUGCAUGAUCAUGGCU
AUG no 4 is proposed to be the functional initiator codon.
Note 2
This is the first AUG in the cDNA clones. However, it is suspected that 
the sequence at the 5' end of the cDNA is in error, because of cloning 
artefacts (285). Genomic clones indicate that there is another AUG 
12 b upstream, which may be the actual initiator. The N-terminal 
sequence of the protein is unknown.
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Fig 3K-7: Plant initiation environments: all sequences
-6 -5 -4 -3 -2 -1 AUG +4
A 13 5 15 15 8 11 8
U 3 3 1 4 6 7 1
C 8 10 5 3 9 5 1
G 0 6 3 2 1 1 14
Con: A C A A CA A G
Data from fig 3K-6.
The Zein group comprising clones Z4, ZG7, ZG124 and ZG31 has
been counted twice, once with U at -2 and once with C (See fig 3K3-2).
Con - consensus sequence
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Fig 3K-8: Plant initiation environments: Selected sequences
Source -6 -5 -4 -3 -2 -1 +4 Ref
Napin A C A C G A G 95
Phased in U C U A C U A 258
Soybean lectin A A A G C A A 262
Pea vicilin C C G U U A U 268
Thai matin A C A U C A G 264
Soybean actin U A A A A G G 281
Barley amylase C G C G C C G 283
Soybean SSU A A G A A A G 304
Pea legunin C U C U U C G 267
Wheat gliadin U C C A C C A 269
Parsley CS A A A A A A G 284
Octopine T-DNA Tr7 C A C A U C A 287
Totals A: 5 ’ 5 5 “' Z 3 “‘ Z 4
Us 3 1 1 3 3 1 1
C: 4 5 4 1 5 4 0
G: 0 1 2 2 1 1 7
Cons ACU
AC AC A C
AC G
Abbreviations:
SSU - small subunit of ribulose bisphosphate carboxylase/oxygenase 
CS - chaleone synthase
Tr7 - Transcript 7 
con • consensus sequence
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uncertain. The consensus above becomes less strong: all that is 
apparent is a preference for A or C in positions -1 to -6, and 
a complete absence of G from position -6.
The validity of consensus sequences derived in this way 
is limited, first by the small number of sequences examined, and also 
by the dissimilarities between the different genes and their 
requirements for regulation. That is, if the sequences 
surrounding the AUG are important, then it is more meaningful 
to compare only those sequences whose modes of regulation are 
known to be similar. Consensus sequences derived here, and by other 
authors, probably include sequences which are so different that 
they should not directly be compared without some other organising 
factor.
The castor bean lectin initiator AUG environments are shown 
below along with various consensus sequences:
First castor bean lectin AUG:
Second.......... . " :
Kozak (300):
Messing (301):
Here:
The first castor bean lectin AUG is a better fit with the Kozak and 
Messing consensus sequences than is the second; the two are equal when 
compared with the present consensus. Again, the inadequacy of 
consensus sequences must be emphasised: although the first AUG 
may have a 'better' environment, castor bean ribosomes may not 
agree! That is, deviation from the consensus sequences may imply that 
castor bean ribosomes have a different specificity than others,
UGUAAU AUG G 
AUAUGG AUG U 
OCqCC AUG G 
A^AXX AUG G 
£££aCA AUG G
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and the details of the difference may reflect sane special 
feature of the regulation of translation of the particular mRNA 
species examined here.
The position of the initiator AUG may be of greater significance 
than the sequence surrounding it: although most eukaryotic mRNAs 
initiate at the first such codon, not all do. For example, 
fig 3K3-2 shows that three zein mRNAs have upstream AUGs, 
the soybean actin mRNA probably has two, Phaseolus vulgaris 
lectin has two or three, and one of the soybean leghaemoglobin 
sequences may have one (the translation start site is uncertain).
The importance of these mRNAs, and of the present sequences, 
to the scanning model of translation initiation is unclear.
It is conceivable that upstream AUGs are themselves involved in 
regulation of translation. Thus, a ribosome might migrate 
along a mRNA, stop at an upstream AUG codon, and then wait for 
sane signal to continue, such a signal perhaps being a 
developmentally regulated gene product.
3K4 The 3' non-coding region
The preproricin cDNA sequence contains 159 bases of 3' non-coding 
sequence, including the termination codon, as determined from clone 
pRCL17. The preproagglutinin sequence has only 69 3' non-coding 
bases, and these are identical to their counterparts in the 
preproricin sequence.
The stop codon is UGA, and is immediately followed by another 
stop codon, UAG. A survey of termination codons and their 
environments (305) found that such tandem stop codons are unusual 
in eukaryotic mRNAs, and may even be selected against (the only 
two cases found in 74 sequences examined were from related viruses).
Few plant sequences were included in this report, so a number 
are listed in fig 3K-9. This shows that of the 23 sequences 
presented, three have tandem stop codons: a wheat gamna-gliadin 
(21) has UGA-UAA, the pea vicilin 50 kDal precursor has UAA-UGA (268) 
and a pi as tocyanin sequence has UAA-UAG (337). The importance of 
tandem stops is obscure, as in eukaryotes termination at a single 
such codon is apparently extremely efficient (305). In the 'all 
eukaryotes' sample, the stop codon UAA is used more frequently than 
UAG and UGA (which are used roughly equally) (305); in the 
plant mRNAs, no obvious trend is seen (UAA, UAG and UGA occur 
9, 7 and 7 times respectively). The sample is of course very 
small - accumulation of more plant sequences may indicate the 
existence of the other eukaryote trend, or a plant preference 
may became apparent.
Fig 3K-10 shows the frequencies of occurrence of each base
'in the codons before and after the termination codon; also shown 
are similar results from the survey already mentioned (305), 
when significant deviations from randomness were observed.
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ÏÜL 3K-9: Plant termination environments
Source Environment Ref
Lemna glbba SSU ACC UAA GCU 285
Soybean seed lectin AUC UAA AUG 262
Soybean Lb's (two of these) GCA UAA UUA 278
Thaumatin GAG UAA GAG 264
Soybean actin UUC UAA CUU 281
Pea vieilin (50 kDal) UUU UAA UGA * 268
Octopine T-DNA Tr7 AGC UAA GCU 287
S pratensis plastocyanin AAC UAA UAG * 337
Pea chlorophyll a/b BP AAA UAA ACA 338
Wheat gliadin AAC UGA GAA 269
Wheat gamna-gliadin UAC UGA UAA * 286
Barley alpha-amylase AGC UGA AGU 283
Parsley chalcone synthase CAC UGA AGU 284
Soybean vieil in (Gtncp53.58) AAA UGA CAA 306
Phaseolin UAC UGA AUA 258
Castor bean lectins UUU UGA UAG * This work
Pea legumin GCU UAG AUU 307
Napin UAC UAG AUU 95
Pea seed lectin GCA UAG UUU 260
Zeins UUU UAG AUU 265,276,303
Fhaseolus lectin CUC UAG ACU 266
Maize Adhl AAC UAG AUU 279
Soybean Lb's (two of these) UUU UAG GAU 280,282
Notes
Several zeins are counted together, as all in this report had the 
same termination environment.
Sequences marked with an asterisk have tandem termination codons.
Lb - leghaemoglobin; SSU - small subunit of rlbulose bis phosphate
carbocylase/axygenase.
S pratensis is Silene pratensis; BP - binding protein
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Fig 3K-10: Distribution of bases flanking plant stop codons
Stop codon Base -3 -2 -1 ♦ 1 ♦ 2 +3
UAA A 5 3 2 2 2 3
U 2 3 1 3 3 3
C 0 2 5 1 3 0
G 2 1 1 3 1 3
USA A 3 5 1 3 4 4
U 3 1 1 2 1 2
c 1 0 5 1 0 0
G 0 1 0 1 2 1
UAG A 1 2 1 5 1 0
U 3 3 3 1 5 7
C 1 2 3 0 1 0
G 2 0 0 1 0 0
ALL A 9 10 4 10 7 7
U 8 7 5 6 9 12
C 2 4 13 2 4 0
G 4 2 1 5 3 4
R-ifirdf'irunt results from ref 305 (present results in brackets) 
All values in percentages.
Stop_codgn
UAA
USA
UAG
_ _  -3__________-2  _  _  - 1_  _
0069(22)
Af90(71)
00(14) 068(432
+1 +2 +3
OA-82(65) all stops
0067(55) all stops
Above The number of sequences (out of 23) having specified bases In 
positions before and after the stop codons are tabulated by 
stop codon.
Below Significant results for specified positions from ref 305 are
reproduced, with present results for those positions in brackets.
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Results obtained here at those positions are given in brackets. 
Although the sample of plant sequences is small, they do appear 
to prefer the proceeding codon to be of the form ^ AC, and the 
subsequent codon to be A^ U. Further sequences may or may not 
bear this out.
The majority of 3' non-coding regions of eukaryotic nRNAs 
contain the hexanucleotide sequence AAUAAA, usually 10-40 bases 
from the poly(A) addition site. Polyadenylation occurs in the 
nucleus, and probably involves site-specific cleavage of the 
pre-nRNA followed by addition of A residues to the exposed 
3' terminus (308). The cleavage site may be defined by hybridisation 
of the pre-nRNA with snRNA U4, through the AAUAAA signal and 
other sequences (309). Although most animal nRNAs contain only one 
AAUAAA sequence, examples are known with multiple signals (297,
310-312).
Plant nRNAs are distinctly different in that multiple polyadenyl ation 
signals appear to be the rule, rather than the exception (291,301).
Poly(A) addition rarely follows the first AAUAAA signal, though in 
one case, an octopine T-DNA gene (transcript 7, ref 287), 
polyadenyl ation does occur after the first signal In the pre-nRNA, 
not after the second signal.
The castor bean nRNAs are quite typical of plant nRNAs with 
respect to polyadenyl ation signals, with one 39 bases from the 
last coding base, and another 38 bases from the polyadenyl ation site.
The first is a typical AAUAAA sequence, and the second is a variant, 
AAUAAG: this pattern has previously been noted (301).
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Berget (309) analysed 3' non-coding sequences in more detail, 
and found that most animal genes contain variations on the 
consensus sequence CAYUG (where Y - a pyrimidine), either between 
the polyadenylation signal and the polyadenylation site, or 
a short distance downstream of the polyadenylation site.
In many cases, a 4 out of 5, or only a 3 out of 5 fit was obtained. 
She suggested that the AAUAAA signal provides primary recognition 
for pre-mRNA cleavage, while the CAYUG signal directs the 
precise cleavage point. Benoist et al (313) found that several 
animal sequences contain variations of the model sequence 
UUUUCACUGC (note that this contains CAYUG), the polyadenylation 
site often immediately following this. Lycett et al (291) noted that 
pea legunin mRNA contains ALJUUCAGUGC, a variation on the 
Benoist sequence, the polyadenylation site following after a 
further two bases.
Since arguments such as these may explain the selection 
of the appropriate polyadenylation signal in plant mRNAs, a 
search of a number of such sequences was undertaken. The 
computer programme RE SITES (See Appendix 1) was used to find 
sequences which matched, or gave a 4 out of 5 fit with, CAYUG. 
Potential polyadenylation sequences were located by visual 
examination of published data.
The sequences examined were from references 95,258,262, 
264-6,269,276,278,283-7,303 and 306-7.
First, the frequencies of the numbers of AAUAAA sequences
are tabulated:
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No_of signaljs 
0 
1 
2
3
4
5
6
No_of seguence^  
0
3 
8
4 
4 
0 
1
Thus, Che nulCipliciCy of polyadenylation signals (AAUAM and 
variants) is amply confirmed.
Although three sequences contain only one such signal, all of 
these may be special cases. First, the barley alpha-amylase mRNA 
(283) contains an additional GAUUAC upstream of the functional 
signal - this may be a variant of AAUAAA. Second, the octopine 
T-DNA transcript 7 gene (287) contains a second AAUAAA signal 
downstream of the cleavage site - the significance of this 
is unclear, and this appears to be a completely non-functional 
signal. Finally, the zein clone pZ22.3 (276) may conceivably 
contain another signal downstream: genomic clones were not 
given in this case, but another report (303), in which cENA and 
genomic sequences were compared, indicated that zein genes can use 
either of two signals. That 1s, although the second signal may 
be the dominant one, earlier ones can also result in polyadenylation.
Of the 20 sequences examined, 8 contained perfect matches 
or 4 out of 5 matches with the CAYUG sequence, between the 
AAUAAA signal and the polyadenylation site. If this sequence is as 
important in plants as it appears to be in animals, it may well be 
that in the remaining 12 sequences, its location is downstream 
of the polyadenylation site. Examination of the polyadenylation 
signals (that is, AAUAAA signals) in the 8 mRNAs mentioned reveals
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Chat the last signal in 5 cases is a variant, rather than a 
perfect match: of the remaining 12 sequences, only three 
have AAUAM variants, as opposed to perfect matches.
The distance between the polyadenylation signal and the CAYUG 
variant in the 8 tnRNAs is variable, ranging from 0 to 20 bases.
In two cases, pea legumin (307) and the castor bean lectins 
(present work) the CAYUG sequence can be extended to variants of 
the UUUUCACUGC sequence of Benoist et al (313):
Legunin: AAUAAAGGUAAAAUUUCAGUGCUC - poly (A)
CB Lectins:AAUAAGAGCACAACUAUUGUCUUGUGCAUUCUAAAUUU - poly(A)
In the twelve sequences lacking the CAYUG variants after the 
polyadenylation signal, there is no consistent presence or 
absence of CAYUG variants before the signal, and there is no 
consistent relationship with upstream AAUAAA signals.
A similar search of six genomic sequences (262,267,269,278,287) 
revealed that four of these contain AAUAAA sequences downstream 
of the polyadenylation site. Three of these lack CAYUG variants 
between the functional AAUAAA signal and the polyadenylation site, 
and of these three, two had CAYUG variants just downstream of the 
polyadenylation site, by IS and 30 bases. In only one case of 
downstream AAUAAAs was a CAYUG variant close, this being the pea 
legunin gene (267), which has a CAYUG variant some 20 bases 
beyond a double AAUAAA.
Note that the pea seed lectin mRNA (260) has an unusually large 
distance between its polyadenylation signal and its polyadenylation 
site, 57 bases, and the signal is lnmediately followed by a 
CAYUG variant.
Although this sample is severely limited by size, it appears that 
the mechanism of polyadenylation site selection may well be
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similar Co that in animals, involving hybridisation Co a snRNA 
species, as most of Che plant sequences examined here have features 
cannon to many other eukaryotic mRNAs.
In stannary, the castor bean lectin nRNAs have typical plant 
3' non-coding regions, though the tandem stop codons may turn out to 
be unusual, though certainly not unique.
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3L Primer extension
A primer was cloned which corresponded Co Che region of pRCL6 
encoding pare of Che signal sequence and Che beginning of Che A chain 
sequence, as described in section 2J1. The fragment was excised 
from ics plasmid, end-labelled and purified from a gel. After 
heat denaturation it was annealed with total poly(A)+ mRNA from 
maturing castor beans and extended with reverse transcriptase, 
the products of the reaction being analysed on a 6 X acrylamide,
7 M urea sequencing gel.
Fig 3L-1 shows such a gel, with dideaxy sequencing products 
as size markers: the number of bases between the unextended primer 
and the extended product is about 143, indicating that the mRNA 
has this lumber of bases 5' to the end of the primer. The end of the 
primer is 61 bases from the 5' terminus of the cDNA sequences 
present in the clones, indicating that the mRNA has approximately 80 bases 
which are not represented in the clones. The number is approximate 
because extension may be terminated 2 - 3  bases before a 5' cap 
structure (238).
The castor bean lectin mRNAs thus contain seme 195 bases of 
5' non-coding sequence. It was originally intended to attempt to 
sequence this part of the mRNA by inhibition of the primer extension 
reaction with dideoxynucleotides, but the amount of mRNA available 
was unfortunately inadequate.
Fig 3L-1! Primer extension.
Bands corresponding to unextended primer and to extension product 
are marked (dashed lines). Track + contains nRNA, track - is a 
control. Marks at right are spilled over from adjacent track. 
Dideaxy sequencing ladders act as size markers.
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i
Fig 3L-1: Primer extension.
Bands corresponding to unextended primer and to extension product 
are marked (dashed lines). Track + contains mRNA, track - is a 
control. Marks at right are spilled over from adjacent track. 
Dideaxy sequencing ladders act as size markers.
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3M Northern blotting
Total poly(A)+ RNA from maturing castor beans was run on a formamide 
agarose gel and transferred to nitrocellulose, and hybridised with 
nick-translated pRCL6. The resulting autoradiograph is 
shown in fig 3M-1; identical results were obtained with 
nick-translated insert from the same plasmid, though in this case 
the markers were not visible (markers are digests of pBR322 DNA, 
the vector for pRCL6)•
Lane 1 contains the noRNA, and three bands are visible, with 
sizes estimated at 3000 , 2000 and 1700 bases. The largest and 
smallest bands comigrated with bands visible on the ethidiun bromide 
stained gel (not shown) - these correspond to ribosomal RNA species, 
indicating that the probe has hybridised non-specifically, and that 
the washing conditions were not sufficiently stringent.
It is of course possible that the remaining band, of 2000 bases, 
is also an artefact, but its similarity of size with estimates from 
the sequences, and from the primer extension experiment, suggest that 
it may indeed represent castor bean mRNA. Unfortunately the 
experiment could not be repeated due to lack of castor beans.
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Fla 3M-1» Northern blot of castor bean nflNA 
Lane 1: 10 yg of castor bean poly(A)+ nRNA was run on a 1 X
fonnamide-agarose gel, transferred to nitrocellulose and hybridised 
with nick-translated pRCL6. This also hybridises with pBR322, 
allowing the markers to be visible.
Markers are digests of pBR322i lave 2 with Hinfl and lane 3 with
Pati and PvuII.
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Flg 3M-1: Northern blot of castor bean nflNA 
Lane 1: 10 pg of castor bean poly(A)+ mRNA was run on a 1 %
f ormanide-agarose gel, transferred to nitrocellulose and hybridised 
with nick-translated pRCL6. This also hybridises with pBR322, 
allowing the markers to be visible.
Markers are digests of pBR322: lave 2 with Hinfl and lane 3 with 
PstI and PvuII.
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3N Oocyte injections
It was of Interest to determine whether the lectin cDNA-containing
plasmids could direct the synthesis in Xenopus oocytes of the
proteins which they encode. The eight plasmids screened by
translation of hybridisation-selected mRNA were injected into
35oocytes and labelled in the presence of ( S)methionine 
(experiment performed by Professor H Woodland). Expression of a 
number of sequences in this system has previously been reported (336).
Fig 3N-1 shows that although a large ruober of proteins were 
made, there were no polypeptides which reacted with anti-RCA serum. 
The failure to obtain expression was not further investigated.

-  1 9 8  -
« 1  2 3 4  S « 7 • M 1 3
Fig 3N-1: Oocyte Injection.
Plasmids were injected into oocytes and incut 33( S)methionine. Left side tracks are irnnunc 
anti-RCA serum; right side tracks are total ] 
MW markers as fig 3A-3.
Lanes 1-8 are, respectively, pRCL 6,15,17,!
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CHAPTER 4; Final Discussion
At the outset of this work it was desired to determine the 
nature of the precursor-product relationships of the castor bean 
lectins. This arose from previous work which indicated that the 
then putative B chain precursor was far larger than the 
authentic B chains (44), the requirement for this extra size being 
unclear. At this time little work had been reported on plant 
storage protein and lectin precursors, those for legunin (93) 
and canavalin (314) having been published in 1980: in each of these 
cases it was shown that the mature heterodimers were assembled 
post-translationally from single-chain precursors containing 
both subunits.
During the following three years it has became clear that 
this class of precursor-product relationship is common in 
plant storage proteins and lectins; Butterworth and Lord (45) In 1981 
obtained evidence from Immunological and proteolytic cleavage 
approaches that castor bean lectins are also synthesised in this 
manner. Thus, it was shown that the large 'B chain precursor' almost 
certainly contained polypeptides corresponding to both the 
A and the B chains of the mature proteins. The present studies 
were designed to elucidate the structure of this precursor by 
cDKA cloning and sequencing - an approach already used to confirm 
these precursors in plants (eg 95, 307).
The results obtained here confirm the protein-based evidence 
previously reported, and also show that the castor bean lectin 
precursor has a signal sequence and a linker between the two 
chains, which must be removed post-translationally, very likely in 
the protein bodies. In addition, two different sequences were 
obtained, which have been tentatively identified as ricin and 
Ricinus cr»m»”via agglutinin. Although the full significance of
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Che differences between Che primary structures of these two proteins 
Is somewhat unclear, It Is hoped that collaborations with groups 
using more sophisticated computer modelling techniques (eg ref 335) 
will help to elucidate this aspect, especially when good X-ray 
diffraction structures become available.
The existence of two proteins of similar sequences, but which are 
different In their quaternary structures and detailed functions, is 
Intriguing. It might be supposed that the differences have 
arisen by genetic drift (315) and by lack of selection against 
them, but the existence of similar situations In other plants, 
such as Abrus precatorius (3), may imply evolutionary importance for 
two related, but different lectins. It Is of note that some toxins 
similar to ricln, such as vis cumin, also tend to form dimers (57), 
dimer formation in this case being dependent on concentration.
Perhaps the agglutinins in Rlclnus and Abrus have evolved to 
stabilise such dimeric forms.
In a similar vein, it Is interesting that many plants contain 
toxins which enzymatically inhibit ribosomes, while only in 
certain species are they associated with lectin chains (37), and that 
whenever a lectin chain Is present, It Is specific for terminal 
galactosyl residues. This may imply that only galactose-bearing 
receptors can mediate the uptake of the toxins, though this argument 
suggests the supposition that the molecules evolved for the 
specific purpose of being toxic. It Is also possible that the 
A chains have some Important but as yet unknown function In the 
cells which synthesise them (for example In the regulation of 
protein synthesis), and that some plants may have improved the 
interaction of the A chain - like species with a receptor 
by linking them with galactose-binding moieties - namely lectin
The existence of gene families in plants encoding variant forms 
of storage proteins is a widely documented feature (eg 286,316-319), 
and there are probably over 100 zein genes (55). Such gene 
families have not been examined in the case of the castor bean 
lectins - extensive analysis of the present cDNA library with 
this aim in mind has not been performed. Southern blot analysis 
of genomic DNA from castor bean tissues is currently being 
undertaken in this laboratory (JM Lord, personal connunication). 
However, the finding reported here that of eight large lectin- 
specific clones, all appear to fall into one of two restriction 
site classes is a preliminary indication that only the two are present: 
that is, a ricin gene and an agglutinin gene. It is of note that 
analysis of lectin precursors synthesised in the presence of 
tunicamycin reveals two bands on SDS/PAGE, very close together.
If a wide variety of genes were transcribed and translated, then 
more bands, or a smear, would be expected (JM Lord, personal 
communication). Genomic cloning has also been undertaken, to determine 
the structural features of the lectin genes, and to investigate the 
mechanisms by which they arose. It will be of interest to 
locate any short repeats around the genes, which might have been 
involved in duplication events. Also of interest from the 
genrmir sequences will be the detection of any relationship between 
exons and functional domains. Thus, if the genes for the two 
chains arose separately, and then became linked by recombination, 
one might expect to find introns between their coding sequences. 
Similarly, an intron might be present between the two halves of the 
B chain coding sequence. Such relationships between exons and 
structural and functional domains have been suggested in animal
chains, already present and subserving seme other purpose.
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systems by Go (320,321), though Rashin (322) argued against them, 
suggesting that structural domains are "stable protein fragments 
found in biochemical experiments" - that is, artefacts.
Curious evolutionary events have certainly occurred in other 
plant lectins, notably within the conA homology group. There is 
considerable homology among lectins from Phaseolus vulgaris,
Vicia faba. pea, jackbean and lentil (see ref 323). A detailed 
comparison of favin and conA revealed a relationship defined by 
a circular permutation, such that the termini of the two proteins 
were homologous to the central regions of the other (325). This 
relationship is indicated in fig 4-1, and a discussion of how 
it may have arisen is to be found in reference (325).
Complex events may also have occurred in the evolution of the 
castor bean lectins. Villafranca and Robertus (72) compared the 
two halves of the ricin B chain, and found that 26 amino acids 
were conserved - see fig 4-2, which is reproduced from reference 72. 
A similar analysis of the present ricin sequence is shown in 
fig 4-3, along with the cDNA sequence. In this amino acid sequence 
41 residues are conserved bwteen the two halves 6f the B chain, 
or 28.6 1 (note that Villafranca and Robertus did not box two of 
the conserved residues in their sequence; also I have introduced 
three extra gaps to maximise homology). The great amount of 
divergence within the cDNA sequences encoding the non-conserved 
residues (26.3 Z homology), and the surprisingly large amount of 
divergence in the codons for the conserved amino acids (71.7 X 
homology; differences especially notable in leucine codons), implies 
that the conserved residues may be important functionally. That is, 
the DNA gfT'wv’a appears to have changed nearly as much as it can 
without changing its coding properties.
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Fjg 4-1t Circular homology of conA and favin 
Schematic drawing of the alignment of favin alpha and beta chains 
(open bar) with conk (solid bar) showing the circular permutation 
that gave nunclimm homology between the two sequences.
Reproduced from reference 325.
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Fig 4-2: Structural homologies within the ricin B chain. 
Reproduced from Villafranca & Robertus (ref 72).
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Fig 4-3
Comparison of Che two halves of Che ricin B chain, and their cDNA 
sequences. Upper line is Che N-terminal 134 residues, lower line 
is residues 135 Co 262. Identical amino acids are enclosed in boxes.
-  206 -
That che changes in Che sequences encoding Che cwo halves of 
the B chain are subject to the constraint chat Che general properties 
are not too greatly altered is indicated by the conservation of 
the hydropathy profile: fig 4-4 shows the hydropathy plot of 
the ricin B chain, with the two halves one above the other. It is 
clear that the profile is not greatly altered, even though the 
amino acids are grossly different.
A similar analysis of the agglutinin B chain is shown in 
fig 4-5. This also has 41 residues conserved between the Cwo 
halves of the B chain, though only 37 of these are the same 
residues as are conserved in the ricin B chain.
Note that overall, the two B chains differ at 15.65 X of their 
amino acids: it would thus be expected that, of the 82 residues 
of the ricin B chain which are involved in the intrachain 
homology, 12.8 of these would be different in the agglutinin B chain. 
The observed number is 6 - which may support the suggestion that 
these are indeed important residues. The differing sugar 
specificities of the ricin and agglutinin B chains may be 
reflected in these differences, though the other differences may 
in fact be responsible. Similarly, which of the differences 
between the two B chains are responsible for the different 
quaternary structures is unclear.
That the intrachain homology formed much earlier than the 
duplication of the whole precursor is indicated by the much greater 
conservation of nucleotides between the two B chains than between 
the two halves of each B chain. Of the 74 residues participating 
in the ricin intrachain homology which are identical in the 
agglutinin B chain, all but 9 have identical codons: much less 
mutation has occurred between the two types of B chain than 
between the two halves of each type.
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Fig 4-5
Comparison of the two halves of the agglutinin B chain, and their 
eDNA sequences. Upper line is the N-tenninal 134 residues, and the 
lower line the remaining residues, 135 to 262. Identical 
amino acids are enclosed in boxes.
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Thus che results obtained here strengthen the argument of 
Villafranca and Robertus. A possible series of events in the 
evolution of the castor bean lectins is as follows: 
first, there would be a primitive A chain gene and a primitive 
'half-B' chain gene. The 'half-B' gene would then duplicate to 
form the complete B chain gene. At some stage, probably after 
the formation of the whole B chain gene, the A and B chain genes 
would form a single expressing unit, which later would become 
duplicated. Subsequent nutations, under whatever influence of 
selection applied, would generate Che two lectin genes present today.
It is of interest that, during the sequencing of the 
C-terminus of the A chain and the linker sequence, a gel reading 
error showed that, given a deletion of a single base at the 
C-terminus of the linker, a passable signal sequence is produced.
This is 22 amino acids long, and has a signal-like hydropathy plot, 
shown in fig 4-6. In this region there are two base changes 
between ricin and the agglutinin, one changing an isoleucine to 
a valine, and one changing a threonine to an alanine.
The signal-like sequence overlaps the end of the A chain and the 
linker peptide. It is conceivable that the B chain gene, complete 
with signal peptide, became attached to the end of the A chain 
gene, in such a way as to delete the stop codon of the latter. 
Insertion of a base by mutation could then have restored the 
reading frame, leading to the expression of the heterodimer as a 
single-chain precursor. In time, the appropriate enzymatic 
processing mechanism would evolve to produce the correct product 
from this precursor. This is entirely speculative, and its 
elucidation may be achieved by analysis of genomic clones: if there 
is an incron in this region, then such a scenario is unlikely to
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be correct.
Future developments
The definitive identification of the two sequences presented here 
needs to be determined: the tentative identification is based 
only on the degree of similarity to the published protein 
sequences for the ricin chains; the accuracy of these may be 
questionable. Approaches to solving this problem have already 
been discussed, in section 3G1.
The most important advances related to the use of the clones 
have been in the inrnunotoxin field. Major problems have been encountered 
using native toxins for this purpose, and it is probable that the best 
toxic agent will be the whole ricin molecule, but lacking it3 
sugar-binding function, and its carbohydrate. Work is in progress 
on the construction of clones which will express the sequences in 
yeast, using the vector pMA91 (247; provided by A and S Kingsman).
Once expression of functional proteins is obtained, and adequate 
screening methods for alteration of function have been devised, 
a variety of mutagenesis techniques can be applied - libraries of 
nutagenised clones will be screened for loss of the galactose­
binding site. As well as providing clones suitable for the 
development of immunotoxins, however, characterisation of mutated 
sequences will help to elucidate the location and mechanism 
of the galactose-binding site, and the second fuction of the B chain 
in transmembrane penetration of the A chain.
As far as obtaining the modified protein in unglycosylated form 
is concerned, yeast mutants have been constructed which are 
deficient in N-linked glycosylation of proteins (324). If the 
appropriate product can be obtained from such cells, and if it can 
be correctly linked to sufficiently specific antibodies, then the
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remaining problem will be char of scale of producción.
Other possibilities for exploiting the clones include their 
use as probes for genomic lectin sequences - not only from castor 
beans, but also to determine any homologies between these and 
related proteins in other species - and further mutagenesis 
experiments may be of value in understanding the functions of the 
A chains. Mutants of the A chains with increased toxicity may even 
be found - these would be even better than non-mutant A chains 
in inmuno tox ins!
Conclusions
The work described here reports the determination of a new plant 
cDNA sequence, to be added to a small, but now rapidly growing 
group of such sequences. The castor bean lectin sequences 
contain features characteristic of comparable sequences - that is, 
they encode a single chain precursor which is post-translationally 
cleaved to form a disulphide-linked heterodimeric protein.
The precursor has a transiently associated signal sequence, and 
a short linker peptide is removed during processing of the translation 
product. Also, the 3' non-coding region is characteristic of plants, 
in that it contains multiple polyadenylation signals, and is of 
characteristic length, as is the 5' non-coding region.
Although there are unusual features - the tandem stop codon, 
and the upstream initiator codon - these have been observed before 
in plant systems.
The problems of definitively identifying the two sequences have 
been discussed, as have the possible uses of the clones, with 
special emphasis on the lmmunotoxin field.
The construction and characterisation of these clones is but the 
first of many steps, in a number of directions, towards the
achievement of a variety of ultimate goals, 
raises many questions....
Every answer
Sequences were analysed on an Apple II Europlus computer with 48 k 
8AM. Two such systems were used: one was equipped with a disk 
drive and a printer, and the other used tape storage and lacked 
a printer. Since the disk operating system uses sene 10,000 
bytes of RAM, this memory space was used for programing and data 
storage in the diskless system. This has the consequence that the 
restriction enzyme site searching progranme is unoperable on the 
disk system, as presented here. Where programme were run on both 
systems, the disk version is presented, the other differing in 
the memory areas used for sequence storage, and in instructions 
relating to disk control. For a description of the hardware and 
the programming languages used, see references 326-330.
The programming languages available on the Apple are the Appleso^ c 
dialect of BASIC, and 6502 machine code. The latter was used alone 
for the restriction sites progranme, because of its speed, and in 
combination with Applesoft as simple subroutines. These subroutines 
are stored in the BASIC segment of progracmes, and written into 
memory using READ...DATA instructions, and accessed by CALL 
commands. Routines and data are loaded into defined memory areas 
using POKE commands, and retrieved with the PEEK instruction.
There are three major advantages in using defined memory locations 
to store data: (i) the length of the sequence is limited only by 
the amount of memory available (in Applesoft the toaxinun character 
string length is some 255 characters); (il) machine code programmes 
can directly access the data, allowing fast-running progracmes; 
and (iii) data can be recoded into a format less arbitrary than 
letters of the alphabet, cutting down on ’irrelevant' processing 
tin. Thus, each nucleotide or combination of nucleotides was 
recoded as a number from 1 to 15: A,T,C and G were represented as
1,2,4 and 8 respectively, and uncertainties, such as 'A or T' were 
generated additively. Each base is consequently represented as 
a single bit in each byte: bits set to 1 contain information as to 
which base(s) is located at the position represented by the byte.
Simple logical comparisons can be performed on this data. For example, 
the AND function is able to detect similarities: if two bases being 
compared are identical, the product of AND is 0, whereas if they are 
different, the product is NOT 0; the zero flag in the processor 
status register being adjusted accordingly. Subsequent instructions 
can cause the programme to jump, branch or continue, in response to 
the zero flag, and thus to the result of the comparison.
Protein sequences were not re-encoded, except inasmuch as their 
amino acids were represented by ASCII codes. This does not 
allow comparisons such as are described above for nucleotides, but 
does allow long sequences to be stored and rapidly retrieved.
Programmes on the disk system were organised in a menu-driven 
format. The menu programs itself is not presented here, as it is 
trivially simple. Some of the programmes end with the statement 
"RUN MENU", vAiich allows a subsequent programme to be loaded for 
analysis of data already entered. Loss of data in response to the 
RUN command is prevented by prior execution of a HIMEM: instruction.
Each programme will be introduced, briefly annotated, and 
listed in full. References 326-330 will assist in the interpretation 
of instruction usage and syntax, and further information will 
be provided on request.
A number of other programmes were also used, but are not 
described here, either because they are very simple or because the 
results are not presented. These include programmes to determine 
base composition, dinucleotide frequencies, codon usage and
for plotting dot matrix homology plots.
SEQUENCE LOADER; NOTES & OOEMEOTS
The p r o g ra m m e  asks for input in the form of base or instruction codes. 
The former are letters representing bases or combinations of bases, 
as detailed below. Instruction codes are numbers, and allow clear 
screen presentation of sequence entered thus far, or corrections. 
Corrections can be changes, additions or deletions of bases. 
Alternatively, all data entered can be deleted and entering restarted.
Base and instruction codes
Basejcode _ Meaning________________ Instr code_ Meaning_____T “fcrint sequence £ Bid2 Print & continue3 Change base(s)4 Add base(s)5 Delete base(s)
6 Start again
1 ________ Ptint_paxt flf—sequence
S
TCGBDEFHIJKLM
N
or C or G or G or G
A flr_T_pt £  QC_G_
Programme functions are now described by line number.
Line_ _  _
3
20-50
80
90 - 160
Comments_____________ ___________________ _______
Protect memory above byte 25000. NB Sequence data start at 
byte 25003, with length at 25001 (lsb) and 25002 (msb).
Assign base code letters to CS 
Initialise base number
Gets and interprets each keypress. Line 100 detects a letter 
code & skips line 110, which directs the programme to the 
line specified by the number entry. GOSUB 900 is to a 
subroutine which converts the letter code to the number code; 
line 140 stores the result in memory.
2 1 7  -
260 - 
310 -
380 - 
500 -
599 - 
610 -
900 -
1000
1100
1300
2 0 0  - 258 GOSUB 1000 prints the end of the sequence on screen; lines 
220 - 240 determine and store the length of the sequence.
GOTO 610 is to the routine which handles hard copy 
and disk storage.
300 Prints last part of sequence on screen for checking 
and returns to get another base or instruction code.
370 Line 330 gets range for base changes; D is the no of the 
first base to change, and E is the no of bases to change.
Line 331 allows exit if routine called by error. Lines 
335-365 enter the new data, interpret it (ie GOSUB900) 
and store it in place of the old bases. Line 370 returns 
to "print DNA and continue".
440 Line 410 gets the range of bases to be added. Lines 420 - 
440 move following bases up in memory, and lines 450 - 485 
get the new bases and place them in position.
570 Line 510 gets the range: in this case, parameters are 
entered as strings, to allow input of "E" to mean 
"delete to end". Line 527 reduces the length parameter 
to D, if range is "E". Line 525 converts the string 
characters to tunerical values. Lines 530 - 550 move bases 
beyond the deletion down, and line 560 modifies the 
length parameter.
600 On "scrap entry" instruction, line 600 executes RUN.
800 If hard copy is required, subroutine at 1300 provides it.
If disk storage is required, line 790 handles this.
Line 800 then returns to the MENU progranme.
940 Compares the entered base code to all its possible values 
and assigns a lumber to the variable A. If no assignation 
is made, lines 932 - 935 announe an input error, and 
request a replacement base.
- 1070 Prints last 100 - 120 bases of sequence on screen, in
groups of 10 bases, 3 such groups per line. The lumber 
of the last base in the line is displayed at right.
-1210 Prints specified region of sequence on screen; format as above.
- 1370 As 1000 - 1070, escept that the whole sequence is printed.
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1 REM ***SEQUENCE LOADER***3 HIMEM: 250005 DIM C9(15)10 HOME20 FOR T - 1 TO 15 : READ CS(T) : NEXT 50 DATA A,T,B,C,D,F,J,G,E,H,K,I,L,M,N60 PRINT "SEQUENCE LOADER" : PRINT70 PRINT "ENTER BASE OR INSTRUCTION CODE" s PRINT80 N - 190 GET AS100 IF VAL(AS) - 0 THEN 120110 ON VAL(AS) GOTO 200,260,310.380,500,600,1100120 GOSUB 900130 PRINT AS;140 POKE 25002 + N, A 150 N - N + 1160 GOTO 90
200 REM ***PRINT DNA AND END***210 GOSUB 1000220 A - INT((N - 1) / 256)230 B - N - 1 - 256 * A240 POKE 25001,B : POKE 25002,A250 PRINT s PRINT N - 1; " BASES"258 GOTO 610
260 REM ***PRINT DNA AND CONTINUE***270 GOSUB 1000280 PRINT * PRINT s PRINT N - 1; " BASES"290 PRINT : PRINT "ENTER BASE OR INSTRUCTION OOI«"295 PRINT i PRINT300 GOTO 90
310 REM ***CHANGE BASES***325 PRINT : PRINT : PRINT : PRINT330 INPUT "CHANGE BASES__ENTER RANGE "s D,E331 IF E - 0 THEM 260333 PRINT s PRINT : PRINT "ENTER NEW BASES" : PRINT i PRINT 335 FOR T - 1 TO E340 GET AS345 PRINT AS;350 GOSUB 900360 POKE 25001 + D + T, A365 NEXT T370 GOTO 260
380 REM ***ADD BASES***400 PRINT : PRINT410 INPUT "ADD BASES....ENTER RANGE "} D,E415 IF E - 0 THEN 260 ___420 FOR T - N - 1 T 0 D + 1  STEP -1430 POKE 25002 + T + E, PEEK (25002 + T)
440 NEXT450 PRINT : PRINT t PRINT "ENTER NEW BASES" : PRINT : PRINT 
453 N - N ♦ E455 FOR T - 1 TO E460 GET AS > PRINT AS;465 GOSUB 900480 POKE 25002 ♦ D + T, A
219
485 NEXT490 GOTO 260500 REM ***DELETE BASES***505 PRINT : PRINT s PRINT510 INPUT "DELETE BASES__ENTER RANCE DS.ES520 IF Eg - "0" THEN 260 525 D - VAL(DÍ) : E - VAL(ES)527 IF ES - "E" THEN N - D s GOTO 260530 PORT-D + E T O N - 1540 PORE 25001 + T - E, PEEK(25002 + T)550 NEXT560 N - N - E570 GOTO 260
599 REM ***RESTART***600 RUN
610620640650660670680690700710730735737740750760770790800
REM ***FRINT HARD OOPY***PRINT : PRINT "HUNT SEQUENCE?" « GET ASIF AS ft "Y" THEN 730HOMEINPUT "NAME OF SEQUENCE? "; AS PR#1PRINT AS : PRINT : PRINT GOSUB 1300 PRINT s PRINT
PRI0PRINT s PRINTPRINT "STORE ON DISK? " : GET BS IF BS "Y" THEN PRINT CHRS(4)IF BS + "Y" THEN PRINT : PRINT CHRS(4);
IF LEN(AS) > 1 THEN 790PRINT : INPUT "NAME OF SEQUENCE? "} AS
"RUN MENU"
PRINT ORS(4)j "BSAVE";AS; ",A25001,L";N*2 PRINT s PRINT CHRS(4);"RUN MENU"
900910
920
930
931932933934935 940
RBI ***BASE CODE TO NUMBER CODE*** _A » (AS - "A") + 2 * (AS -"T") + 4 * (AS - "C") + 8 * (AS - 
IF A ^  0 THEM 940A -3 * (AS - "B") + 5 * (AS - "D") + 9 * (AS - "E") +
6 * (AS - "F") + 10 * (AS -"H") ♦ 12 * (AS -"I") i
AF„A7 * (AS^'J") ♦ 11 *(AS - "K") + 13 * (AS - "L"> ♦
15 * (AS - "N")IF A 0 THEN 940 CATi, 64477PRTWT , PRINT "INPUT ERROR...TRY AGAIN ...BASE CODES ONLY"
GET AS GOTO 910 RETURN
"G*
1000 REM ***PRINT DNA SUBROUTINE***
1010 HOME
1022 IfV - ’i < 130 THEN R - 1 t GOTO 1030
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485 NEXT490 GOTO 260500 rem ***DELETE BASES***505 PRINT : PRINT s PRINT510 INPUT "DELETE BASES... .ENTER RANGE Dg.Eg 520 IF Eg - "0" THEN 260 525 D - VAL(DjS) s E - VAL(Eg)527 IF Eg - "E" THEN N - D s GOTO 260530 POR T - D  + E T O N - 1540 POKE 25001 + T - E, PEEK(25002 + T)550 NEXT560 N - N - E570 GOTO 260
599 REM ***RESTART***600 RUN
610 REM ***FRINT HARD COPY***620 PRINT s PRINT "PRINT SEQUENCE?" : GET Ag 640 IF Ag i* "Y" THEN 730650 HOME660 INPUT "NAME OF SEQUENCE? "; Ag670 PR#1680 PRINT Ag : PRINT : PRINT690 GOSUB 1300700 PRINT : PRINT710 PR|0730 PRINT : PRINT735 PRINT "STORE ON DISK? " s GET Bg737 IF Bg "Y" THEN PRINT CHRg(4)740 IF Bg "Y" THEN PRINT s PRINT CHRg(4) ; "RUN MENU"750 IF LEN(Ag) > 1 THEN 790760 PRINT : INPUT "NAME OF SEQUENCE? "j Ag770 PRINT790 PRINT CHtg(4); "BSAVE";Ag; ",A25001,L";N+2800 PRINT ! PRINT CHRg(4);"RUN MENU’
900 REM ***BASE CODE TO NUMBER OOI«***910 A - (Ag - "A") + 2 * (Ag -"T") + 4 * (Ag - "C") + 8 * (Ag - "G"):IF A it 0 THEN 940920 A - 3 * (Ag - "B") + 5 * (Ag - "D") + 9 * (Ag - "E") +
6 * (Ag - "F") + 10 * (Ag -"H") + 12 * (Ag -"I") :IF Ag it 0 THEN 940930 A - 7 * (Ag - "J") + 11 *(Ag - "K"> + 13 * (Ag - "L") +15 * (Ag - "N")931 IF A it 0 THEN 940932 CALL 64477933 PRINT : PRINT "INPUT ERROR...TRY AGAIN ...BASE CODES ONLY"
934 GET Ag935 GOTO 910940 RETURN
1000 REM ***PRINT ENA SUBROUTINE***
1010 HOME1020 S - 0 « U - 01022 IF N - 1 < 130 THEN R - 1 : GOTO 1030
-  2 2 0  -
1024103010401050
10601070
1100
1110
112011301140115011601170
11801190
1200
1210
130013101320133013401350
13601370
R - 10 * INK (N - 1) / 10) - 109FOR T ■ R TO N - 1PRINT C$ (PEEK(25002 + T));S - S + 1 : I F S - 1 0  THEN PRINT " s S - 0 t U - U + 1 :IF U - 3 THEN PRINT " ";T s PRINT « U - 0
NEXTRETURN
REM ***PRINT PART OF SEQUENCE***PRINT : PRINT t PRINTINPUT "ENTER PRINT RANGE D,E
HOMES - 0 t U - 0FOR T - D TO EPRINT C0 (PEEX(25002 + T)>; _ - „S - S + 1 i IF S ■ 10 THEN PRINT " : S - 0 * UIF U - 3 THEN PRINT " "iT : PRINT : U - 0
NEXTPRINT : PRINT : PRINT PRINT "ENTER INSTRUCTION CODE ": GET A ON A GOTO 200,260,310,380,500,600,1100
REM ***PRINT HARD COPY SUBROUTINE***
HOMES - 0 : U - 0FOR T - 1 TO N - 1 PRINT C$ (PEEK(25002 + T>);S - S + l  : IF S ■ 10 THEN PRINT " S
U + 1 »
IF U - 3 THEN PRINT "NEXTRETURN
";T : PRINT s U - 0
s U - U + 1 t
-  2 2 1  -
The DNA sequence entered by SEQUENCE LOADER, or from disk, is used 
to generate amino acid sequences from all six possible reading frames. 
The first three frames start at the first, second and third bases, 
using the sequence as entered, assisting that it is 5' to 3'.
Note that the DNA sequence must be absolutely certain.
One-letter amino acid codes are stored in a three-dimensional array, 
indexed by numbers 1-4. Since the sequence is stored in terms 
of numbers 1,2,4 & 8, a machine code routine carries out the 
appropriate conversion - for the complementary frames, a second 
machine code routine converts 1,2,4 & 8 into 2,1,8 & 4 respectively. 
These routines are stored in READ...DATA statement in the BASIC 
prograrane. Operation requires only the entering of the sequence
TRANSLATION: MOTES & OCEMENTS
Lire_rnjnber 
20-80 
100 - 140 
142 
150
160 - 190
200
201 - 206 
210 & 390 
300 & 370 
310 - 350 
360 
400
Comments___________________________________
Store one-letter codes in 3-dimensional array.
Store machine code subroutine on p3 of memory,
Switch on printer (later switched off by PR#0)
Read sequence length
Read reading frame parameters; MS - title of frame;
CA - adrs of machine code subroutine; D - direction 
of translation
Reading frame parameters: S - first base in specified frame
Reading frame parameters: E - last base
Control loop calling each frame in turn
Control loop reading through DNA sequence
Determine indexes for array containing AA codes
Print appropriate one-letter AA code
Return_to MENU_prograirae__________________________
2 2 2  -
5 REM ***TRANSLAIION***7 HIMEM: 2000010 HOME20 DIM WS(4,4,4)30 FOR X - 1 TO 440 FOR Y - 1 TO 450 FOR Z - 1 TO 460 READ WS(X,Y,Z)70 NEXT Z,Y,X80 DATA K,N,N,K,I,I,I,M,T,T,T,T,R,S,S,R,*,Y,Y,*,L,F,F,L,S,S,S,S,*,C,C,W,Q,H,H,Q,L,L,L,L,P,P,P,P,R,R,R,R,E,D,D,E, V,V,V,V,A,A,A,A,G,G,G,G 100 FOR N - 768 TO 823110 READ A120 POKE N,A130 NEXT140 DATA 165,8,201,1,208,1,96,201,2,208,1,96,201,4,208,5,169,3,133,8,96,169,4,133,8,96,165,8,201,4,208,1,96,201,1,208,5,169,2,133,8,96,201,2,208,5,169,1,133,8,96,169,3,133,8,96141 INPUT "NAME OF SEQUENCE? AS142 PR#1143 PRINT AS144 PRINT : PRINT150 L - PEEK<25001) + 256 * PEEK(25002)160 FOR N - 1 TO 6170 READ MS(N), CA(N), D(N)180 NEXT190 DATA RF1,768,1.RF2,768,1,RF3,768,1.CRF1,794,-1.CRF2,794,-1,CRF3 794 -1200 S(l) - 1 s S(2) - 2 : S(3) - 3 s S(4) - L : S(5) - L - 1 :S(6) - L - 2201 E(l) - 3 * INT(L / 3) - 2202 E(2) - 3 * INK (L - 1) / 3) - 1203 E(3) - 3 * INT((L - 2) / 3)204 E<4) - L - 3 * INT(L / 3) + 2205 E(5) - L - 3 * INK(L - 1) / 3) + 1206 E(6) - L - 3 * INT((L - 2) / 3)210 PGR P - 1 TO 6220 PRINT MS(P)300 FOR Z - S(P) TO E(P) STEP 3 * D(P)310 FOR N - 0 TO 2320 POKE 8, PEEK(25002 ♦ D(P) * N + Z)330 CALL CA(P)340 W(N) - PEEKC8)350 NEXT N360 PRINT WS(W(0),W(l),W(2))t370 NEXT Z380 PRINT * PRINT390 NEXT P392 PR#0395 PRINT : PRINT "PRESS ANY KEY TO RETURN TO MENU " : GET AS 
397 PRINT400 PRINT CHRS(4); "RUN MENU"
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This program* is written entirely in machine code, and comprises 
four parts: (1) the main control loop, located at $7D01;
(2) NFILE, the file of restriction enzyme names, at $7531,
which also contains the actresses of the restriction enzyme recognition 
sequences, and the lengths of the sequences; (3) the list of 
recognition sequences, at $7F01; and (4) a number of subroutines 
which start at $8100. These subroutines are: (1) ADD1, which increments 
a two-byte runber on the zero page, at $8100; (2) PRNFILE, at $8120, 
tfiich displays the name of the current restriction enzyme on screen;
(3) RDADRS, at $8170, which reads the adress of the current enzyme's 
recognition sequence, and places it in a location accessible by the main 
programme, and also reads its length.
The main programme starts by initialising a number of variables, 
and by printing the first message ("RE SITES") in the NFILE on screen.
The programme then enters the main control loop by calling the next 
entry in NFILE. If this is $FF, with which NFILE must end, then the 
programme prints the message "END" on screen, and ends. Otherwise, 
the next NFILE entry is displayed on screen, and the adress and 
length of the current enzyme are read. The first base of the RE 
sequence is then comapred with the first base of the DNA sequence, 
the variable measuring the latter being incremented. If these two 
bases are different, a test is performed to determine whether the 
whole DNA sequence has been examined; if so, the programme 
reinitialises parameters relating to it, and returns to get the 
next enzyme sequence. If the end of the DNA sequence haw not been 
reached, the next base is compared with the first RE sequence base.
When the first RE sequence base is the same as a base in the 
DNA sequence, the position of the latter is stored and a 
variable (the "+ counter") is incremented. The next base in the 
RE is then compared with the next in the DNA sequence,
and a test is performed to determine whether a complete site has
found. If not, then the next 2 bases are compared, and so on 
until either a complete recognition sequence is found, or until 
a mismatch is found. In the latter case, the programme returns to 
the main loop and looks at the next base in the DNA sequence. If a 
complete RE site is found, its location In the DNA sequence is printed
RE SITES
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and the programs returns to examine the next base in the DNA 
sequence.
These events are suoraarised in the flow chart presented on the 
next page. Programs control variables are located on the zero page, 
and are listed below:
Adre8s_(£)_____________ Name__________________________
6,7 NFILE current address
8,9 RE-FILE current address
18 RE-FILE current length minus one
19 ENDFLAG
1A.1B DNA sequence current address
1C,10 Current base number (hexadecimal)
IE,IF Last base number
4A,4B RE-FILE address working location
4D ♦ counter
CE,CF DNA sequence address working location
EBaEC,ED_______________Current base_rajmber Cbod^_________
The programme is used as follows: it is loaded from tape by 
entering the system monitor with CALL-151, and loaded with the 
instruction 7531.8190R. (Note that a DNA sequence must be loaded 
with loader - both programmes can reside in memory at the
same time, so the sequence can be loaded after loading RE SITES, 
as long as RE SITES is not run without a sequence in position.)
RE SITES is then run with the instruction 7D01G. After each 
enzyme search the computer beeps; the next search is initiated by 
pressing any key.
The program» is listed on following pages in assembler 
format, though JSR and JMP destination addresses have been replaced 
with mnemonics.
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and Che program» returns to examine the next base in the ENA 
sequence.
These events are summarised in the flow chart presented on the 
next page. Programs control variables are located on the zero page, 
and are listed below:
Adress ($) Name
6,7 NFILE current address
8,9 RE-FILE current address
18 RE-FILE current length minus one
19 ENDFLAG
1A.1B DNA sequence current address
1C,ID Current base number (hexadecimal)
IE,IF Last base number
4A,4B RE-FILE address working location
4D + counter
CE.CF DNA sequence address working location
EB.EC.ED Current base number (bed)
The programme is used as follows: it is loaded from tape by 
entering the system monitor with CALL-151, and loaded with the 
Instruction 7531.8190R. (Note that a DNA sequence must be loaded 
with sequence loader - both programme can reside in memory at the 
same time, so the sequence can be loaded after loading RE SITES, 
as long as RE SITES is not run without a sequence in position.)
RE SITES is then run with the instruction 7D01G. After each 
enzyme search the computer beeps; the next search la initiated by 
pressing any key.
The programs is listed on following pages in assembler 
format, though JSR and JMP destination addresses have been replaced 
with mnemonics.
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RE SITES: Flow chart
P r in t iy /6an,Dl « t S ss s Inc ♦
r a iu lc •— n M j e  l l t t l / 1 counter
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The RE file
This begins at address $7F01, and contains the RE sequences, 
encoded as described in the notes for SEQUENCE LOADER.
Each sequence follows directly on from the one proceeding it, 
giving it a continuous series of bases. The loactions of the 
first base in each sequence are stored in NFILE, as is the length 
(minus one).
THE NFILE
This contains a series of messages to be printed on the screen.
Apart from the first two, each one also contains the address within 
the RE file of the appropriate sequence, and the length - 1 of the 
recognition sequence.
The first message is displayed at Che end of the programme, 
and is as follows:
7531 C5 CE C4 FF END FF Indicates end of programme
This file entry should under no circumstances be changed, as its 
address, and that of the second file entry, are contained In the 
main programme loop.
The second entry is displayed at the beginning of the 
programme, and may be changed according to the nature of the 
searches being conducted. In the present case it contains the 
message "RE SITES" :
7535 D2 C5 A0 D3 C9 D4 C5 D3 00
The 00 at the end must be added to inform the programme main loop 
t-hmr the message has ended. Note that messages are represented by 
the ASCII codes of their characters. These are found in the 
Apple II Refemce Manual plS.
Subsequent entries contain the RE name in ASCII codes, 
followed by 00 to indicate end of entry, followed by the address of 
the in»q’v*r‘™  (msb first), then by the length of the sequence - 1. 
Entries follow continuously, and the last one is followed by $FF, 
which Indicates end of NFILE.
RE SITES: LISTING
7D01 20 58 FC JSR CLRSCRN7D04 A9 00 LDA #$00 ENDFLAG Inlt7D06 85 19 STA $197D08 A9 35 LDA #$35 Init NFILE adrs to $75357D0A 85 06 STA $067D0C A9 75 LDA #$757D0E 85 07 STA $07
7D10 20 20 81 JSR PRNFILE Print "RE SITES"
7D13 20 8E U JSR CROUT7D16 20 8E FD JSR CROUT
7D19 A9 42 LDA #$42 Init DNA sequence adrs7D1B 85 1A STA $1A to $9C427D1D A9 9C LDA #$9C7D1F 85 IB STA $1B
7D21 A9 00 LDA #$00 Init both base counters7D23 85 1C STA $1C to $007D25 85 ID STA $1D7D27 85 EB STA $EB7D29 85 EC STA $EC7D2B 85 ED STA $ED
7020 20 20 81 JSR PRNFILE Print RE name
7D30 A5 19 LDA $19 ENDFLAG test7D32 C9 01 CMP #$017D34 00 01 BNE $7D37 Brach if clear7D36 60 RTS End programne if set
7037 20 8E FD JSR CROUT7D3A 20 8E FD JSR CROUT7D3D 20 70 81 JSR RDAERS Read adrs of RE sequencefrom NFILE
7D40 38 SEC Init last base7D41 AD 41 9C LDA $9C417D44 E5 18 SBC $187D46 85 IE STA $1E7D48 E9 00 SBC #$007D4B 85 IF STA $1F7D4F A2 1C LDX #$1C Inc hexadecimal base counter7D51 20 00 81 JSR ADD1
7054 F8 SED Inc bed base counter7D55 18 CLC
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7D5D B5 EB IDA $EB,X7D5F 69 01 ADC #$017D61 95 EB STA $EB,X7D63 C9 00 CMP #$007D65 F0 FI BEQ $7D587D67 D8 CLD
7D68 A2 1A LDX $1A7D6A 20 00 81 JSR ADDI
7D6D A0 00 LDY #$007D6F Bl 1A LDA ($1A),Y
7D71 31 08 AND ($08),Y7D73 D0 27 BNE $7D9C
7D75 A5 1C LDA $1C7D77 C5 IE CMP $1E7D79 F0 03 BEQ $7D7E7D7B 4C 4F 7D JMP $7DAF7D7E A5 ID LDA $1D7D80 C5 IF CMP $1F7D82 F0 03 BEQ $7D877D84 AC 4F 7D JMP $7DAF
7D87 20 DD FB JSR BELLI7D8A 20 0C FD JSR RDKEY7D8D 20 58 PC JSR CLRSŒN7D90 AC 19 7D JMP $7D19
7D93 EA X  9 NOP codes
Jump to here on bases same:
7D9C A5 08 LDA $087D9E 85 AA STA $AA7DA0 A5 09 LDA $097DA2 85 AB STA $4B
7DAA A5 LA LDA $1A7DA6 85 CE STA $CE7DA8 A5 IB LDA $1B7DAA 85 CF STA $CF
7DAC A9 00 LDA #$007DAE 85 AD STA $AD
7DB0 A2 AA LDK $AA7DB2 20 00 81 JSR ADDI
7DB5 A2 CE LDK $CE7DB7 20 00 81 JSR ADDI
Inc current DNA address
LDA current DNA base
Compare with RE base Branch if bases sane
End of DNA sequence? No... jimp to $7DAF Yes. .continue
Beep the speaker Get keypress
Jump to next enzyme
Space to allow programme modification
Transfer RE-FILE adrs to working location
Transfer DNA sequence address to working location
I nit + counter
Inc RE-File adrs in working location
Inc DNA adrs In working location
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7DBA A0 00 LDY #$007DBC B1 CE LDA ($CE),Y
7DBE 31 4A AND ($4A),Y
7DC0 D0 03 BNE $7X57DC2 4C 75 7D JMP $7D757DC5 E6 4D INC $4D7DC7 A5 4D LDA $4D7DC9 C5 18 CMP $187DCB D0 E3 BME $7DB07DCD EA x 10 NOP codes
7DD7 A5 ED LDA $ED7DD9 20 DA FD JSR PRBYTE7DDC A5 EC LDA $EC7DDE 20 DA FD JSR PRBYTE7DE1 A5 EB LDA $EB7DE3 20 DA FD JSR PRBYTE7DE6 20 48 F9 JSR PRBLNK
7DE9 4C 75 7D JMB $7D75
LDA DNA base
Compare with RE base
Branch if sameReturn if differentInc + counterTest for complete RE site
Next pair of incomplete Space for modification
Print result on screen
Return to ENDTEST
Subroutine: ADD1
Increments a 2-byte nuriber on the zero page; needs the address of the first of these (the lsb) in the X register on entry.
8100 8A TXA8101 8D 08 81 STA $81088104 8D 0A 81 STA $810A8107 E6 00 INC $008109 A5 00 LDA $00810B C9 00 CMP #$00810D F0 01 BEQ $8110810F 60 RTS8110 E8 INC X8111 8A TXA8112 8D 16 81 STA $81168115 E6 00 INC $008117 60 RTS
lsb into INC instruction lsb into LDA instruction Inc lsbTransfer to accumulator Inc msb?Yes...go and do it No....return
msb into INC instructionInc msbReturn
Subroutine: PRNFILE
Prints c t i of current entry in NFILE. Each byte is tested for $FF, which indicates no more RE nan» files, and then for $00, which indicates end of current entry. NFILE current address is incremented 
for every byte read.
812081228124
A0 00 B1 06C9 FF
LDY #£00 LDA ($06).Y CMP #$FF
Load byte from NFILE 
End of programme?
8126 F0 17 BEQ $813F Yes...goto endroutine8128 B1 06 LDA ($06),Y Reload byte from NFILE812A C9 00 CMP #$00 End of current entry?812C D0 06 BNE $8134 No...goto print character812E A2 06 LDX #$06 Inc NFILE address8130 20 00 81 JSR AD018133 60 Return
8134 20 F0 FD JSR C0UT1 Print character8137 A2 06 LDX #$06 Inc NFILE address8139 20 00 81 JSR ADD1813C 4C 22 81 JMP $8122 Get next byte from NFILE
813F A5 19 LDA $19 ENDFLAG set?8141 C9 00 CMP #$008143 D0 0F BNE $8154 Yes...Goto return8145 A9 01 LDA #$01 Set ENDFLAG8147 85 19 STA $198149 A9 31 LDA #$31 Set NFILE adrs for "END"814B 85 06 STA $06 message814D A9 75 LDA #$75814F 85 07 STA $078151 4C 20 81 JMP $8120 Prine "END" from NFILE8154 60 RTS Return
Subroutine: RDAERS
This reads the address of the first byte of the current enzyme In the NFILE, storing it in $08, $09. It then reads the (length - 1) of the recognition sequence and stores it in $18.
8170 A0 00 LDY #$00 lab goes into $088172 B1 06 LDA ($06),Y8174 85 08 STA $08
8176 A2 06 LDX #$06 Inc NFILE address8178 20 00 81 JSR ADDl
817B B1 06 LDA ($06),Y msb goes into $09817D 85 09 STA $09
817F A2 06 LDA #$06 Inc NFILE address8181 20 00 81 JSR ADDl
8184 B1 06 LDA ($06),Y Length - 1 goes into $188186 85 18 STA $18
8188 A2 06 LDX #$06 Inc NFILE address818A 20 00 81 JSR ADDl
818D 60 RTS Return
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Protein Hydropathy» Note« *■ r/nnwnra
Hydropathy values for Individual amino acids were obtained from 
reference 235. These are averaged over a specified number of 
residues (the span) and the result is plotted against the 
position In the polypeptide chain of the first residue In the span.
Line
15
20-40
Comments
Reserve memory above 20000
Read hydropathy values into variable A, indexed by ASCII 
codes for single letter amino acid codes.
50 -100 Enter sequence name, and sequence, and poke latter Into 
memory locations starting at 20001.
110
120
140
Adjust length variable.
Print sequence on screen for checking.
END programme to allow for error correction. This Is done by 
calculating position of error (ie position In sequence 
■•■20000), and POKEing the ASC function of the character into 
this location, in immediate mode.
200
210
220-310
Determines horizontal distance plotted per residue.
Switch on prlnter/plotter and adjust origin of graph.
Draw axes with markers. GET lines (285,305) stop the programs 
to allow adjustment of paper position in plotter.
320
340-400
350-380
Enter span variable.
Control loop for calculations.
Reset hydropathy variable, then accumulate hydropathies 
over the set span.
390
410-460
Calculate average hydropathy over the span and plot it. 
Print name of sequence and span, then ask If another span, 
or another sequence, Is required.
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1015
203040
5051 55 60 70 80 90 
100 
110 
120 130 140
200205
210
220230250270
280290300
305310320330340350360370380390400410420430440450460
REM ***HYERQPATHY***HIMEM: 20000 DIM A(89)FOR N - 65 TO 89 : READ A(N) : NEXTDATA 1.8,0,2.5,-3.5,-3.5,2.8,-.4,-3.2,4.5,0,-3.9,3.8,1.9,-3.5,0,-1.6,-3.5,-4.5,-.8,-.7,0,4.2,-.9,0,-1.3 HOMEPRINT "ENTER SEQUENCE NAME " : INPUT NS : PRINT : PRINT PRINT "ENTER SEQUENCE " : PRINT : PRINT : PRINT 
Q “ 1GET AS : PRINT AS; s IF AS - "Z" THEN 110 POKE 20000 + Q, ASC(AS)
Q - Q ♦  1GOTO 70HOME : Q - Q - 1FOR A - 1 TO Q : PRINT CHRS(PEEK(20000 + A)); : NEXT PRINT t PRINTPRINT "CORRECT ANY ERRORS" : PRINT s PRINT "THEN TYPE GOTO 200" : ENDHOME s INPUT "PLOT POINTS PER RESIDUE? Y 
PRI1PRINT CHRSC18); "I"; "M0.-999"; "I"C - 799 - C * QPRINT "L0"; M200,"C; "D200,999,0,999,350,999"PRINT "M200.999"FOR T - 999 TO C STEP - 50 * Y s PRINT "M200,'T s PRINT "D250,"T : NEXT s PRINT "M200.999"GET CS PRI1FOR T - 999 TO C STEP - 10 * Y : PRINT "M200,"T ; PRINT "D210,"T s NEXT s PRINT "M200.999"
(XT CS PRI0HOME t PRINT "ENTER SPAN " t INPUT S 
PRI1FOR N - 1 T 0 1 + Q - S  H - 0FOR P « 0 TO S - 1 H - H + A(PEEK(20000 + N + P))NEXT PPRINT "D"200 + 30 * H / S, 999 - Y * N 
NEXT NPRINT "M0,950"; "Ql"PRINT : PRINT "P"; NS; " SPAN - "; SPRINT "M0,"C - 100PR|0HOME t PRINT "ANOTHER PLOT? " : GET XS ; IF XS - "Y" THEN 200 PRINT : PRINT "ANOTHER SEQ? " t GET XS : IF XS - "Y" THEN RUN
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HYDROPATHY DIFFERENCE: NOTES & CO*EOTS
Values for hydropathies of individual amino acids are as in HYDROPATHY. 
This programme functions in the same way as the previous one, but 
stores two sequences, no 1 at byte 30000 and no 2 at byte 32000.
As the programne steps through the sequences, the average hydropathy 
value is calculated for both sequences simultaneously, and the 
difference is plotted. Since the operation of the progranme is 
the same as that of HYDROPATHY, no further details are given here.
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1015
2030
100
110
120130140150160180190
200
210
220250260265270300310360
370380390
395397400410420430460450460470480490
500510
REM ***HYEROPATHY DIFFERENCE***HIMEM: 30000
DIM A(89) : FOR N « 65 TO 89 : READ A(N) s NEXT DATA 1.8,0,2.5,-3.5,-3.5,2.8,-.4,-3.2,4.5,0,-3.9,-3.8,1.9,-3.5,0,-1.6,-3.5,-4.5,-.8,-.7,0,4.2,-.9,0,-1.3 FOR N - 0 TO 1 : HOMEPRINT "ENTER NAME OF SEQ N + 1 s INPUT AS <N + 1)PRINT : PRINT "ENTER SEQ N + 1 : PRINTIF N - 0 THEN PRINT "SEQ 2 IS SUBTRACTED FROM SEQ 1" : PRINTB - 1GET A$ : PRINT AS; : IF A3 - "Z" THEN 200 POKE 30000 + B + 2000 * N, ASC(AS)B - B + 1 GOTO 150PRINT : PRINT "CORRECT ANY ERRORS" : PRINT IF N - 0 THEN PRINT "THEN TYPE GOTO 250" s END PRINT "THEN TYPE GOTO 260" : END NEXT NHOME i PRINT "ENTER SPAN "; S 
PRI1PRINT CHti(18); "I" s C - 4 * B s PRINT "M0.-999"; "I"PRINT "M200," 999 - C; "D200, 999"; "M0.999"PRINT "D400.999"; "M200.999"FOR T - 999 TO 999 - C STEP -200 s PRINT "M200,"T s PRINT "D250,'T : NEXT : PRINT "M200.999"GET D0 PR#1FOR T - 999 TO 999 - C STEP -40 : PRINT "M200,"T s PRINT "D210,"T : NEXT s PRINT "M200.999"GET Dg PRI1FOR N - 1 TO B - S H(l) - 0 < H(2) - 0 FOR P - 0 TO S - 1H(l) - H(l) + A(PEEK(30000 + N + P))H(2) - H(2) + A(PEEK(32000 + N + P))NEXT PD - (H(l) - H(2)) / SPRINT "D"200 + 50 * D","999 - 4 * N
NEXT NPRINT "M10,980"; "Ql"; "PHYEROPATHY DIFFERENCE: "; AS(1);" - "; A$(2); " SPAN - "; S PRINT "M0,"900 - C 
PR#0
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Secondary structure prediction programme
The prediction method of Gamier et al (331) was used, since a 
comparison of various methods (332) found that it is methodologically 
simpler, more computer-adaptable and more objective than others, 
including that of Chou and Fasman (333).
The sequences were first analysed with both decision constants 
set to zero, as suggested by Thornton & Taylor (334). This 
indicated that the A chains are possible beta/alpha proteins (as 
categorised by Thornton & Taylor), while the B chains are all-beta 
proteins, having only about 5 X of alpha structure. Again, on the 
suggestion of Thornton & Taylor, the A chains, as possible 
beta/alpha proteins, were reanalysed with the alpha decision constant 
set to 100. This reduced its predicted alpha content to 9.2 X, 
putting it into the all-beta category.
The programme starts by setting up a three-dimensional array of 
4 x 25 x 17 elements. The first dimension refers to the 
conformational states alpha, extended, turn and coll, that is to tables 
1 to 4 in ref 331. The second dimension represents the one-letter 
irtnn acid codes (the unused ones are filled with zero's). The third 
dimension refers to the relative position of the amino acid to the 
one whose conformational state is being predicted. The programme 
then loads sequence data as ASCII codes, and runs through the sequence 
evaluating the informational parameters S(1 - 4) for each amino acid 
residue. For each, the largest is selected, and indicates 
which conformational state is most likely for that residue.
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10
2030405060708085to880
1000
10101015
10201025103010401050
1100
1110
11201130114011801190
1200
1210
1220123012401243124512501260129013001310132013301335133713401360137013801390
5 HIMEM: 30000REM ***GARNIER PROT PREDICTION***
UTMIT
DIM A(4,25,17)POR N - 1 TO 4 FOR P - 1 TO 25 FOR Q - 1 TO 17 READ A(N,P,Q)NEXT Q,P,N
DATA statements
HOMEPRINT "ENTER AA SEQUENCE" : PRINT : PRINT L - 1GET AS : PRINT AS;IF AS - "Z" THEM L - L - 1 : GOTO 1100 POKE 30000 + L, ASC(AS)L - L + 1 GOTO 1020REM ***DECISION CONSTANTS***HOMEPRINT "DECISION CONSTANTS" s PRINT s PRINT INPUT "DC-ALPHAs ";DA s PRINT ; PRINT INPUT "DC-EXTEN: ";DE REM ***CALCULATIONS***
HOME : K - 0 FOR N - 9 TO L - 8S(l) - 0 : S(2) - 0 : S(3) - 0 : S(4) - 0 FOR M - -8 TO 8 FOR P - 1 TO 4S(P) - S(P) ♦ A(P,PEEK(30000 + N + M) - 64, M + 9) 
NEXT P NEXT MS(l) - S(l) - DA S(2) - S(2) - DE X - S(l) « Y - 1IF S<2) > X THEN X - S(2) i Y - 2 IF S(3) > X THEN X - S(3) : Y - 3 IF S(4) > X THEN X - S(4) i Y - 4IF K - 0 THEN PRINT Y : K - 1 : GOTO 1340 PRINT Y; " : K - K + 1 j  IF K - 21 THEN K -IF N - 149 THEN CALL 64477 : GET XS : HOME 
NEXT NINPUT "NEH X'S? "; XS IF XS - "Y" THEN 1100PRINT » PRINT : INPUT "ANOTHER SEQUENCE? "; XS 
IF XS - "Y" THEN
1 :
)
PRINT
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Appendix 2: Restriction sites and maps
Restriction sites were located in the two lectin sequences using the 
program» described in Appendix 1. Recognition sequences were 
obtained from a chart supplied by BRL (1983 edition). Only one 
enzyme per recognition sequence was examined. In the table below, 
numbers refer to those given in figs 3H-1 and 31-1 for preproricin 
and preproagglutinin respectively; the absence of a number indicates 
the absence of a recognition sequence.
Enzyme Preproricin Preproagglutinin
Aatl
Aatll
AccI
Aflll
AflIII
Ahalll 1509 1506
Alul 58,78,105,200,479,756,977 58,78,105,200,753
Apal
AsuII 479
Aval
Avail 424 421
Avalll 233 233
Avril
Ball 946,1473 943,1470
BamHI -42,852,1551 -42,849,1548
Bbel
Bbvl 532,1084,1159 240,529,1156
Bell
Bgll
Bglll 589,1141 586
Blnl -42,852,1446,1551 -42,598,849,1443,
BsePI
BstEII 1591,1610 1607
BstXI
Continued....
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Enzyme Preproricin Preproagglutlnin
Cfrl 946,1473 943,1470
Cl «I 338
Dde I -34,397,444,476,857,1385 -34,394,441,473,854,1382
EcoPI -26,889,1282 -26,391,886,1144
EcoP15 1082 38,1051
EcoRI 913
EcoRII
EcoRV
219
FnuAHI 532,1084,1159 248,251,529,1156
FokI -74,222,280,513,909, -74,222,280,327,510,
Gdill
1466,1484 1463,1481
Haell 447 444
Haelll
Hgal
HglAI
815,947,1459,1474 812,944,1456,1471
HgiCI
HgiDI
822,1180 1177
HglEII 34,1601 1598
Hhal
HincII
Hindlll
266,448,564,776 84,254,266,445,773
Hinel 348,1006 348,478,1003
Hinfl
Hpal
539,658,917,1052,1417 477,536,655,969
Hpall -99, 585,1048 -99,582
HphI 227,1591 227,907,1059,1575
Kpnl 822,1180 1177
Mbol -41,590,601,853,1010,1065, -41,587,598,850,1007,1139
1142,1446,1547,1552 1443,1544,1549
MboII
Mlul
295,914 295,910,917
Mill -95,-35,-12,433,436,553, -95,-35,-12,389,430,550,778
781,1321,1384,1449,1469,
1542,1582
1318,1381,1446,1466,1539
83,772
Continued....
Enzyme Preproricin Preproagglutinin
Mstll
Nael
-35 -35
Neil -99,1048 -99
Ncol
Ndel
Nrul
NspBII
Nso7S24 I
Nsp7524 II
Paci
1587 1584
Pvul
PvuII
1546 1543
Rsal
Sali
464,579,726,823,1041,1181 543,576,723,1076,1178,1325
Sau96I
Seal
424,1459
463
421,1456
ScrFI -99,219,1048 -99
SfaNI
Smal
Snal
SphI
SSCI
Sstll
seul
298,512,773,967,1093,1465 43,298,509,770,1414,1462
Taql 339,410,882,1008 480,879,920,1005,1119
Thal
Tthlll I
85 253
Tthlll
Xbal
Xhol
II 9,137,843,1288,1294 9,137,694,840,1021,1285,1291
XhoII
Xmalll
-42,589,852,1141,1551 -42,586,849,1188,1548
N
e
il
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